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To	   study	   the	   impact	  of	   incubation	   solution	   complexity	  on	  protein	  deposition	   to	   silicone	  hydrogel	   (SH)	  




The	  SH	  materials	  investigated	  in	  this	  thesis	  included	  senofilcon	  A	  (SA),	  lotrafilcon	  B	  (LB),	  and	  balafilcon	  A	  
(BA).	  Contact	  lenses	  were	  incubated	  in	  both	  a	  simple	  saline	  solution	  containing	  only	  one	  protein	  and	  a	  
more	   complex	   artificial	   tear	   solution	   (ATS)	   containing	   numerous	   proteins,	   lipids,	   and	  mucins.	   Protein	  
deposition	  was	  determined	  at	  days	  1,	  7,	  14,	  and	  28.	  
	  
• For	   the	   first	   in	   vitro	   experimental	   chapter	   (Chapter	   3),	   125Iodine	   radiolabeled	   albumin,	  
lactoferrin,	  and	   lysozyme	  were	   the	  proteins	  of	   interest.	  Protein	  deposition	   to	   the	  different	  SH	  
contact	  lenses	  was	  quantified	  using	  a	  gamma	  counter.	  	  
• For	   the	   second	   in	   vitro	   experimental	   chapter	   (Chapter	  4),	   125Iodine	   radiolabeled	   lysozyme	  was	  
the	  protein	  of	   interest	  and	  the	  effect	  of	  a	  contact	   lens	  care	  regimen	  (OPTI-­‐FREE	  RepleniSH)	  on	  
lysozyme	  deposition	  to	  SH	  lenses	  was	  determined.	  	  
	  
The	  effect	  of	  contact	  lens	  cleaning	  solutions	  on	  lysozyme	  activity	  and	  removal	  was	  also	  determined.	  	  
	  
• For	   the	   third	   in	   vitro	   experimental	   chapter	   (Chapter	   5),	   the	   effect	   of	   cleaning	   solutions	   on	  
lysozyme	  activity	  was	  determined.	  OPTI-­‐FREE	  RepleniSH	  (OFR),	  BioTrue	  (BT),	  and	  Clear	  Care	  (CC)	  
were	  the	  cleaning	  solutions	  used	  in	  this	  study.	  Lysozyme	  activity	  was	  determined	  at	  hours	  1,	  12,	  






The	   three	   proteins	   investigated	   exhibited	   unique	   deposition	   profiles	   which	   were	   impacted	   by	   the	  
complexity	   of	   the	   incubation	   solution	   and	   the	   SH	   materials.	   In	   Chapter	   3,	   BA	   lenses	   incubated	   in	   a	  
complex	   analogue	   of	   the	   human	   tear	   film	   accumulated	   the	   most	   lysozyme	   and	   albumin.	   Lactoferrin	  
deposited	  in	  greater	  amounts	  when	  LB	  lenses	  were	  incubated	  in	  a	  simple	  saline	  solution	  containing	  only	  
lactoferrin.	  Protein	  deposited	  similarly	  on	  SA	  lenses,	  independent	  of	  incubation	  solution	  used.	  	  
	  
In	   Chapter	   4,	   the	   cleaning	   efficacy	   of	   OFR	  was	   determined	   for	   different	   SH	  materials.	   Lysozyme	  was	  
more	   efficiently	   removed	  when	   both	   SA	   and	   LB	   lenses	  were	   incubated	   in	   a	   complex	   ATS.	   As	   seen	   in	  
Chapter	   3,	   SA	   lenses	   were	   not	   impacted	   by	   the	   complexity	   of	   the	   incubation	   solution.	   The	   protein	  
removal	  efficacy	  of	  multi-­‐purpose	  solution	   (MPS)	   for	  BA	   lenses	  was	  similar	   independent	  of	   incubation	  
solution	   used.	   BA	   lenses	   incubated	   in	   ATS	   attracted	   the	   greatest	   amount	   of	   lysozyme;	   however,	   LB	  
lenses	  incubated	  in	  the	  same	  solution	  allowed	  for	  the	  greatest	  protein	  removal	  by	  OFR.	  
	  
In	  Chapter	  5,	  MPS	  had	  varying	  effects	  on	   lysozyme	  activity.	  For	  OFR,	  there	  was	  an	  enhanced	  lysozyme	  
activity	   throughout	   the	   48-­‐hour	   time	   period.	   For	   BT,	   the	   activity	   at	   hr	   1	   was	   relatively	   low,	   but	   an	  
increase	  was	  seen	  by	  hr	  12,	  which	  remained	  stable	  up	  to	  hr	  48.	  For	  CC,	  there	  was	  a	  denaturing	  effect	  on	  




Protein	   deposition	   profiles	   varied	  when	   lenses	  were	   incubated	   in	   either	   a	   simple	   saline	   solution	   or	   a	  
complex	  artificial	   tear	  solution	  and	  deposition	  patterns	  varied	  between	  SH	  materials.	  The	  efficacy	  of	  a	  
contact	  lens	  care	  regimen	  (OFR)	  to	  remove	  deposited	  lysozyme	  from	  SH	  lenses	  was	  dependent	  on	  both	  
lens	   material	   and	   incubation	   solution.	   Lysozyme	   activity	   was	   impacted	   differently	   by	   the	   three	   care	  
regimens,	  with	  OFR	  seemingly	  enhancing	  activity,	  BT	  stabilizing	  it,	  and	  CC	  exhibiting	  decreased	  activity.	  
Future	  in	  vitro	  studies	  should	  use	  more	  appropriate	  analogues	  of	  the	  human	  tear	  film	  in	  order	  to	  better	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1 INTRODUCTION	  
	  
1.1 CONTACT	  LENSES	  
	  
Contact	   lenses	   have	   become	   increasingly	   popular	   to	   correct	   refractive	   errors,	   mainly	   due	   to	   their	  
cosmetic	  and	  optical	  advantages	  over	  spectacles	   [1-­‐4].	  Contact	   lenses	  are	  more	  convenient	  to	  wear	   in	  
certain	  weather	  conditions	  (such	  as	  rain	  and	  humidity)	  or	  to	  prevent	  fogging	  in	  the	  winter.	  Athletes	  also	  
benefit	  from	  the	  use	  of	  contact	  lenses	  in	  their	  activities	  and	  the	  incidence	  of	  injury	  to	  the	  face	  as	  a	  result	  
of	  direct	  impact	  is	  greatly	  reduced.	  It	  may	  be	  more	  convenient	  to	  wear	  contacts	  in	  a	  sport	  that	  requires	  
constant	  movement,	  running,	   jumping	  or	  tackling	  to	  ensure	  steady	  vision.	  	  Contact	   lenses	  also	  provide	  
increased	   peripheral	   vision.	   Additionally,	   managing	   various	   medical	   conditions	   requires	   the	   use	   of	  
contact	   lenses.	  Patients	  suffering	   from	  keratoconus	  may	  not	  have	  the	  visual	  ability	   to	  wear	  spectacles	  
due	  to	  significant	  corneal	  distortion.	  Finally,	  a	  patient	  with	  a	  high	  refractive	  error	  requires	  thicker	  lenses	  
and	  perhaps	  a	  limited	  choice	  of	  frames	  and	  may	  choose	  to	  wear	  contact	  lenses	  over	  spectacles.	  The	  use	  
of	   contact	   lenses	   is	   aesthetically	   appealing	   for	  many	   patients	   and	   has	   the	   potential	   to	   increase	   self-­‐
esteem	  and	  confidence	  in	  social	  settings.	  
	  
The	  prevalence	  of	  myopia	  has	  increased	  significantly	  over	  the	  past	  few	  decades,	  with	  over	  40%	  of	  young	  
adults	  in	  the	  Unites	  States	  [5]	  and	  70%	  in	  East	  Asian	  countries	  [6]	  now	  being	  myopic.	  Interestingly,	  the	  
prevalence	   of	  myopia	   has	   increased	   since	   1971	   by	   66%	   [5].	  Over	   125	  million	   people	  worldwide	  wear	  
contact	   lenses	  [1],	  and	  the	  different	  materials	  available	  for	  soft	   lenses	  have	  been	  classified	  under	  four	  
Food	  and	  Drug	  Administration	  (FDA)	  groups	  (Table	  1-­‐1).	  Two	  properties	  of	  contact	  lens	  materials	  include	  
oxygen	  permeability	  (Dk)	  and	  oxygen	  transmissibility	  (Dk/t).	  Diffusion	  and	  solubility	  are	  two	  factors	  that	  
determine	  the	  Dk	  of	  a	  material,	  which	  provides	  a	  guide	  to	  the	  ability	  of	  a	  material	  to	  deliver	  oxygen	  to	  
the	   cornea	   [7].	   The	   rate	  at	  which	  oxygen	  molecules	   can	  pass	   through	  a	  polymer	   is	  diffusion,	  whereas	  
solubility	  is	  the	  number	  of	  oxygen	  molecules	  within	  the	  polymer	  [7].	  Dk/t	  refers	  to	  the	  Dk	  of	  a	  specific	  
material	  of	  a	  given	  thickness	   [7].	  Conventional	  hydrogel	  contact	   lens	  materials	  were	   introduced	   in	  the	  
1970’s	   [8,9]	  and	  consist	  of	  poly-­‐2-­‐hydroxyethyl	  methacrylate	   (pHEMA)	  and	  exhibit	   relatively	   low	  DK/t,	  
which	  may	  lead	  to	  hypoxic	  complications	  [10,11].	  Silicone	  hydrogel	  (SH)	  lenses	  were	  introduced	  in	  1999	  
[12],	  nearly	  30	  years	  after	  conventional	   lenses’	  debut	   to	   the	  market.	  The	  high	  Dk/t	  of	   these	  materials	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caused	  fewer	  hypoxic	  complications	  [12,13]	  and	  as	  a	  result,	  the	  number	  of	  pHEMA-­‐based	  hydrogel	  lens	  
wearers	  decreased	  rapidly,	  accounting	  for	  approximately	  25%	  today	  [14].	  	  	  
	  
Table	  1-­‐1:	  Classification	  of	  contact	  lens	  materials	  through	  the	  FDA	  
Property	   Group	  Classification	  
	   I	   II	   III	   IV	  
Water	  Content	   Low	   High	   Low	   High	  
Charge	   Non-­‐ionic	   Non-­‐ionic	   Ionic	   Ionic	  
Low=	  <50%,	  high=	  >50%	  
	  
An	   important	   contact	   lens	  property	   relates	   to	   its	  wettability,	  which	  determines	   the	  ability	  of	   the	   tear	  
film	  to	  uniformly	  spread	  across	  the	  lens	  surface.	  As	  presented	  in	  Table	  1-­‐2,	  in	  order	  to	  improve	  the	  in-­‐
eye	   wettability	   of	   hydrophobic	   SH	   materials,	   various	   treatments	   or	   surface	   modifications	   have	   been	  
used.	  As	  an	  example,	   senofilcon	  A	   (SA)	  and	  galyfilcon	  A	   (GA)	   lenses	  contain	  an	   internal	  wetting	  agent	  
(polyvinyl	  pyrrolidone	  (PVP)),	  which	   is	   incorporated	   in	   the	  material	   [15],	   lotrafilcon	  B	  (LB)	  undergoes	  a	  
plasma	  treatment	  [16],	  and	  balafilcon	  A	  (BA)	  undergoes	  a	  plasma	  oxidation	  process	  [17].	  	  
	  
The	  combination	  of	  silicone	  and	  hydrogel	  components	  give	  SH	  lenses	  unique	  properties	  of	  high	  Dk/t	  and	  
ion	  permeability.	  These	  key	  features	  allow	  for	  SH	  lenses	  to	  be	  worn	  for	  extended	  periods	  of	  time,	  with	  
certain	  materials	  being	  approved	  for	  up	  to	  30	  days	  without	  removal	   [18];	  however,	  deposition	  of	   tear	  
film	   components,	   such	   as	   lipids	   [19,20]	   and	   proteins	   [21,22],	  may	   cause	   ocular	   complications	   and/or	  











Table	  1-­‐2:	  Properties	  of	  common	  silicone	  hydrogel	  contact	  lens	  materials	  	  
USAN	   Balafilcon	  A	   Comfilcon	  A	   Galyfilcon	  A	   Lotrafilcon	  A	   Lotrafilcon	  B	   Senofilcon	  A	  
Trade	  Name	   PureVision	   Biofinity	   Acuvue	  
Advance	  
Air	  Optix	  Night	  




Manufacturer	   Bausch	  &	  
Lomb	  
Cooper	  Vision	   Johnson	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1.1.1 Deposition	  Profiles	  	  
	  
It	  is	  evident	  that	  pHEMA-­‐based	  and	  SH	  contact	  lens	  materials	  result	  in	  different	  deposition	  profiles,	  due	  
to	   variations	   in	   water	   content,	   surface	   charge	   and	   surface	   hydrophilicity	   [23,24].	   The	   relatively	  
hydrophilic	  nature	  of	  pHEMA-­‐based	  lenses	  results	  in	  them	  accumulating	  relatively	  low	  amounts	  of	  lipids	  
and	   relatively	   higher	   amounts	   of	   proteins	   than	   SH	   materials;	   this	   trend	   is	   reversed	   for	   the	   more	  
hydrophobic	   SH	  materials	   [19,25-­‐31].	  When	   comparing	   in	   vitro	   study	   data,	   1434-­‐1800μg	   of	   lysozyme	  
deposit	   onto	   pHEMA	   lenses	   [32-­‐34],	   whereas	   SH	   lens	   materials	   accumulate	   significantly	   less	   protein	  
(<20μg	  per	  lens)	  [27,35].	  Studies	  have	  further	  shown	  that	  SH	  materials	  accumulate	  a	  greater	  percentage	  
of	  denatured	  protein	   [34]	  compared	  to	  pHEMA	   lenses.	  The	  SH	  material,	   LB,	  accumulates	  at	  most	  25%	  
active	   lysozyme	   [27,34,35],	   whereas	   the	   conventional	   lens	   material,	   specifically	   etafilcon	   A	   (EA),	  
accumulates	   over	   75%	   active	   lysozyme	   [27,34,35].	   With	   respect	   to	   lipids,	   the	   SH	   lens	   material,	   BA,	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accumulates	   up	   to	   600μg	   per	   lens	   compared	   to	   20μg	   accumulated	   onto	   the	   conventional	   EA	   lens	  
material	  [27],	  although	  more	  recent	  work	  has	  questioned	  this	  amount	  and	  demonstrated	  lower	  amounts	  
[36,37].	  In	  a	  recent	  study	  [29],	  specific	  lipids,	  such	  as	  cholesterol	  and	  phosphatidylcholine,	  accumulated	  
in	  greater	  amounts	  onto	  SH	  lens	  materials	  compared	  to	  FDA	  group	  IV	  lenses.	  
	  
1.2 CONTACT	  LENS	  SOLUTIONS	  
	  
The	  main	  purpose	  of	  contact	  lens	  care	  regimens	  is	  to	  disinfect	  the	  lens	  [38,39]	  and	  to	  remove	  tear	  film	  
deposits	   [37,40-­‐42].	   Contact	   lens	   care	   regimens	   have	   the	   ability	   to	   modify	   both	   the	   chemical	   and	  
physical	   properties	   of	   the	   lens	   surface	   [37].	   For	   example,	   the	   hydrophilicity	   of	   contact	   lenses	   is	  
maximized	   through	   the	   addition	   of	   various	   wetting	   and	   lubricating	   ingredients	   to	   contact	   lens	   care	  
solutions	  [43].	  	  	  
	  
1.2.1 Multi-­‐Purpose	  Solutions	  
	  
Multi-­‐purpose	  solutions	  (MPS)	  have	  the	  largest	  market	  share	  today	  [14]	  and	  a	  recent	  study	  has	  shown	  
that	  practitioners	  recommend	  this	  type	  of	  care	  regimen	  to	  77%	  of	  their	  contact	  lens	  patients	  [14].	  MPS	  
consist	  of	  anti-­‐microbial	  agents	  [44],	  chelators,	  buffer	  systems,	  surfactants,	  and	  wetting	  agents	  [45,46];	  
however,	   their	   ability	   to	   remove	   proteins	   from	   contact	   lenses	   is	   typically	   less	   than	   50%	   [40,47].	  
Biocompatibility	  of	  the	  MPS	  with	  the	  anterior	  eye	  is	  important	  [48],	  particularly	  because	  of	  the	  potential	  
release	  of	  MPS	  from	  the	  lens	  onto	  the	  corneal	  surface	  [49].	  
	  
1.2.2 Hydrogen	  Peroxide-­‐Based	  Solutions	  
	  
According	   to	   market	   research	   conducted	   US	   practitioners,	   hydrogen	   peroxide	   (H2O2)	   systems	   are	  
recommended	   to	   approximately	   22%	   of	   contact	   lens	   wearers	   [14].	   At	   a	   concentration	   of	   3%,	   H2O2	  
systems	   have	   proven	   effective	   against	   bacteria	   and	   fungi	   [50,51].	   Neutralisation	   of	   the	   peroxide	   into	  
water	   and	   oxygen	   is	   accomplished	   by	   platinum	   discs	   or	   tablets	   containing	   catalytic	   enzymes	   [52],	  
providing	  a	  preservative-­‐free	  environment	  [45].	  The	  care	  regimens	  AOSept	  and	  Clear	  Care	  use	  platinum	  




1.3 HUMAN	  TEAR	  FILM	  
	  
Consisting	  of	   lipid,	  protein,	  and	  mucin	  components,	   the	  human	  tear	   film	  carries	  out	  a	  number	  of	  vital	  
functions	   for	   the	  eye	   [54].	  Acting	  as	  a	   lubricant	   for	   the	  conjunctiva,	   cornea,	  and	  eyelids	   [55],	   the	   tear	  
film	   allows	   for	   a	   smooth	   optical	   surface	   [56].	   The	   tear	   film	   also	   provides	   nutrients	   to	   the	   avascular	  
cornea	   and	   washes	   exogenous	   components	   from	   the	   anterior	   eye	   [55].	   The	   tear	   lipids	   both	   hinder	  
evaporation	   and	   stabilize	   the	   tear	   film	   [54],	   while	   tear	   proteins	   participate	   in	   a	   number	   of	   roles,	  
including	  protection	  against	  microorganisms	  and	  controlling	  immune	  responses	  [57].	  The	  mucins	  in	  the	  
tear	  film	  provide	   lubrication	  to	  the	  ocular	  surface,	  decreasing	  friction	  during	  blinking	  [58],	  and	  protect	  
the	  cornea	  and	  conjunctiva	  by	  coating	  foreign	  bodies	  in	  order	  to	  shield	  the	  epithelial	  surfaces	  [54].	  	  
	  
1.3.1 Tear	  Film	  Deposits	  
	  
Human	  tear	  film	  components	  deposit	  on	  the	  contact	  lens	  once	  it	  is	  inserted	  onto	  the	  anterior	  surface	  of	  
the	   eye.	   These	  deposits	  may	   result	   in	   reduced	   visual	   acuity	   [59],	   decreased	  wettability	   [60],	   and	  may	  
cause	   a	   dryness	   sensation	   or	   discomfort	   [61].	   Furthermore,	   some	   deposits	   may	   lead	   to	   increased	  
bacterial	  adhesion	  [62]	  and	  inflammatory	  complications,	  such	  as	  giant	  papillary	  conjunctivitis	  (GPC)	  [63].	  
A	  number	  of	  symptoms	  are	  associated	  with	  GPC,	  such	  as	  itchiness	  and	  decreased	  lens	  tolerance	  due	  to	  
contact	   lens	   awareness	   [64].	   The	  mechanical	   strain	   caused	  by	   the	   contact	   lens	   in	   rubbing	   against	   the	  
upper	   tarsal	   conjunctiva	   [63]	   and	   denatured	   proteins	   deposited	   on	   the	   lens	   surface	   can	   trigger	   this	  
condition	  [65].	  	  
	  
1.3.2 In	  Vitro	  vs.	  Ex	  Vivo	  Studies	  	  
	  
In	   vitro	   studies	   are	   those	   that	   occur	   outside	   the	   living	   organism,	   whereas	   ex	   vivo	   studies	   are	   those	  
experiments	   that	   are	   conducted	   in	   a	   laboratory	   setting	   outside	   of	   the	   living	   organism.	   Contact	   lens	  
studies	   that	   conduct	   experiments	   on	   patient-­‐worn	   lenses	   are	   commonly	   considered	   ex	   vivo	   studies.	  	  
Both	   in	  vitro	  and	  ex	  vivo	  studies	  allow	  an	  experimenter	   to	  conduct	   trials	   that	  do	  not	  require	  an	   intact	  
organism.	   Nonetheless,	   each	   study	   design	   has	   its	   advantages	   and	   disadvantages.	   In	   vitro	   studies	   are	  
generally	  inexpensive,	  less	  time	  consuming,	  and	  provide	  the	  ability	  to	  control	  variables.	  However,	  one	  of	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the	  major	  disadvantages	  of	   in	   vitro	  studies	   is	   that	   they	  do	  not	   closely	  mimic	   the	   in	  vivo	   situation	  and	  
hence	  struggle	  to	  provide	  accurate,	  truly	  predictive	  results.	  	  
	  
Naturally,	  the	  protein	  sorption	  profiles	  of	  in	  vitro	  contact	  lens	  studies	  differ	  from	  those	  of	  ex	  vivo	  studies	  
[27,32-­‐35,66-­‐69].	  A	  number	  of	  effects	  are	  lacking	  in	  the	  in	  vitro	  model,	  such	  as	  blinking,	  surface	  drying,	  
and	  cleaning	  processes,	  and	  therefore	  it	  is	  not	  uncommon	  that	  in	  vitro	  and	  ex	  vivo	  models	  elicit	  different	  
deposition	   patterns.	   Despite	   all	   of	   the	   differences	   between	   in	   vitro	   and	   ex	   vivo	   study	   designs,	   SH	  
materials	  have	  not	  shown	  great	  differences	  between	  protein	  deposition	  profiles;	  for	  example,	  worn	  SA	  
lens	  materials	  accumulate	  about	  7μg	  [37,67,68]	  (25%	  of	  which	  is	  lysozyme	  [67,68]),	  whereas	  incubated	  
SA	  lenses	  accumulate	  6-­‐13μg	  of	  lysozyme	  [33,34].	  Over	  7μg	  of	  total	  protein	  [69-­‐71],	  of	  which	  less	  than	  
25%	   is	   lysozyme	   [67,68],	   accumulate	   on	   patient-­‐worn	   LB	   contact	   lenses;	   however,	   in	   vitro	   models	  
accumulate	   6-­‐10μg	   of	   lysozyme	   per	   lens	   [34,40].	   Worn	   BA	   lenses	   accumulate	   5-­‐34μg	   of	   protein	  
[37,67,68],	  where	  32-­‐50%	  [40,72]	  is	  lysozyme.	  In	  vitro	  studies	  have	  shown	  that	  about	  10μg	  of	  lysozyme	  
deposit	  onto	  BA	  lenses	  [33,72].	  Conventional	  hydrogel	  materials,	  unlike	  SH	  materials,	  show	  differences	  
between	   in	  vitro	  and	  ex	  vivo	  deposition	  patterns;	   for	  example,	  with	  regards	  to	   ionic	  pHEMA	   lenses,	   in	  
vitro	  models	   accumulate	   1434-­‐1800μg	   of	   lysozyme	   [32-­‐34],	  whereas	  ex	   vivo	  models	   accumulate	   985-­‐
991μg	  of	  lysozyme	  [27,66].	  
	  	  
1.3.2.1 Incubation	  solution	  	  
	  
For	  in	  vitro	  studies,	  the	  composition	  of	  incubation	  solution	  plays	  a	  pivotal	  role	  in	  protein	  deposition	  onto	  
contact	   lens	   materials.	   In	   a	   number	   of	   previous	   studies	   [33-­‐35,40,73-­‐75],	   the	   incubation	   solution	  
consists	   of	   a	   simple	   saline	   that	   contains	   a	   single	   protein	   of	   interest.	   The	   competitive	   nature	   and	  
complexity	  of	  the	  human	  tear	  film	  is	  not	  considered,	  hence	  deposition	  patterns	  are	  not	  an	  appropriate	  
representation	  of	  the	  in	  vivo	  situation.	  Few	  studies	  [76-­‐78]	  have	  incorporated	  the	  complexity	  of	  the	  tear	  
film	  in	  order	  to	  understand	  the	  deposition	  behaviour	  and	  competitive	  nature	  of	  both	  lipids	  and	  proteins	  
when	  depositing	  onto	  pHEMA-­‐based	  contact	  lens	  materials.	  Specifically,	  Mirejovsky	  and	  colleagues	  [76]	  
confirmed	  that	  lipid	  deposition	  patterns	  seen	  on	  hydrogel	  lenses	  incubated	  in	  an	  artificial	  tear	  solution	  
(ATS)	   that	   contained	   proteins,	   glycoproteins,	   and	   lipids	   were	   similar	   to	   patient-­‐worn	   study	   lenses.	  
Similarly,	   Prager	   and	   Quintana	   [77]	   determined	   that	   protein	   deposition	   patterns	  were	   dependent	   on	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incubation	   solution	   composition	   (both	   simple	   and	   complex	   solutions),	   lens	   material	   used,	   and	   lens	  
exposure	  time	  to	  the	  ATS.	  It	  is,	  however,	  unclear	  whether	  similar	  competitive	  behaviour	  is	  present	  when	  
various	   SH	   materials	   are	   incubated	   in	   a	   more	   complex	   ATS.	   A	   recent	   study	   conducted	   by	   Ng	   and	  
colleagues	  [79],	  determined	  that	  both	  lactoferrin	  and	  lipids	  impact	  lysozyme	  deposition	  to	  both	  SH	  and	  
conventional	   hydrogel	   lens	   materials,	   where	   deposition	   patterns	   were	   lens	   material-­‐dependent.	   FDA	  
group	   I	   and	   II	   lenses	   accumulated	   less	   lysozyme	   in	   the	   presence	   of	   lipids;	   however,	   the	   presence	   of	  
lactoferrin	   decreased	   the	   amount	   of	   lysozyme	   accumulated	   onto	   group	   IV	   lenses	   [79].	   Overall,	   the	  
complexity	  of	   the	   tear	   film	   impacted	   the	  deposition	  pattern	  of	  protein,	  whereas	  previous	  studies	   that	  
incubated	  lens	  materials	  in	  a	  simple	  solution	  did	  not	  show	  similar	  deposition	  patterns.	  	  
	  
1.4 PROTEIN	  DEPOSITION	  
	  
1.4.1 Lysozyme	  	  
	  
Lysozyme	  was	  discovered	  in	  the	  early	  20th	  century	  and	  is	  a	  bacteriolytic	  protein	  [80]	  with	  immune	  and	  
anti-­‐tumour	  properties	  [81].	  Spanning	  a	  length	  of	  129	  amino	  acids	  [82],	  this	  small	  (14.5	  kDA)	  positively	  
charged	  protein	  is	  derived	  from	  the	  lacrimal	  glands	  [83],	  constituting	  1.9	  mg/mL	  of	  the	  human	  tear	  film	  
[84].	  Lysozyme	  is	  one	  of	  the	  most	  abundant	  proteins	  in	  the	  tear	  film	  and	  has	  also	  been	  detected	  in	  other	  
bodily	   fluids,	  although	   in	  much	   lower	  concentrations	   [85].	  Biological	   fluids	   in	  which	   lysozyme	   is	   found	  
include	   blood	   serum,	   mucous,	   and	   saliva.	   The	   antimicrobial	   properties	   of	   lysozyme	   allows	   for	   the	  
hydrolyzing	  of	  glycosidic	  bonds	  in	  the	  peptidoglycan	  (outer	  sugar	  coating)	  of	  gram-­‐positive	  bacteria	  [81].	  
The	  hydrolysis	  of	  the	  β-­‐1,4	  linkage	  between	  N-­‐acetylmuramic	  acid	  and	  N-­‐acetyl-­‐D-­‐glucosamine	  residues	  
causes	   the	   cell	  wall	   to	   rupture,	   leading	   to	   cell	   lysis	   [86].	  Other	   studies	   have	   investigated	  protein-­‐lipid	  
interactions	  [87]	  and	  protein	  adsorption	  to	  interfaces	  [88]	  using	  lysozyme	  as	  a	  model	  protein	  [81].	  	  
	  
Lysozyme	  concentration	  in	  the	  tear	  film	  remains	  relatively	  constant	  when	  tear	  flow	  is	  stimulated	  (reflex	  
tears)	   [89,90]	   and	   during	   open	   or	   closed	   eye	   conditions	   [84].	   Pietsch	   and	   Pearlman	   reported	   that	  
lysozyme	   concentrations	   are	   highest	   between	   11	   and	   20	   years	   of	   age	   [91],	   and	   the	   concentration	  
decreases	  at	  a	  rate	  of	  1mg/dL	  per	  year	  after	  the	  age	  of	  40	  [92].	  In	  the	  tear	  film	  of	  lens	  wearers,	  lysozyme	  
has	   a	   slightly	   reduced	   biological	   activity	   compared	   to	   non-­‐lens	   wearers,	   as	   determined	   by	  
electrophoresis	   [93],	  which	  could	   lead	  to	  an	   increased	  risk	  of	  corneal	   inflammation	  and	   infection	  [94].	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Kramann	  and	  colleagues	  further	  determined	  a	  decrease	  in	  lysozyme	  protein	  with	  contact	  lens-­‐wear	  [95].	  
With	   regards	   to	   overnight	   wear,	   Choy	   and	   colleagues	   found	   that	   there	   was	   no	   change	   in	   lysozyme	  
concentrations	  when	  orthokeratology	  (ortho-­‐k)	  lenses	  were	  worn	  [96].	  
	  
1.4.2 Lactoferrin	  	  
	  
Lactoferrin	  is	  a	  positively	  charged	  iron-­‐binding	  protein,	  with	  a	  molecular	  weight	  of	  80	  kDA	  [97,98].	  The	  
length	  of	   the	  protein	   spans	  as	  a	   single	  polypeptide	  chain	   [99]	  made	  up	  of	  692	  amino	  acids	   [100,101].	  
Lactoferrin	   is	  mainly	   secreted	   from	   lacrimal	   gland	   acini	   [102,103]	   and	   has	   a	   concentration	   of	   1.5-­‐2.2	  
mg/mL	  in	  the	  human	  tear	  film	  [97].	  The	  concentration	  of	   lactoferrin	   in	  the	  blood	  plasma	  is	  0.2	  μg/mL,	  
which	   is	   significantly	   lower	   in	   comparison	   to	   human	   tears	   [104,105].	   A	   major	   source	   of	   lactoferrin	  
protein	   is	   breast	  milk	   [106],	   however	   varying	  amounts	   are	   found	   in	  mammals.	   Post-­‐natal	   breast	  milk,	  
known	  as	   colostrum,	  has	   concentrations	  of	   lactoferrin	  up	   to	  7	  mg/mL,	  whereas	  mature	   lactation	  milk	  
contains	  7-­‐fold	  less	  [107-­‐109].	  	  
	  
Lactoferrin	   is	   a	   part	   of	   the	   non-­‐specific	   immune	   system	   [108,110]	   and	   plays	   a	   role	   in	   the	   first	   line	   of	  
defense	  against	  microbial	  infections,	  as	  it	  is	  conveniently	  situated	  at	  the	  mucosa	  [106].	  The	  mucosa	  is	  a	  
moist	   tissue	   lining	  organs	  and	  various	  areas	   in	   the	  body	  cavity,	  where	  pathogens	  may	  enter	   the	  body	  
[106].	   Lactoferrin	   is	   not	   only	   known	   to	   protect	   lysozyme	   from	   losing	   its	   activity	   [111],	   but	   it	   aids	   in	  
lysozyme’s	  accessibility	  to	  bacteria	  [112].	  It	  does	  this	  by	  interfering	  with	  the	  lipopolysaccharide	  layer	  of	  
gram-­‐negative	   bacteria	   by	   increasing	   its	   permeability	   [113].	   Lactoferrin	   is	   involved	   in	   inhibiting	   the	  
growth	   of	   and	   killing	   gram-­‐positive	   bacteria	   [114-­‐116]	   and	   is	   also	   fungicidal,	   particularly	   towards	  
Candida	   species	   [108,110].	   Lactoferrin	  also	  acts	   to	   sequester	   iron	   from	  bacteria,	  which	   is	   required	   for	  
growth	   [108,110].	   It	   is	   further	   known	   to	   possess	   anti-­‐inflammatory	   [117-­‐119],	   anti-­‐oxidant	   [120,121],	  
and	  anti-­‐tumour	  [122-­‐124]	  properties.	  Lactoferrin	  performs	  anti-­‐viral	  activity	  against	  a	  number	  of	  DNA	  
and	  RNA	  viruses	  [106].	  
	  
Lactoferrin	  has	  a	  number	  of	  important	  functions	  in	  the	  tear	  film;	  it	  stimulates	  iron	  adsorption	  [125]	  and	  
supports	  the	  defense	  mechanism	  against	  bacteria	  [126-­‐128]	  by	  targeting	  the	  microorganisms	  growing	  in	  
the	  conjunctival	  sac	  [125,129].	  The	  concentration	  of	   lactoferrin	   in	  the	  tear	  film	  remains	  quite	  constant	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when	  the	  eye	  is	  placed	  under	  particular	  conditions;	  for	  example,	  reflex	  tears	  and	  closed	  eye	  conditions	  
provide	  the	  same	  concentration	  of	   lactoferrin	  (1.8	  mg/mL);	  however,	  there	   is	  greater	   lactoferrin	  when	  
the	  eye	  is	  open	  (2.6	  mg/mL)	  [84].	  Interestingly,	  with	  a	  decrease	  in	  tear	  production,	  due	  to	  dry	  eye,	  there	  
is	   a	   decrease	   in	   lactoferrin	   concentration	   [130,131].	   Similar	   to	   lysozyme,	   Choy	   and	   colleagues	  
determined	  there	  was	  no	  change	  in	  lactoferrin	  concentration	  when	  ortho-­‐k	  lenses	  were	  worn	  over-­‐night	  
compared	  to	  over-­‐night	  sleep	  without	  ortho-­‐k	  lens-­‐wear	  [96].	  Carney	  and	  colleagues	  demonstrated	  that	  
during	  extended	  contact	  lens-­‐wear,	  there	  was	  no	  change	  in	  tear	  lactoferrin	  concentration	  after	  1	  night,	  
1	  week,	  or	  6	  months	  [132].	  A	  decrease	  in	  lactoferrin	  of	  approximately	  50%	  has	  however	  been	  found	  in	  
lens	   wearers	   that	   developed	   GPC,	   compared	   to	   lens	   wearers	   without	   this	   condition	   (0.876±0.42	   vs	  




Albumin	  is	  a	  negatively	  charged	  protein	  with	  a	  molecular	  weight	  of	  66	  kDA	  [134]	  and	  is	  built	  as	  a	  single	  
polypeptide	  chain	  of	  585	  amino	  acids	  [135].	  Albumin	  is	  synthesized	  in	  the	  liver	  [136]	  and	  is	  mixed	  into	  
the	   human	   tear	   film	   by	   leaking	   out	   of	   conjunctival	   capillaries	   [137].	   It	   is	   the	  most	   abundant	   protein	  
found	   in	   blood	   plasma,	   constituting	   50	  mg/mL	   [138]	   and	   is	   found	   in	   the	   tear	   film	   at	   a	   concentration	  
ranging	  from	  0.02	  to	  0.5	  mg/mL	  [139,140].	  Fatty	  acids	  and	  hormones	  are	  both	  insoluble	  products	  of	  the	  
human	  serum	  and	  hence	  require	  a	  carrier,	  such	  as	  albumin	  [141],	  which	  consists	  of	  four	  distinct	  binding	  
sites	   [135].	  Albumin	   is	   known	  as	  a	  major	  antioxidant	   in	  human	  plasma	   [142-­‐144],	   scavenging	   reactive	  
oxygen	  species	  [145]	  and	  has	  a	  half-­‐life	  of	  approximately	  19	  days	  in	  the	  human	  body	  [146,147].	  
	  
Researchers	   test	   the	   alteration	   in	   tear	   protein	   concentration	   in	   order	   to	   conclude	   if	   an	   increase	   or	  
decrease	  in	  ocular	  concentration	  is	  seen	  when	  the	  eye	  is	  under	  certain	  conditions	  [96,148].	  For	  example,	  
during	  closed	  eye	  conditions	  or	  inflammation	  of	  the	  conjunctiva,	  limbal	  blood	  vessel	  dilate	  and	  allow	  for	  
serum	  proteins	  to	  leak	  into	  the	  tear	  film,	  which	  increases	  the	  concentration	  of	  albumin	  in	  the	  tear	  film	  
[148].	  Non-­‐lens	  wearers	  have	  a	  lower	  albumin	  concentration	  in	  their	  tear	  film	  compared	  to	  contact	  lens	  
wearers	  (0.045	  ±	  0.032	  vs.	  0.059	  ±	  0.054	  mg/mL),	  as	  determined	  by	  Baleriola-­‐Lucas	  and	  colleagues	  [148].	  
The	  concentration	  of	  albumin	  increases	  significantly	  overnight,	  both	  with	  and	  without	  contact	  lens-­‐wear	  
[96].	   Without	   lens-­‐wear,	   albumin	   concentrations	   increased	   9-­‐fold	   in	   tears	   when	   comparing	   values	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before	   sleep	   (0.02	   [0.01-­‐0.05]	   mg/mL)	   and	   after	   sleep	   (0.20	   [0.15-­‐0.58]	   mg/mL)	   [96].	   Furthermore,	  
participants	  wearing	  ortho-­‐k	  lenses	  presented	  with	  albumin	  concentrations	  13-­‐fold	  greater	  in	  their	  tears	  
than	   those	   not	  wearing	   lenses	   [96].	   Choy	   and	   colleagues	   suggested	   a	   few	   reasons	   for	   the	   significant	  
increase,	  such	  as	  intrinsic	  diurnal	  rhythm,	  a	  hypoxic	  environment,	  and	  cellular	  leakage	  [96].	  	  
	  
1.5 PROTEIN	  QUANTIFICATION	  TECHNIQUES	  
	  
	  
1.5.1 Amino	  Acid	  Analysis	  	  
	  
Automated	  amino	  acid	  analysis	  in	  the	  picomole	  range	  is	  well	  recognized,	  as	  stated	  by	  Bohlen	  in	  a	  1982	  
publication	  [149].	  High-­‐sensitivity	  amino	  acid	  detection	  is	  determined	  by	  post-­‐column	  derivatization	  of	  
amino	  acids	  by	  use	  of	   fluorogenic	  reagents,	  such	  as	   fluorescamine	  [150]	  and	  OPA2/2-­‐mercaptoethanol	  
[151].	  As	  the	  detection	  sensitivity	  of	  amino	  acid	  analysis	  increases,	  contamination	  issues	  become	  more	  
important,	  as	   interference	  limits	  the	  degree	  of	  sensitivity	  attainable	  [149].	  Contamination	  by	  ammonia	  
in	  the	  buffer	  system	  causes	  buffer	  change	  and	  artifactual	  peaks	  [152-­‐154].	  Hydrochloric	  acid	  is	  a	  major	  
source	  of	  contamination	  that	  interferes	  with	  buffer	  preparation	  and	  peptide	  hydrolysis	  [155,156].	  	  
	  
1.5.2 Bicinchoninic	  Acid	  (BCA)	  Assay	  
	  
Introduced	  in	  1985	  by	  Smith	  and	  colleagues	  [157],	  the	  BCA	  assay	  is	  considered	  one	  of	  the	  most	  popular	  
colorimetric	  methods	  in	  the	  detection	  and	  quantification	  of	  protein	  [158,159].	  It	  is	  a	  copper-­‐based	  assay	  
that	  combines	  two	  separate	  reactions	  -­‐	  the	  reduction	  of	  copper	  ions	  (Cu2+)	  to	  cuprous	  ions	  (Cu+)	  using	  an	  
alkaline	  medium	   and	   the	   colorimetric	   detection	   of	   the	   BCA-­‐	   Cu+	   complex	   [160].	   BCA	   forms	   a	   purple-­‐
coloured	   complex	   between	   the	   peptide	   bonds	   of	   the	   protein	   and	   copper	   [157].	   The	   intensity	   of	   the	  
colour	   change	   is	   dependent	   on	   the	   concentration	   of	   protein	   present	   in	   the	   sample,	   whereby	   colour	  
production	  increases	  proportionally	  with	  increasing	  protein	  concentration	  [157].	  	  
	  
1.5.3 Enzyme-­‐Linked	  Immunosorbent	  Assay	  (ELISA)	  
	  
Theorized	   and	   developed	   by	   the	   principle	   investigator	   Peter	   Perlmann,	   along	   with	   a	   colleague,	   Eva	  
Engvall,	   the	   ELISA	   technique	   incorporates	   the	   principle	   of	   an	   immunoassay	   coupled	   with	   a	   reporter	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labeling-­‐enzyme	  [161].	  In	  1971,	  alkaline	  phosphatase	  was	  used	  as	  the	  reporter	  label	  that	  quantitatively	  
measured	   IgG	   in	   rabbit	   serum	   [162].	   In	   the	   late	   1960s,	   a	   group	   of	   researchers	   in	   Villejuif,	   France	  
reported	  successful	  coupling	  of	  antigens	  or	  antibodies	  with	  enzymes	  (alkaline	  phosphatase	  and	  glucose	  
oxidase	   are	   a	   couple	   of	   examples)	   [161].	   A	   study	   conducted	   by	   Avrameas	   [163]	   coupled	   enzymes	   to	  
proteins	  with	  glutaraldehyde.	  	  
	  
A	  protein	  is	  detected	  by	  an	  antibody	  that	  is	  covalently	  bond	  to	  an	  enzyme	  [164].	  A	  substrate	  (dye)	  that	  
will	   cause	   a	   colour	   change	   in	   the	   presence	   of	   enzyme	   is	   added	   once	   protein	   is	   bound	   to	   the	   specific	  
antibody	   [164].	   The	   intensity	   of	   the	   colour	   change	   is	   proportional	   to	   the	   amount	   of	   protein	   in	   the	  
sample	  [164].	  The	  ELISA	   is	  advantageous	   in	  that	   it	  can	  process	  up	  to	  96	  samples	  at	  once	  and	   is	  not	  as	  
time-­‐consuming	  as	  other	  protein	  quantification	  techniques,	  such	  as	  Western	  Blotting.	  	  
	  
1.5.4 High	  Performance	  Liquid	  Chromatography	  (HPLC)	  
	  
Used	  to	  both	  identify	  and	  quantify	  protein,	  the	  HPLC	  technique	  separates	  proteins	  based	  on	  molecular	  
size	  by	  mass	  transfer	  between	  stationary	  and	  mobile	  phases	  [165].	  A	  solvent	  is	  added	  to	  the	  proteins	  in	  
a	   sample	   mixture,	   followed	   by	   flowing	   through	   a	   chromatographic	   column	   in	   order	   to	   separate	   the	  
proteins	  [165].	  Retention	  time	  identifies	  each	  individual	  protein	  as	  it	  exits	  the	  HPLC	  [165].	  
	  
Size	  exclusion-­‐HPLC	  (SE-­‐HPLC)	  is	  used	  to	  fractionate	  tear	  protein	  samples	  which	  is	  followed	  by	  another	  
technique	  (sandwich	  ELISA,	  for	  example)	  to	  quantify	  the	  protein,	  as	  SE-­‐HPLC	  alone	  cannot	  quantitatively	  
identify	   protein	   [166].	   Protein	   fractioning	   in	   aqueous	   solutions	   is	   advantageous	   in	   that	   it	   minimizes	  
protein	  exposure	  to	  conformational	  change	  and	  denaturation	  and	  is	  less	  time-­‐consuming	  [166].	  	  	  
	  
1.5.5 Micrococcal	  Assay	  
	  
A	  protein	  has	  the	  ability	  to	  undergo	  conformational	  changes-­‐	  specifically,	  when	  lysozyme	  deposits	  onto	  
contact	   lens	   materials,	   it	   is	   likely	   to	   denature	   and	   lose	   its	   antimicrobial	   properties	   [167].	   Lysozyme	  
activity	   has	   been	   determined	   using	   a	   turbidity	   assay,	   where	   Micrococcus	   lysodeikticus	   bacteria	   is	  
presented	  as	  the	  target	  for	  lysozyme	  protein	  [168].	  An	  occurrence	  known	  as	  the	  ‘clearing	  phenomenon’	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takes	  place	   [169,170],	  where	   the	  yellow	  colour	  of	  bacteria	   is	  diminished	   into	  a	  near	   clear	   tone	  as	   the	  
optical	  density	  (OD)	  of	  the	  buffer	  solution	  decreases.	  The	  N-­‐acetylglucosamine	  linkages	  in	  the	  cell	  wall	  of	  
this	  organism	  are	  hydrolyzed	   [169,170]	  and	  hence	  the	  activity	  of	   lysozyme	   is	  determined	  over	  a	   time-­‐
interval.	  When	  greater	  concentrations	  of	  protein	  are	  found,	  the	  sample	  solution	  is	  more	  likely	  to	  clear	  at	  
a	  faster	  rate.	  Studies	  [34,35,171]	  have	  determined	  the	  kinetic	  denaturation	  of	  lysozyme	  extracted	  from	  




In	   1958,	   the	   iodine	   monochloride	   (ICL)	   method	   was	   introduced	   to	   conjugate	   isotopes	   with	   proteins	  
[172],	  by	  binding	  to	  the	  aromatic	  ring	  of	  tyrosine	  [173].	  There	  are	  3	  tyrosine	  residues	  in	  lysozyme	  [174],	  
22	   in	   lactoferrin	   [175],	   and	   18	   in	   albumin	   [176],	   although,	   not	   all	   of	   them	   may	   be	   accessible	   for	  
conjugation.	  The	  iodine	  atoms	  are	  in	  a	  reactive	  state	  as	  soon	  as	  the	  conjugation	  reaction	  occurs	  [172],	  
which	  is	  quite	  preferable.	  Radiolabeling	  is	  advantageous	  in	  that	  protein	  does	  not	  need	  to	  be	  extracted	  
from	  contact	  lens	  materials	  in	  order	  for	  protein	  to	  be	  quantified.	  	  
	  
This	  method	   of	   protein	   quantification	   is	   quick	   and	   simple;	   however,	   there	   is	   a	   possibility	   of	   isotope-­‐
detachment	   from	  the	  protein	  of	   interest	  causing	   free	   isotopes	   to	  generate	   false	  positive	   results.	  False	  
positives	   can	  be	  minimized	  by	   the	  use	  of	   a	  dialyzing	  process	   that	  decreases	   free	   isotopes	   in	   solution.	  	  
Radiolabeling	  is	  strictly	  a	  quantification	  technique	  and	  does	  not	  provide	  the	  specific	  location	  of	  protein,	  
that	   is,	   whether	   protein	   has	   been	   adsorbed	   to	   the	   lens	   surface	   or	   absorbed	   into	   the	   lens	   matrix.	  
Therefore,	   proteins	   are	   conjugated	   with	   fluorescent	   probes	   in	   order	   to	   use	   confocal	   scanning	  
microscopy	  to	  determine	  location-­‐specific	  sorption	  profiles.	  	  
	  
1.5.7 Western	  Blotting	  (WB)	  
	  
In	   the	  WB	   technique,	   protein	   transfers	   from	  a	   sodium	  dodecyl	   sulfate	   (SDS)	   polyacrylamide	   gel	   to	   an	  
adsorbent	   membrane	   [177],	   where	   the	   blotted	   proteins	   provide	   an	   exact	   replica	   of	   the	   gel	   [178].	  
Proteins	   are	   transferred	   to	   the	   adsorbent	   membrane	   once	   separated	   using	   SDS-­‐polyacrylamide	   gel	  
electrophoresis	   (PAGE)	   [179],	   followed	  by	   staining	  with	   antibodies	   in	   order	   to	   view	   the	  proteins.	   This	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technique	  has	  the	  ability	  to	  detect	  proteins	  of	   low	  abundance	  [178].	  Before	  the	  WB,	  molecular	  probes	  
did	   not	   have	   easy	   access	   to	   the	   separated	   proteins	   in	   the	   gel	   matrix	   [178].	   The	   introduction	   of	  WB	  
allowed	   proteins	   to	   be	   equally	   accessible	   by	   ligands	   [178].	   Although	   the	   WB	   has	   a	   number	   of	  
advantages,	   it	   is	  outcompeted	  by	  the	  ELISA	  technique	  when	  comparing	  time	  efficiency,	  as	  the	  ELISA	   is	  






















2 THESIS	  RATIONALE	  	  
	  
Conventional	  hydrogel	  and	  silicone	  hydrogel	  (SH)	  contact	  lenses	  present	  with	  a	  number	  of	  differences,	  
the	  most	  obvious	  being	  the	  higher	  oxygen	  transmissibility	  found	  in	  SH	  lenses.	  SH	   lenses	  are	  also	  more	  
resistant	   to	   deformation	   due	   to	   their	   higher	   modulus,	   and	   are	   typically	   less	   wettable	   compared	   to	  
conventional	  hydrogels.	  Contact	   lenses	  are	  categorized	  under	  the	  Food	  and	  Drug	  Administration	  (FDA)	  
into	   four	   groups:	  Groups	   I	   and	   III	   are	   low	   (<50%)	  water	   content	  and	  groups	   II	   and	   IV	  are	  high	   (>50%)	  
water	   content.	   Silicone	   is	   relatively	   hydrophobic,	   and	   as	   a	   result	   most	   SH	   lenses	   require	   surface	  
modification	  in	  order	  to	  increase	  wettability	  and	  to	  improve	  on-­‐eye	  performance.	  	  
	  
The	  deposition	  profile	  of	  tear	  film	  components	  to	  contact	  lens	  materials	  is	  distinctly	  different	  between	  
both	  material	  groups,	   showing	  that	   the	  more	  hydrophobic	  SH	   lenses	  attract	  greater	  quantities	  of	   lipid	  
and	   only	   small	   amounts	   of	   protein,	   while	   poly-­‐2-­‐hydroxyethyl	   methacrylate	   (pHEMA)-­‐based	  
conventional	   lenses	   accumulate	   primarily	   proteins.	   Protein	   deposition	   became	   a	   major	   focus	   of	  
numerous	  previous	  studies,	  particularly	  because	  of	  the	  ocular	  response	  that	  may	  result	  from	  it.	  Studies	  
have	   associated	   lens	   deposits	   with	   an	   increase	   in	   discomfort,	   dryness,	   and	   certain	   inflammatory	  
responses;	  however	   lens	  age	  might	  be	  an	  equally	   important	  factor.	  An	   inflammatory	  reaction	  that	  has	  
earned	  attention	  is	  giant	  papillary	  conjunctivitis	  (GPC),	  which	  arises	  due	  to	  both	  mechanical	  reasons	  and	  
has	  also	  been	  associated	  with	  denatured	  protein	  deposits	  on	  lenses,	  resulting	  in	  an	  immune	  response.	  	  	  
	  
To	  investigate	  the	  deposition	  profile	  of	  major	  tear	  film	  components	  to	  different	  contact	  lens	  materials,	  
numerous	   ex	   vivo	   and	   in	   vitro	   studies	   have	   been	   conducted	   in	   the	   past.	   In	   vitro	   experiments	   are	  
performed	  in	  order	  to	  have	  complete	  control	  over	  the	  surrounding	  variables.	  They	  allow	  narrowing	  in	  on	  
a	   specific	   question	   and	   can	   determine	   individual	   variables	   in	   a	   complex	   environment.	  Ex	   vivo	   studies	  
might	  be	  closer	  to	  the	  truth,	  however,	  human	  data	  are	  typically	  more	  variable	  and	  less	  cost	  efficient.	  
	  
The	  purpose	  of	  this	  thesis	  was	  to	  use	  a	  more	  advanced	  in	  vitro	  method	  and	  to	  compare	  these	  findings	  to	  
ex	  vivo	  data.	  The	  contact	  lens	  deposition	  profile	  of	  three	  major	  tear	  film	  proteins	  was	  determined	  using	  
solutions	   of	   different	   complexity	   for	   incubation.	   A	   common	   practice	   used	   in	   previous	   years	   was	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determining	   protein	   deposition,	   particularly	   lysozyme,	   lactoferrin,	   and	   albumin,	   when	   each	   of	   these	  
proteins	  was	  individually	  used	  in	  a	  phosphate	  buffered	  saline.	  This	  method	  did	  not	  accurately	  mimic	  the	  
complexity	  of	  the	  human	  tear	  film	  and	  lacked	  competitiveness	  between	  tear	  components,	  which	  include	  
hundreds	  of	  proteins,	  numerous	  lipids	  and	  mucins.	  In	  this	  thesis	  work	  a	  complex	  artificial	  tear	  solution	  
(ATS)	  was	  used	  to	  better	  simulate	   the	  human	  tear	   film.	  The	  purpose	  of	   the	   first	  experimental	  chapter	  
(Chapter	   3)	   was	   to	   determine	   whether	   the	   complexity	   of	   an	   incubation	   solution	   impacts	   protein	  
deposition	   to	  SH	   lenses.	   In	   this	   study,	  one	   solution	   contained	   saline	  and	  a	   single	  protein	   (Solution	  A),	  
whereas	  the	  other	  solution	  contained	  saline,	  proteins,	  lipids,	  and	  mucins	  (Solution	  B).	  The	  use	  of	  three	  
different	   contact	   lens	  materials	   permitted	   a	   comparison	   between	   lens	  materials.	   These	   findings	  were	  
then	  compared	  with	  patient-­‐worn	  lenses	  in	  Appendix	  A.	  	  
	  
Contact	   lens	   care	   regimens	   disinfect	   the	   worn	   lens	   and	   remove	   protein	   deposits	   from	   the	   lens.	   The	  
second	   experimental	   chapter	   investigated	   how	   efficiently	   cleaning	   solutions	   removed	   deposited	  
proteins	   from	   contact	   lenses	   when	   the	   incubation	   solution	   for	   the	   contact	   lenses	   was	   either	   very	  
complex	   or	   much	   more	   simplified.	   This	   study	   is	   similar	   to	   the	   one	   described	   in	   Chapter	   3,	   with	   the	  
addition	  of	  cleaning	  steps.	   In	  Chapter	  4	   the	   impact	  of	  other	   tear	   film	  components	  was	   investigated	  to	  
determine	  whether	   they	   enhance	  or	   reduce	   the	   binding	   strength	   of	   certain	   proteins	   to	   different	   lens	  
materials.	  	  
	  
Contact	  lens	  care	  systems	  are	  essential	  for	  reusable	  contact	  lenses	  for	  disinfection	  and	  overall	  cleaning	  
of	   the	   lenses	   between	   wearing	   cycles.	   A	   number	   of	   multi-­‐purpose	   solutions	   (MPS)	   and	   hydrogen	  
peroxide	   cleaning	   systems	   are	   currently	   available	   on	   the	   market.	   Cleaning	   systems	   allow	   for	   a	  
biologically	   healthy	   state	   for	   the	   eye	   and	   keep	   proteins,	   which	   are	   deposited	   on	   the	   lens	   surface,	  
“active”	  so	  that	  they	  may	  contribute	  to	  microbial	  killing	  and	  not	  induce	  inflammatory	  responses.	  Hence,	  
the	  purpose	  of	  Chapter	  5	  was	  to	  investigate	  the	  effect	  of	  MPS	  and	  a	  hydrogen	  peroxide-­‐based	  system	  on	  
lysozyme	   activity.	   Denatured	   proteins	   present	  with	   ocular	   adverse	   inflammatory	   effects	   and	   proteins	  
depositing	  onto	  the	  lens	  may	  cause	  bacterial	  adhesion	  and	  increase	  the	  risk	  of	  microbial	  keratitis.	  
	  
This	  thesis	  work	  will	  provide	  valuable	  information	  for	  future	  study	  designs	  using	  in	  vitro	  models	  to	  look	  
at	  contact	  lens	  deposition.	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3 COMPOSITION	  OF	  INCUBATION	  SOLUTION	  IMPACTS	  IN	  VITRO	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Purpose:	  To	  determine	  the	  impact	  of	  incubation	  solution	  composition	  on	  protein	  deposition	  to	  silicone	  
hydrogel	  (SH)	  contact	  lenses	  using	  a	  simplistic	  and	  a	  complex	  model	  of	  the	  tear	  film.	  
	  
Methods:	  Three	  SH	  materials	  -­‐	  senofilcon	  A	  (SA),	  lotrafilcon	  B	  (LB)	  and	  balafilcon	  A	  (BA)	  -­‐	  were	  incubated	  
in	  two	  different	  solutions;	  Solution	  A	  was	  a	  simplistic	  augmented	  buffered	  saline	  solution	  containing	  a	  
single	  protein,	  whereas	  Solution	  B	  was	  a	  complex	  artificial	  tear	  solution	  (ATS),	  containing	  the	  augmented	  
buffered	   saline	   solution	   in	   addition	   to	   proteins,	   lipids	   and	  mucins	   (pH=	   7.4).	   The	   proteins	   of	   interest	  
(lysozyme;	   lactoferrin;	   albumin)	   were	   radiolabeled	   with	   125Iodine	   (2%	   protein	   of	   interest)	   and	   the	  
accumulation	  of	  the	  conjugated	  protein	  to	  the	  lens	  materials	  was	  determined	  after	  1,	  7,	  14,	  and	  28	  days	  
of	   incubation.	   Protein	   deposition	   was	   measured	   using	   a	   gamma	   counter	   and	   the	   raw	   data	   was	  
translated	  into	  absolute	  amounts	  (µg/lens)	  via	  extrapolation	  from	  standards.	  	  
	  
Results:	  After	  28	  days,	  lysozyme	  uptake	  was	  significantly	  lower	  on	  BA	  lenses	  when	  incubated	  in	  Solution	  
A	  (33.7μg)	  compared	  to	  Solution	  B	  (56.2μg),	  p<0.001.	  SA	  lenses	  deposited	  similar	  amounts	  of	  lysozyme	  
when	   incubated	   in	   either	   Solution	   A	   (2.6μg)	   or	   Solution	   B	   (4.1μg),	   p>0.05.	   LB	   lenses	   also	   deposited	  
similar	  amounts	  of	  lysozyme	  for	  both	  solutions	  (Solution	  A:	  5.0μg	  vs.	  Solution	  B:	  4.7μg,	  p>0.05).	  After	  28	  
days,	   BA	   lenses	   accumulated	   approximately	   twice	   the	   amount	   of	   lactoferrin	   than	   the	   other	   lens	  
materials,	   with	   30.3μg	   depositing	   when	   exposed	   to	   Solution	   A	   and	   22.0μg	   with	   Solution	   B.	   The	  
difference	   between	   the	   two	   solutions	   was	   statistically	   significant	   (p<0.001).	   LB	   materials	   deposited	  
significantly	  greater	  amounts	  of	  lactoferrin	  when	  incubated	  in	  Solution	  A	  (16.6μg)	  compared	  to	  Solution	  
B	   (10.3μg),	   p<0.001.	   Similar	   amounts	   of	   lactoferrin	   were	   accumulated	   onto	   SA	   lenses	   regardless	   of	  
incubation	  solution	  composition	  (Solution	  A:	  8.2μg,	  Solution	  B:	  11.2μg,	  p>0.05).	  After	  28	  days,	  albumin	  
deposition	  onto	  BA	   lenses	  was	   significantly	   greater	  when	   lenses	  were	   incubated	   in	   Solution	  B	   (1.7μg)	  
compared	  to	  Solution	  A	  (0.9μg),	  p<0.001.	  Similar	  amounts	  of	  albumin	  were	  deposited	  on	  SA	  lenses	  when	  
incubated	  in	  either	  solution	  (0.6μg	  vs.	  0.7μg,	  p>0.05).	  LB	  lenses	  incubated	  in	  Solution	  A	  deposited	  more	  
albumin	  compared	  to	  Solution	  B	  (0.9μg	  vs.	  0.6μg),	  p=0.003.	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Discussion:	  Protein	  deposition	  onto	  SH	  materials	  varied	  when	  contact	  lenses	  were	  incubated	  in	  either	  a	  
complex	   ATS	   compared	   to	   a	   single	   protein	   solution.	   More	   lysozyme	   accumulated	   onto	   BA	   lenses	  
incubated	   in	  a	  complex	  analogue	  of	  the	  human	  tear	  film,	  whereas	  more	   lactoferrin	  deposited	  onto	  SA	  
lenses	   independent	   of	   incubation	   solution	   composition.	   In	   order	   to	   better	   mimic	   the	   ex	   vivo	  
environment,	  future	  studies	  should	  use	  more	  appropriate	  analogues	  of	  the	  tear	  film.	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Silicone	  hydrogel	   (SH)	   lenses	   became	   increasingly	   popular	   over	   the	   last	   decade	  primarily	   due	   to	   their	  
higher	  oxygen	  permeability,	  leading	  to	  reduced	  hypoxic	  complications	  compared	  to	  poly-­‐2-­‐hydroxyethyl	  
methacrylate	  (pHEMA)-­‐based	  lenses	  [1,2].	  A	  recent	  survey	  indicated	  that	  54%	  of	  all	  contact	  lens-­‐wearers	  
in	  the	  United	  States	  (US)	  were	  fitted	  with	  SH	  materials	  for	  daily	  wear,	  as	  compared	  with	  only	  15%	  using	  
hydrogel	  lenses	  [3].	  This	  has	  changed	  greatly	  since	  2005,	  where	  only	  22%	  of	  the	  lens	  wearers	  in	  the	  US	  
were	  fitted	  with	  silicone	  hydrogel	  lenses	  [4].	  	  
	  
Contact	   lenses	  are	  prone	  to	  protein	  deposition,	  the	  amounts	  of	  which	  are	  dependent	  on	  the	  chemical	  
composition	  of	  the	   lens	  materials	   [5,6].	  A	  number	  of	  studies	  have	  shown	  that	  deposition	  onto	  contact	  
lenses	  may	  cause	  discomfort	  [7]	  acute	  red	  eye	  [8],	  and	  inflammatory	  reactions	  [9].	  Deposited	  proteins	  
denature	  over	  time	  and	  hence	  may	  cause	  inflammatory	  responses	  to	  the	  palpebral	  conjunctiva,	  such	  as	  
giant	  papillary	  conjunctivitis	  [10].	  Contact	  lens	  wear	  can	  lead	  to	  microbial	  keratitis	  through	  infection	  of	  
the	  cornea	  by	  pathogenic	  organisms,	  such	  as	  gram-­‐negative	  Pseudomonas	  aeruginosa,	  which	  adhere	  to	  
the	   protein-­‐coated	   lens	   material	   [11].	   Tear	   film	   deposits	   may	   further	   reduce	   visual	   acuity	   [12]	   and	  
surface	  wettability	  [13].	  
	  
A	  number	  of	  different	  tear	  film	  proteins	  have	  been	  detected	  in	  the	  proteomic	  profiles	  deposited	  on	  SH	  
contact	  lenses,	  including	  albumin,	  lipocalin,	  lactoferrin,	  and	  lysozyme	  [14,15].	  Many	  other	  proteins	  have	  
been	  identified	  in	  the	  human	  tear	  film,	  some	  examples	  are	  complement	  C3	  [16],	  IgE	  [17],	  IgG	  [18],	  and	  
secretory	  phospholipase	  A2	  [19].	  Using	  antibody	  arrays,	  a	  number	  of	  chemokines,	  cytokines,	  and	  growth	  
factors	   have	   been	  detected	   in	   the	   human	   tear	   film	   [20],	   as	  well	   as	   proteases	   and	  protease	   inhibitors	  
detected	  through	  mass	  spectrometers	  [21].	  There	  are	  more	  than	  100	  different	  proteins	  identified	  in	  the	  
tear	  film	  [21,22],	  constituting	  a	  protein	  concentration	  of	  around	  8mg/mL	  [21,23].	  Lysozyme	  is	  primarily	  
used	  as	  the	  “model	  protein”	  for	  in	  vitro	  studies	  investigating	  deposition	  on	  lenses.	  The	  main	  reasons	  for	  
this	   are	   the	   high	   abundance	   of	   this	   positively	   charged	   protein	   in	   the	   tear	   film	   and	   the	   fact	   that	   it	  
accounts	   for	   approximately	  90%	  of	   the	  deposited	  protein	  on	   ionic	   (negatively	   charged)	  pHEMA-­‐based	  
lenses	  [16,24].	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Most	   SH	  contact	   lenses	  available	   today	  are	  non-­‐ionic	  and	  deposit	   substantially	   less	  protein	   than	   ionic	  
conventional	  hydrogels	   [25].	  Deposition	  profiles	  are	  often	  determined	  using	  simplified	   in	  vitro	  models,	  
however,	   there	   are	   several	   differences	   between	   in	   vitro	   and	   ex	   vivo	   results	  when	   comparing	   protein	  
accumulation	   on	   contact	   lenses	   [14,26-­‐28].	   The	   in	   vitro	   model	   typically	   lacks	   the	   effect	   of	   blinking,	  
surface	   drying,	   the	   cleansing	   process	   of	   contact	   lenses	   between	   hours	   of	  wear,	   and	   the	   physiological	  
events	  that	  are	  naturally	  occurring	  in	  the	  eye.	  As	  a	  result,	  the	  level	  of	  lysozyme	  deposition	  determined	  
on	  ionic	  pHEMA	  lenses	  is	  typically	  slightly	  lower	  on	  worn	  lenses	  compared	  to	  data	  collected	  on	  in	  vitro	  
deposited	   lenses	   (ex	   vivo=	   985-­‐991μg	   of	   lysozyme	   [26,29],	   in	   vitro=	   1434-­‐1800μg	   of	   lysozyme	  
[27,30,31]).	   In	   comparison	   to	  pHEMA,	   SH	   lenses	  deposit	  much	   lower	   amounts	  of	   lysozyme,	   averaging	  
<20	  μg/lens	  [26,32].	  SH	  materials	  generally	  accumulate	  similar	  amounts	  of	  protein,	  except	  for	  the	  ionic	  
SH	   material	   balafilcon	   A	   (BA),	   which	   deposits	   much	   great	   amounts	   of	   protein	   per	   lens	   [5,30].	  
Subbaraman	  and	  colleagues	   illustrated	   in	  an	   in	  vitro	  study	  that	  senofilcon	  A	  (SA)	  and	   lotrafilcon	  B	  (LB)	  
lenses	  deposited	  3.7μg	  and	  6.1μg	  of	   lysozyme,	  whereas	  BA	  deposited	  approximately	   three	   times	   that	  
amount	  (19.4μg)	  after	  two	  weeks	  of	  incubation	  [30].	  Ex	  vivo	  data	  from	  Subbaraman	  have	  further	  shown	  
that	  after	  two	  weeks	  of	  lens-­‐wear,	  SA	  and	  LB	  deposit	  similar	  amounts	  of	  total	  protein	  -­‐	  4.6μg	  and	  6.6μg	  
respectively-­‐	  whereas	  BA	  deposits	  approximately	  26.9μg	  [33],	  which	  is	  only	  marginally	  higher	  compared	  
to	  the	   lysozyme	   in	  vitro	   results.	  Zhao	  and	  colleagues	  demonstrated	  a	  similar	  pattern,	  where	  BA	   lenses	  
deposited	  the	  greatest	  amount	  of	  protein	  and	  SA	  the	   least;	  however,	  SA	   lenses	  deposited	  significantly	  
less	  protein	  (0.1μg	  [5])	  than	  findings	  by	  Subbaraman	  and	  colleagues	  (4.6μg).	  	  
	  
In	   vitro	   deposition	   studies	   have	   limitations	  when	   single	   protein	   solutions	   are	   utilised,	   as	   they	   cannot	  
accurately	  mimic	  the	  ocular	  tear	   film,	  due	  to	  their	   lack	  of	  other	  tear	   film	  components,	   including	  other	  
proteins,	  lipids	  and	  mucins	  [30].	  The	  use	  of	  more	  complex	  artificial	  tear	  solutions	  (ATS)	  on	  pHEMA-­‐based	  
contact	  lenses	  has	  shown	  to	  impact	  lipid	  and	  lysozyme	  uptake	  onto	  the	  lens	  material	  [34-­‐36].	  Whether	  
proteins	  that	  are	  different	  in	  size	  and	  charge	  respond	  in	  a	  similar	  fashion	  when	  depositing	  to	  SH	  lenses	  is	  
not	  clear,	  therefore	  the	  purpose	  of	  this	  in	  vitro	  study	  was	  to	  compare	  the	  amount	  of	  protein	  uptake	  on	  
different	   SH	   lens	   materials	   using	   two	   different	   in	   vitro	   models.	   The	   first	   model	   uses	   an	   augmented	  
buffered	  saline	  solution	  with	  a	  single	  protein	  added,	  whereas	  the	  second	  model	  uses	  a	  far	  more	  complex	  





A	   single	  protein	   solution	  and	  a	   complex	  ATS	  were	  used	   to	   investigate	  potential	   differences	   in	  protein	  
deposition	  to	  SH	  materials,	  using	  radiolabeled	  lysozyme,	  lactoferrin	  and	  albumin.	  	  
	  
Three	   SH	   contact	   lens	   materials	   were	   investigated	   in	   this	   study,	   senofilcon	   A	   (SA,	   ACUVUE	   OASYS,	  
Johnson	  &	  Johnson,	  Jacksonville,	  FL),	  lotrafilcon	  B	  (LB,	  Air	  Optix,	  CIBA	  VISION,	  Duluth,	  GA)	  and	  balafilcon	  
A	  (BA,	  PureVision,	  Bausch	  &	  Lomb,	  Rochester,	  NY).	  These	  lenses	  have	  been	  categorized	  in	  different	  Food	  
and	  Drug	  Administration	  (FDA)	  groups,	  with	  both	  SA	  and	  LB	  belonging	  to	  FDA	  group	  I	  (low	  water	  content	  
<50%,	  non-­‐ionic),	  whereas	  BA	  belongs	  to	  FDA	  group	  III	  (low	  water	  content	  <50%,	  ionic).	  
	  
Two	   independent	   studies	  were	  performed	   in	   parallel	   to	   investigate	   the	  deposition	  of	   a	   single	   protein	  
when	  added	  to	  a	  saline	  solution	  compared	  to	  a	  complex	  ATS.	  To	  identify	  the	  protein	  of	   interest	   in	  the	  
solution	   and	   on	   the	   lens,	   proteins	   were	   conjugated	   with	   Iodine-­‐125	   (125I).	   The	   conjugated	   proteins	  
included	  hen	  egg	   lysozyme	   (HEL)	  bovine	   colostrum	  and	  milk	   lactoferrin	   (BCL/BML),	   and	  bovine	   serum	  
albumin	   (BSA).	   The	   iodine	  monochloride	   (ICL)	  method	   [37,38]	  was	   used	   to	   radiolabel	   the	   proteins	   of	  
interest,	  by	  covalently	  binding	  125I	  to	  the	  tyrosine	  ring	  [39,40].	  The	  radiolabeled	  proteins	  were	  added	  to	  
the	   incubation	   solutions	   at	   a	   concentration	   of	   2%	   of	   the	   individual	   protein	   concentration.	   Control	  
solutions	   not	   containing	   a	   contact	   lens	  were	   used	   in	   order	   to	   verify	   radioactivity	   in	   the	   solution	   and	  





Figure	  3-­‐1:	  Flowchart	  depicting	  layout	  of	  two-­‐part	  study,	  where	  each	  time	  point	  contained	  three	  
replicates.	  
	  
Single	  protein	  solution	  
	  
The	  single	  protein	  solution	  (A)	  consisted	  of	  an	  augmented	  buffered	  saline	  solution	  containing	  different	  
salts,	  glucose,	  and	  urea	  (Table	  3-­‐1).	  This	  was	  adapted	  from	  Van	  Haeringen	  [41]	  and	  further	  modified	  at	  













Table	  3-­‐1:	  Components	  of	  the	  Saline	  Solution	  	  	  
Component	   mM	  (mmol/mL)	  	   MW	  (g/mol)	  
C6H12O6*	   0.2	   180.2	  
CaCl2*	   0.5	   147	  
H2O	  	   -­‐	   -­‐	  
HCl	  (10	  M)*	   -­‐	   -­‐	  
KCl#	   16	   74.55	  
KHCO*	   3	   100.12	  
Na2CO3+	   12	   105.99	  
Na2HPO4*	   24	   141.96	  
Na3C6H5O7^	   1.5	   294.1	  
NaCl*	   90	   58.44	  
(NH2)2CO!	   1.2	   60.06	  
ProClin	  300*	   -­‐	   -­‐	  
C6H12O6	   (glucose),	   CaCl2	   (calcium	   chloride),	   H2O	   (Milli-­‐Q	   gradient),	   HCl	   (10	   M,	   hydrochloric	   acid),	   KCl	   (potassium	   chloride),	  
KHCO3	   (potassium	   bicarbonate),	   Na2CO3	   (sodium	   carbonate),	   Na2HPO4	   (sodium	   hydrogen	   phosphate),	   Na3C6H5O7	   (trisodium	  
citrate),	  NaCl	  (sodium	  chloride),	  (NH2)2CO	  (urea)	  
*	   Sigma-­‐Aldrich,	   Oakville,	   ON,	   #	   BDH	   Inc.,	   Toronto,	   ON,	   +	   EMD	   Chemicals	   Inc.,	   Gibbstown,	   NJ,	   ^	   Caledon	   Laboratories	   LTD.,	  
Georgetown,	  ON,	  !	  EM	  Science,	  Gibbstown,	  NJ	  	  
	  
The	  saline	  solution	  was	  prepared	  with	  Milli-­‐Q	  water	  in	  a	  glass	  beaker	  using	  a	  stir	  bar	  for	  constant	  mixing.	  
The	   individual	   components	  were	   added	   to	   the	   solution.	   Finally,	   ProClin-­‐300	   (200µL/L	   solution,	   Sigma,	  
Oakville,	  ON),	  an	  antimicrobial	  agent,	  was	  added	  to	  the	  solution	  in	  order	  to	   inhibit	  bacterial	  growth.	   If	  
necessary,	  NaOH	  was	  used	  to	  adjust	  the	  solution	  to	  a	  physiological	  pH	  of	  7.4	  [43].	  The	  pH	  was	  further	  
determined	   at	   each	   study	   time	  point	   using	   pH	  paper	   (VWR,	  Mississauga,	  ON)	   to	   verify	   an	  unchanged	  
environment	  of	  the	  solution	  at	  a	  pH	  of	  about	  7	  on	  a	  scale	  of	  1-­‐12.	  
	  
The	  solution	  was	  split	  into	  three	  batches	  and	  one	  protein,	  either	  HEL	  (1.9mg/mL),	  BCL/BML	  (1.9mg/mL)	  




The	  complex	  ATS	  (B)	  consisted	  of	  the	  saline	  solution	  described	  above,	  plus	  proteins,	   lipids	  and	  mucins	  
(Table	  3-­‐2).	  All	  lipids	  and	  proteins	  were	  purchased	  from	  Sigma-­‐Aldrich,	  Oakville,	  ON.	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Table	  3-­‐2:	  Components	  of	  the	  Complex	  Artificial	  Tear	  Solution	  
Lipids	   C	  (mg/mL)	   Proteins	  	  	   C	  (mg/mL)	  
Cholesterol	  [34-­‐36]	   0.0018	  	  	   Albumin	  [44]	   0.5	  
Cholesteryl	  oleate	  [34]	   0.024	  	   IgG	  [45-­‐47]	   0.02	  
Oleic	  acid	  [35,36]	   0.0018	   Lactoferrin	  [34,36]	   1.8	  
Oleic	  acid	  methyl	  ester	  [34]	  	   0.012	   Lysozyme	  [34,36]	   1.9	  
Phosphatidyl	  choline	  [48,49]	   0.0005	   Mucin	  [34,36]	   0.15	  
Triolein	  [34]	   0.016	   Saline	  solution	  	   -­‐	  
	  
The	   concentration	   of	   cholesterol	   was	   adapted	   through	   a	   formulation	   from	   a	   couple	   of	   studies-­‐	  
Haberland	   and	   colleagues	   state	   in	   a	   study	   that	   the	   concentration	   of	   cholesterol	   that	   will	   dissolve	   is	  
0.0018	  mg/mL	  [50],	  whereas	  a	  study	  undertaken	  by	  Saatci	  and	  colleagues	  states	  that	  the	  concentration	  
of	  this	  lipid	  is	  found	  in	  higher	  amounts	  in	  the	  tear	  film	  [51].	  The	  IgG	  concentration	  was	  adapted	  from	  a	  
number	  of	  literature	  values	  [45-­‐47].	  Coyle	  and	  Sibony	  provide	  a	  range	  of	  IgG	  concentration	  found	  in	  the	  
tear	  film	  that	  better	  relates	  to	  this	  study	  [47].	  
	  
The	   saline	   solution	   was	   prepared	   as	   described	   above	   and	   all	   proteins	   were	   added	   (Table	   3-­‐2).	  
Concentrated	   lipids	  were	  mixed	   in	   a	   separate	   flask	  with	  hexane-­‐ether	   and	   sonicated	   for	   5	  minutes	   in	  
order	   to	  break	  down	  the	   lipids	   into	  micelles.	  The	   lipid	  and	  protein	  saline	  solution	  were	  combined	  and	  
nitrogen	  purged	  with	  nitrogen	  for	  10	  minutes	  to	  adjust	  the	  pH	  and	  evaporate	  hexane-­‐ether.	  	  
	  
Contact	  Lens	  Incubation	  
	  
All	  lenses	  were	  individually	  soaked	  in	  5mL	  of	  the	  prepared	  saline	  for	  24	  hours,	  to	  remove	  any	  packaging	  
solution	  components	  from	  the	  lenses.	  The	  lenses	  were	  handled	  with	  silicone-­‐tipped	  tweezers	  in	  a	  sterile	  
environment.	  Screw-­‐capped	  glass	  vials	   (6mL,	  VWR,	  Mississauga,	  ON)	  were	  autoclaved	  and	  pre-­‐treated	  
for	  4-­‐7	  days	  with	  the	  same	  solution	  used	  for	  lens	  incubation,	  to	  coat	  the	  vials	  and	  minimize	  adsorption	  
of	   elements	   to	   the	  walls	   of	   the	   vials	   during	   the	   lens	   incubation.	  During	   the	  pre-­‐treatment	   phase,	   the	  
concentration	  of	  lactoferrin	  (1.8	  mg/mL)	  was	  halved	  to	  0.9	  mg/mL	  due	  to	  quantity	  and	  cost	  limitations.	  
For	  similar	  reasons,	  both	  IgG	  and	  lactoferrin	  were	  omitted	  when	  pre-­‐treating	  the	  complex	  ATS	  vials.	  
 25	  
	  
In	  order	  to	  fully	  submerge	  the	  lens,	  each	  lens	  was	  incubated	  in	  1.5	  mL	  of	  solution	  at	  37°C	  and	  placed	  on	  
a	   rotatory	   shaker	   at	   60rpm	   (VWR,	   Mississauga,	   ON).	   Time	   periods	   of	   1,	   7,	   14,	   and	   28	   days	   were	  
investigated	  using	  three	  replicates	  per	  lens	  type	  and	  time	  point,	  resulting	  in	  a	  total	  of	  216	  contact	  lenses	  
being	  examined	  in	  the	  study.	  	  
	  
After	  each	  incubation	  period,	  lenses	  were	  removed	  from	  the	  incubation	  solution,	  rinsed	  in	  saline	  twice,	  
placed	   in	   a	   12x75mm	   culture	   tube	   (VWR,	   Mississauga,	   ON),	   air-­‐dried	   for	   12	   hours	   to	   evaporate	   off	  
unbound	  iodine.	  The	  Wallac	  Wizard	  1470	  Gamma	  Counter	  (Perkin	  Elmer,	  Woodbridge,	  ON)	  was	  used	  to	  




This	  study	  consisted	  of	  two	  experiments,	  undertaken	  in	  parallel,	  to	  compare	  the	  deposition	  of	  lysozyme,	  
lactoferrin	   and	   albumin	   to	   SH	   materials,	   when	   incubated	   in	   a	   single	   protein	   versus	   a	   complex	   ATS	  
solution.	  	  
	  
The	  pH	  of	  both	  solutions	  used	  for	   incubation	  (Solutions	  A	  and	  B)	  was	  checked	  at	  each	  time-­‐point.	  The	  
results	  were	   in	   good	  agreement	  with	   the	  human	   tear	   film,	  which	  has	  a	  pH	  of	   approximately	  7.4	   [43].	  
Control	   solutions,	   not	   containing	   a	   contact	   lens,	   confirmed	   the	   anticipated	   amount	   of	   radioactivity	   in	  
each	  solution,	  permitted	  us	  to	  monitor	  the	  radioactive	  decay	  over	  time	  and	  protein	  quantification.	  	  
	  
Data	   analysis	  was	   conducted	  using	   Statistica	   9	   (StatSoft	   Inc.	   Tulsa,	  OK).	   A	   repeated	  measures	  ANOVA	  
(analysis	  of	  variance)	  was	  used	  to	  compare	  protein	  deposition	  to	  the	  different	  lens	  materials	  over	  time.	  
Factors	  included	  in	  the	  ANOVA	  were:	  protein	  of	  interest,	  contact	  lens	  material,	  and	  time	  point.	  	  Tukey’s	  







Results	  are	  presented	  in	  Figure	  3-­‐2.	  All	  lens	  types	  showed	  an	  increase	  in	  lysozyme	  deposition	  between	  
days	  1	  and	  28,	  independent	  of	  solution	  used	  for	  incubation	  (p<0.001).	  	  
	  
After	  1	  day	  of	  incubation,	  SA	  lenses	  accumulated	  similar	  amounts	  of	  lysozyme	  when	  incubated	  in	  either	  
solution	  (Solution	  A:	  0.28±0.03μg,	  Solution	  B:	  0.31±0.03μg;	  p=1.00).	  Slightly	  more	   lysozyme	  was	  found	  
after	  28	  days:	  SA	  lenses	  accumulated	  4.06±0.19μg	  when	  incubated	  in	  Solution	  B	  and	  2.57±1.33μg	  using	  
Solution	  A,	  however,	   this	  difference	  was	  also	  not	   statistically	   significant	   (p=0.20).	   LB	   lenses	  deposited	  
similar	   amounts	   of	   lysozyme	  with	   both	   solutions	   (Solution	   A:	   0.74±0.08μg,	   Solution	   B:	   (0.58±0.09μg);	  
p=1.00)	  after	  1	  day	  of	  incubation.	  This	  amount	  increased	  after	  28	  days	  to	  4.99±0.01μg	  and	  4.70±0.20μg	  
using	  Solution	  A	  and	  B	  respectively	   (p=1.00).	  BA	  accumulated	  similar	  amounts	  of	   lysozyme	  after	  1	  day	  
(Solution	   A:	   4.69±0.19μg,	   Solution	   B:	   4.96±0.19μg;	   p=1.00)	   independent	   of	   the	   solution	   used,	   but	  
deposited	   significantly	   higher	   amounts	   after	   14	   and	   28	   days	   when	   incubated	   in	   Solution	   B	   (Day	   28:	  
Solution	  A	  =	  33.68±1.81μg;	  Solution	  B	  =	  56.22±1.59μg;	  p<0.001)	  (Figure	  3-­‐2).	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Figure	  3-­‐2:	  Lysozyme	  deposition	  to	  senofilcon	  A,	  lotrafilcon	  B	  and	  balafilcon	  A	  lenses	  using	  a	  single	  
protein	  solution	  and	  a	  complex	  ATS	  solution.	  Incubation	  points:	  1,	  7,	  14	  and	  28	  days.	  
	  
Lysozyme	  deposition	  increased	  between	  each	  time	  point	  for	  both	  solutions	  (A	  and	  B)	  over	  a	  period	  of	  28	  
days	   (p<0.001),	   with	   Solution	   B	   depositing	   significantly	   more	   lysozyme	   than	   Solution	   A	   by	   day	   28	  
(p<0.001).	   Independent	   of	   lens	   type,	   lysozyme	   deposition	   increased	   from	   day	   1	   to	   28,	   depositing	  









Results	  are	  presented	  in	  Figure	  3-­‐3.	  From	  day	  1	  to	  28,	  the	  amount	  of	  lactoferrin	  deposition	  to	  SH	  lenses	  
increased	  independent	  of	  solution	  used	  for	  incubation	  (p<0.001).	  	  
	  
After	   1	   day	   of	   incubation,	   SA	   lenses	   accumulated	   similar	   amounts	   of	   lactoferrin	   using	   Solution	   A	  
(0.81±0.09μg)	   and	   Solution	   B	   (0.81±0.04μg)	   (p=1.00).	   After	   28	   days,	   slightly	   less	   lactoferrin	  was	   seen	  
when	   incubated	   in	   Solution	   A	   (8.17±0.70μg)	   in	   comparison	   to	   Solution	   B	   (11.21±0.28μg)	   (p=0.17).	   LB	  
lenses	   incubated	   in	   Solution	   A	   (5.34±0.17μg)	   accumulated	   slightly	   more	   lactoferrin	   than	   Solution	   B	  
(2.16±0.07μg)	  after	  1	  day,	  however	  this	  difference	  was	  not	  significant	  (p=0.13).	  After	  28	  days	  however,	  
LB	   deposited	   significantly	   more	   lactoferrin	   when	   incubated	   in	   Solution	   A	   compared	   to	   Solution	   B	  
(Solution	  A:	  16.62±0.86μg,	  Solution	  B:	  10.28±1.66μg;	  p<0.001).	  BA	   lenses	  also	  attracted	  slightly	  higher	  
amounts	   of	   lactoferrin	   when	   incubated	   in	   Solution	   A	   (5.75±0.86μg)	   compared	   to	   Solution	   B	  
(2.62±0.66μg)	  after	  1	  day	  (p=0.14)	  which	  became	  statistically	  significant	  after	  28	  days,	  where	  Solution	  A	  




The	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Figure	   3-­‐3:	   Lactoferrin	   deposition	   to	   senofilcon	   A,	   lotrafilcon	   B	   and	   balafilcon	   A	   lenses	   using	   a	   single	  
protein	  solution	  and	  a	  complex	  ATS	  solution.	  Incubation	  points:	  1,	  7,	  14	  and	  28	  days.	  
	  
There	   was	   an	   increase	   in	   lactoferrin	   deposition	   between	   days	   1	   and	   28	   (p<0.001),	   with	   Solution	   A	  
depositing	  significantly	  more	  lactoferrin	  than	  Solution	  B	  (p=0.017).	  Independent	  of	  lens	  type,	  lactoferrin	  
deposits	  similarly	  on	  lens	  materials	  incubated	  in	  Solution	  A	  at	  day	  1	  and	  7	  (p=0.91).	  However,	  there	  was	  
an	  increase	  in	  the	  rate	  of	  accumulation	  between	  the	  other	  time	  points	  (day	  7	  and	  14	  (p<0.001);	  day	  14	  
and	  28	  (p=0.001)).	  With	  regards	  to	  Solution	  B,	  there	  was	  not	  a	  significant	  difference	  between	  lactoferrin	  







Results	  are	  presented	  in	  Figure	  4.	  In	  general,	  there	  was	  an	  increase	  in	  albumin	  deposition	  to	  SH	  lenses	  
over	  time,	  independent	  of	  solution	  used	  for	  incubation	  (p<0.001).	  	   	  
	  
After	  1	  day	  of	  incubation,	  SA	  lenses	  accumulated	  similar	  amounts	  of	  albumin	  when	  incubated	  in	  either	  
solution	  (Solution	  A:	  0.32±0.02μg,	  Solution	  B:	  0.45±0.02μg;	  p=0.70).	  A	  similar	  result	  was	  also	  seen	  after	  
28	  days,	  showing	  0.56±0.06μg	  when	  incubated	  in	  Solution	  A	  and	  0.70±0.09μg	  using	  Solution	  B	  (p=0.53).	  
LB	   deposited	   significantly	   more	   albumin	   in	   Solution	   A	   (0.66±0.05μg)	   compared	   to	   Solution	   B	  
(0.40±0.06μg)	  after	  1	  day	  of	  incubation	  (p=0.04).	  Likewise	  more	  albumin	  was	  accumulated	  after	  28	  days	  
when	   lenses	   were	   incubated	   in	   Solution	   A	   (0.92±0.03μg)	   compared	   to	   Solution	   B	   (0.58±0.08μg)	  
(p=0.003).	  After	  1	  day	  of	  incubation,	  BA	  lenses	  deposited	  similar	  amounts	  of	  albumin	  with	  both	  solutions	  
(Solution	  A	  (0.57±0.07μg);	  Solution	  B	  (0.73±0.03μg)	   (p=0.38)).	  With	  a	   longer	   incubation	  of	  28	  days,	  BA	  
lenses	   accumulated	   significantly	   less	   (p<0.001)	   albumin	   in	   Solution	   A	   (0.85±0.00μg)	   in	   comparison	   to	  
Solution	  B	  (1.68±0.04μg)	  (Figure	  4).	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Figure	   3-­‐4:	   Albumin	   deposition	   to	   senofilcon	   A,	   lotrafilcon	   B	   and	   balafilcon	   A	   lenses	   using	   a	   single	  
protein	  solution	  and	  a	  complex	  ATS	  solution.	  Incubation	  points:	  1,	  7,	  14	  and	  28	  days.	  
	  
There	  was	  an	   increase	   in	  albumin	  deposition	  between	  day	  1	  and	  day	  28	  and	  also	  between	  each	  time-­‐
point	   (p<0.001),	   with	   Solution	   B	   depositing	   significantly	   more	   albumin	   than	   Solution	   A	   (p=0.008).	  
Independent	  of	  lens	  type,	  the	  amount	  of	  albumin	  increased	  from	  day	  1	  to	  day	  7	  (p=0.01)	  using	  Solution	  
A	  and	  a	  plateau	  was	  seen	  after	   this	   time	  point	   (day	  7	  and	  14	   (p=0.18),	  day	  14	  and	  28	   (p=0.40)).	  With	  
regards	  to	  Solution	  B,	  there	  was	  a	  significant	  difference	  between	  each	  time	  point,	  as	  protein	  deposition	  







The	   human	   tear	   film	   contains	   a	   variety	   of	   proteins,	   lipids,	   and	  mucins,	   each	   of	   which	   differs	   in	   size,	  
charge,	   and	   concentration	   [29,52,53].	   Positively	   charged	   [1]	   lysozyme	   (14.5	   kDA	   [54])	   and	   the	   iron-­‐
binding	  protein	   lactoferrin	   (80	   kDA	   [55])	   constitute	  major	   proportions	  of	   the	   tear	   film,	  measuring	   1.9	  
mg/mL	   [56]	  and	  1.5-­‐2.2	  mg/mL	   [55],	   respectively.	   Lysozyme	  contains	   three	  positive	  binding	  sites	   [57],	  
whereas	   lactoferrin	  has	  one	  [58].	  Albumin,	  a	  negatively	  charged	  protein,	  has	  a	  molecular	  weight	  of	  66	  
kDA	  [59]	  and	  is	  found	  in	  the	  tear	  film	  at	  a	  concentration	  ranging	  from	  0.02	  to	  0.5	  mg/mL	  [60,61].	  	  
	  
The	  contact	  lens	  materials	  investigated	  in	  this	  study	  were	  incubated	  in	  a	  non-­‐competitive,	  single	  protein	  
solution	   and	   a	   complex	   ATS,	   consisting	   of	   multiple	   proteins,	   mucins,	   and	   lipids.	   This	   complex	   ATS,	  
according	   to	   the	   Vroman	   effect,	   will	   allow	   for	   sequential	   adsorption	   of	   proteins	   to	   the	   lens	   surface	  
[52,62,63].	  Blood	  plasma	  proteins	  undergo	   the	  Vroman	  effect	  when	  adsorbing	  onto	  artificial	   surfaces,	  
particularly	  the	  displacement	  of	  fibrinogen	  by	  other	  plasma	  proteins	  [64].	  Sariri	  and	  Sabbaghzadeh	  have	  
demonstrated	  competitive	  protein	  binding	  onto	  soft	  contact	  lens	  surfaces	  and	  the	  ability	  of	  proteins	  to	  
displace	   one	   another	   [65].	   To-­‐date,	   only	   a	   few	   studies	   have	   determined	   the	   impact	   of	   other	   tear	  
components	  during	   the	   sorption	  process,	   and	  no	  data	  were	   available	  on	  proteins	  of	   different	   charge,	  
size	  and	  abundance	  and	  their	  interaction	  with	  SH	  materials	  [25,30].	  It	  was	  predicted	  that	  the	  negatively	  
charged	   albumin	   would	   deposit	   to	   only	   a	   minor	   extent	   onto	   negatively	   charged	   materials,	   due	   to	  
electrostatic	  repulsion	  [66].	  
	  
The	   three	   SH	   lenses	   investigated	   in	   this	   study	   differed	   in	   material	   composition,	   water	   content	   and	  
surface	   modification.	   The	   SA	   material	   contains	   a	   copolymerization	   of	   HEMA	   and	   N,	   N-­‐dimethyl	  
acrylamide	  with	   (3-­‐methylacryloxy-­‐2hydroxypropyloxy)	  propylbis	   (trimethylsiloxy)	  methylsilane	   [67].	   In	  
addition,	   an	   internal	   wetting	   agent	   (polyvinyl	   pyrrolidone	   (PVP))	   is	   incorporated	   into	   SA	   lenses	   to	  
improve	  wettability	  [68-­‐70].	  Lysozyme	  contributes	  6-­‐13μg	  of	  the	  total	  protein	  deposition	  per	  SA	  lens	  in	  
in	   vitro	   studies	   [27,30],	  whereas	   ex	   vivo	   studies	   report	   up	   to	   7μg	   of	   total	   protein	   per	   lens	   deposited	  
[5,28,33],	   with	   lysozyme	   contributing	   about	   25%	   [28,33],	   demonstrating	   that	   more	   lysozyme	   is	  
deposited	   in	  vitro	   (6-­‐13μg	  vs.	  1.75μg).	  For	  SA	   lenses,	   there	  was	  no	  statistically	  significant	  difference	   in	  
deposition	  of	  any	  of	  the	  proteins	  investigated	  whether	  Solution	  A	  or	  B	  was	  used	  for	  incubation	  (p=NS).	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This	   suggests	   that	   this	  material	   is	   unaffected	   by	   incubation	   solution	   composition.	   Given	   the	   complex	  
nature	   of	   the	   ATS,	   this	   result	   suggests	   that	   little	   competition	   for	   protein	   deposition	   occurs	   with	   this	  
material,	   and	   that	   protein	   deposition	   is	   driven	   by	   non-­‐competitive	   factors.	   After	   28	   days,	   SA	   also	  
deposited	  the	  lowest	  amount	  of	  all	  three	  proteins,	  as	  compared	  with	  the	  other	  two	  materials.	  This	  low	  
level	   of	   deposition	   has	   been	   seen	   in	   other	   in	   vitro	   and	   ex	   vivo	   studies	   [27,28,30,33],	   and	   may	   be	  
attributed	  to	  the	  neutral	  surface	  charge	  and,	  specifically,	   the	  presence	  of	  PVP,	  which	   for	  both	  contact	  
lenses	   and	   other	   biomaterial	   applications	   has	   also	   been	   shown	   to	   exhibit	   low	   levels	   of	   protein	  
deposition	  [30,71].	  
	  
The	   LB	   material	   has	   a	   co-­‐continuous	   biphasic-­‐	   siloxy	   and	   hydrogel	   phase,	   which	   aids	   the	   lens	   in	  
maintaining	   oxygen	   and	   salt	   transmission	   [67].	   This	   lens	   material	   is	   coated	   by	   hydrophilic	   plasma	   to	  
improve	  hydrophilicity	  of	  the	  surface	   [67,72]	  and	  this	  plasma	  coating	  (25nm	  thick)	   limits	  access	  to	  the	  
underlying	  polymer,	  hence	  decreasing	  protein	  deposition	  on	  this	  material	  and	  within	  the	  matrix	  [6,73].	  
In	  vitro	  studies	  on	  LB	  show	  that	  lysozyme	  contributes	  about	  6-­‐10μg	  of	  total	  protein	  deposited	  per	  lens	  
[25,27].	  Ex	  vivo	  studies	   illustrate	  that	  >7μg	  [74,75]	  of	  total	  protein	  per	   lens	   is	  deposited,	  with	  <25%	  as	  
lysozyme	  [28,33].	  After	  28	  days	  of	  incubation,	  no	  differences	  in	  the	  amounts	  of	  lysozyme	  deposited	  on	  
LB	  lenses	  were	  measured	  between	  the	  two	  incubation	  solutions	  (p=NS).	  This	  may	  be	  due	  to	  the	  size	  of	  
lysozyme,	   which	   is	   the	   smallest	   of	   the	   three	   proteins	   and	   may	   outcompete	   the	   other	   two	   proteins,	  
appearing	   as	   if	   it	   is	   accumulating	   on	   the	   lens	   material	   without	   competition	   from	   other	   proteins.	   A	  
significant	  difference	  in	  both	  lactoferrin	  and	  albumin	  accumulation	  occurred	  (p<0.05),	  with	  the	  simplistic	  
incubation	   solution	   (Solution	   A)	   producing	   the	   greatest	   deposition.	   These	   data	   suggest	   that	   when	  
exposed	   to	   Solution	  A,	  which	   has	   no	   lysozyme,	   the	   other	   two	  proteins	   of	   interest	   can	   deposit	   freely,	  
without	  the	  competitive	  binding	  that	  lysozyme	  exhibits.	  After	  28	  days,	  in	  comparison	  with	  the	  other	  two	  
materials,	  LB	  deposits	  more	  protein	  than	  SA,	  but	  less	  than	  BA.	  	  
	  
The	  BA	  material	  has	  a	  biphasic	  character	  due	  to	  copolymerization	  of	  the	  TRIS	  derivative	  vinyl	  carbamate	  
and	  N-­‐vinyl	  pyrrolidone	  [67].	  Hydrophilic	  glassy	  silicate	  ‘islands’	  can	  be	  seen	  on	  the	  surface	  of	  BA	  lenses	  
[6]	  due	  to	  the	  oxidation	  of	  TRIS	  [67].	  BA	  is	  considered	  ionic	  (FDA	  Group	  III)	  due	  to	  its	  incorporation	  of	  N-­‐
vinyl	   aminobutyric	   acid	   and	   as	   a	   result,	   this	   material	   typically	   accumulates	   more	   tear	   proteins,	  
particularly	   those	   that	   are	   positively	   charged,	   compared	   to	   other	   SH	   lenses	   [5,27,30].	   Furthermore,	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unlike	  other	  SH	  lenses,	  the	  surface	  of	  BA	  is	  more	  porous,	  allowing	  for	  protein	  to	  penetrate	  through	  the	  
matrix	  [72,73].	  Previous	  in	  vitro	  studies	  report	  that	  lysozyme	  deposits	  approximately	  10μg	  of	  protein	  per	  
lens	   [30,76].	   Of	   the	   total	   amount	   of	   protein	   depositing	   on	  worn	   BA	   lenses	   (5-­‐34μg)	   [5,33],	   lysozyme	  
accounts	   for	   32%	   [76]	   to	   50%	   [25].	   Lysozyme	   accumulated	   significantly	   more	   on	   BA	   lenses	   (p<0.05)	  
when	   incubated	   in	  the	  complex	  ATS.	  This	   is	  an	   interesting	  phenomenon,	  as	   it	  would	  be	  predicted	  that	  
there	  would	  be	  no	  difference	  between	  the	  two	  solutions	  because	  of	   lysozyme’s	  ability	  to	  deposit	  on	  a	  
negatively	   charged	   material	   in	   large	   amounts,	   independent	   of	   incubation	   solution.	   One	   potential	  
explanation	   could	   be	   that	   when	   exposed	   to	   a	   complex	   ATS	   that	   there	   is	   an	   initial	   deposition	   of	   the	  
positively	   charged	   lysozyme,	  which	   acts	   to	   partially	   neutralize	   the	   surface	   charge	   of	   the	   BA	  material,	  
allowing	  some	  binding	  of	  the	  negatively	  charged	  albumin,	  which	  then	  results	  in	  a	  “layering”	  of	  proteins	  
on	   top	   of	   this	   initial	   layer	   [77,78].	   Lactoferrin,	   as	   expected,	   deposited	   significantly	   more	   on	   the	   BA	  
material	  when	  incubated	  in	  the	  simplistic	  solution.	  This	  is	  due	  to	  the	  decrease	  in	  available	  binding	  sites	  
on	   the	   negatively	   charged	   BA	  material,	   due	   to	   lysozyme’s	   competitive	   behavior.	   In	   contrast,	   albumin	  
deposited	   more	   when	   lenses	   were	   incubated	   in	   the	   complex	   ATS	   (Solution	   B).	   The	   low	   level	   when	  
exposed	  to	  Solution	  A	   is	  expected,	  as	  both	  BA	  and	  albumin	  are	  negatively	  charged	  and	  exhibit	  mutual	  
electrostatic	   repulsion.	  The	  higher	   level	  when	  exposed	  to	  the	  complex	  Solution	  B	  can	  be	  attributed	  to	  
the	  partial	  neutralization	  of	  the	  BA	  material	  by	  the	  positively	  charged	  lysozyme	  and	  lactoferrin,	  allowing	  
albumin	   for	  an	   increased	  opportunity	   to	  bind	   to	   the	  BA	   surface.	  Of	   the	   three	  materials	  examined,	  BA	  
deposits	  the	  highest	  amount	  of	  all	  three	  proteins.	  	  
	  
Patient-­‐worn	   senofilcon	   A	   lenses	   deposit	   approximately	   7μg	   [28,33]	   of	   total	   protein,	   whereas	   lenses	  
incubated	  in	  Solution	  A	  and	  B	  deposited	  approximately	  two	  times	  more	  protein	  (11.30μg	  and	  15.97μg,	  
respectively	   (sum	   of	   125I	   data	   from	   all	   three	   proteins).	   Lotrafilcon	   B	   lenses	   in	   Solution	   A	   deposited	  
approximately	   three	   times	  more	   total	   protein	   (22.53μg)	   than	  what	   has	   been	   found	   in	  ex	   vivo	   studies	  
(>7μg	   [14,74,75]),	   whereas	   Solution	   B	   lenses	   accumulated	   roughly	   two	   times	   more	   total	   protein	  
(15.56μg).	  Ex	  vivo	  studies	  on	  balafilcon	  A	  have	  found	  5-­‐34μg	  [5,33]	  of	  total	  protein,	  whereas	  BA	  lenses	  
incubated	   in	   Solution	   A	   accumulated	   two	   times	   more	   protein	   (64.78μg)	   versus	   approximately	   three	  
times	  more	  total	  protein	  when	  using	  Solution	  B	  (79.94μg).	  A	  number	  of	  reasons	  may	  account	  for	  these	  
differences.	  The	  naturally	  occurring	  physiological	  events	  of	  the	  eye,	  blinking,	  and	  surface	  drying	  are	  all	  
lacking	   in	   this	   in	   vitro	  model.	   The	   lens	   surface	   in	   vivo	   dries	   between	   blinks	   as	   the	   lid	  wipes	   over	   the	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material	  [79]	  and	  this	  drying	  is	  known	  to	  influence	  deposition	  onto	  lens	  materials	  from	  the	  tear	  film	  [80].	  
Most	  importantly,	  ex	  vivo	  studies	  typically	  contain	  the	  use	  of	  a	  care	  regimen	  each	  day,	  which	  would	  be	  
predicted	  to	  decrease	  protein	  accumulation	  on	  the	  lens	  material	  over	  time.	  	  
	  
In	  conclusion,	   this	  study	  confirms	  that	  there	  are	  differences	   in	  amounts	  of	  protein	  deposition	  onto	  SH	  
materials	   incubated	   in	  either	  a	   single	  protein	  or	  complex	  ATS	   incubation	  solution.	  The	   results	   showed	  
that	  protein	  accumulation	  was	   further	  dependent	  on	   incubation	   time,	   the	  nature	  of	   the	  protein	   (size,	  
concentration,	   and	   charge)	   and	   type	   of	   SH	  material.	   BA	  was	   the	   greatest	   accumulator,	   as	   previously	  
reported.	  With	  regards	  to	  lysozyme	  deposition,	  no	  impact	  of	  the	  type	  of	  solution	  was	  seen	  for	  SA	  and	  LB	  
lenses,	   however,	   BA	   lenses	   incubated	   in	   Solution	   B	   deposited	   greater	   amounts	   of	   lysozyme.	   Greater	  
amounts	  of	  lactoferrin	  also	  accumulated	  on	  LB	  and	  BA	  lenses	  when	  incubated	  in	  Solution	  A,	  whereas	  the	  
opposite	   trend	  was	   seen	   for	   SA	   lenses,	  which	   deposited	  more	   lactoferrin	  with	   Solution	   B.	   Finally,	   BA	  
lenses	   deposited	   greater	   amounts	   of	   albumin	   when	   incubated	   in	   Solution	   B,	   whereas	   LB	   lenses	  
accumulated	  greater	  albumin	  when	  incubated	  in	  Solution	  A,	  while	  less	  solution	  impact	  was	  found	  using	  
SA	  lenses.	  	  
	  
The	  diversity	  of	  the	  results	  in	  this	  study	  highlights	  the	  importance	  of	  using	  appropriate	   in	  vitro	  models,	  
as	   the	   outcome	   for	   protein	   accumulation	   to	   certain	   contact	   lens	   -­‐	   protein	   interactions	   is	   strongly	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4 EFFECT	  OF	  MULTI-­‐PURPOSE	  SOLUTION	  ON	  COMPETITIVE	  BINDING	  




























Purpose:	  The	  purpose	  of	  this	   in	  vitro	  study	  was	  to	  determine	  the	  effect	  of	  a	  multi-­‐purpose	  solution	  on	  
removing	   protein	   deposited	   on	   silicone	   hydrogel	   (SH)	   lenses	   incubated	   in	   either	   a	   simple	   protein	  
solution	  or	  complex	  artificial	  tear	  solution	  (ATS).	  
	  
Methods:	  Three	  SH	  materials	  -­‐	  senofilcon	  A	  (SA),	  lotrafilcon	  B	  (LB)	  and	  balafilcon	  A	  (BA)	  -­‐	  were	  incubated	  
in	  two	  different	  solutions	  (n=4	  for	  each	  lens	  type);	  Solution	  A	  was	  a	  simple	  saline	  solution	  containing	  a	  
single	   protein,	   whereas	   Solution	   B	   was	   a	   more	   complex	   ATS,	   containing	   proteins,	   lipids	   and	  mucins.	  
Lysozyme	  protein	  was	  radiolabeled	  with	  125Iodine	  and	  protein	  deposition	  was	  determined	  after	  1,	  7,	  14,	  
and	  28	  days	  of	  incubation.	  Half	  of	  the	  lenses	  were	  cleaned	  with	  OPTI-­‐FREE	  RepleniSH	  (OFR)	  five	  times	  a	  
week	  and	  compared	  to	  the	  un-­‐cleaned	  lenses.	  	  
	  
Results:	   At	   the	   end	   of	   the	   28	   days,	   SA	   lenses	   incubated	   in	   Solution	   A	   accumulated	   significantly	   less	  
lysozyme	  than	  the	  lenses	  incubated	  in	  Solution	  B	  (1.24μg	  vs.	  3.81μg;	  p<0.001).	  A	  similar	  trend	  was	  also	  
seen	  with	  LB	  lenses	  (Solution	  A:	  2.57μg,	  Solution	  B:	  13.66μg;	  p<0.001).	  BA	  lenses	  incubated	  in	  Solution	  A	  
accumulated	  22.37μg	  of	  lysozyme,	  whereas	  Solution	  B	  accumulated	  28.18μg	  (p<0.001).	  When	  SA	  lenses	  
were	  cleaned	  with	  OFR,	  47%	  of	  protein	  was	  removed	  when	  lenses	  were	  incubated	  in	  Solution	  A	  and	  87%	  
was	   removed	   when	   lenses	   were	   incubated	   in	   Solution	   B.	   Both	   incubation	   solutions	   allowed	   for	  
approximately	   0.50μg	   of	   lysozyme	   to	   accumulate	   on	   the	   SA	   lenses	   after	   cleaning.	   For	   LB	   lenses,	  OFR	  
removed	   46%	   when	   lenses	   were	   incubated	   in	   Solution	   A	   and	   75%	   when	   lenses	   were	   incubated	   in	  
Solution	  B.	  There	  was	  a	  plateau	  at	  0.60μg	  and	  1.40μg	  for	  Solution	  A-­‐	  and	  Solution	  B-­‐incubated	   lenses,	  
respectively.	  For	  BA	  lenses,	  about	  a	  70%	  cleaning	  efficacy	  is	  found	  for	  lenses	  incubated	  in	  either	  Solution	  
A	  or	  Solution	  B.	  	  
	  
Discussion:	  The	  two	  different	  incubation	  solutions	  had	  an	  impact	  on	  the	  amount	  of	  lysozyme	  depositing	  
on	   SA,	   LB,	   and	   BA	   lenses.	   Lenses	   incubated	   in	   the	   ATS	   typically	   accumulated	   greater	   amounts	   of	  
lysozyme,	  which	   highlights	   the	   importance	   of	   choosing	  more	   appropriate	  models	  when	   conducting	   in	  
vitro	  experiments.	   	  The	  care	  regimen,	  OFR,	  had	  a	  greater	  efficacy	  when	  removing	  protein	  from	  SA	  and	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LB	   lenses	   incubated	   in	   a	   complex	   ATS;	   however,	   a	   similar	   cleaning	   efficacy	  was	   found	   for	   BA	   lenses,	  
regardless	  of	  incubation	  solution.	  
	  




























Proteins	   enter	   the	   tear	   film	   through	   different	   pathways,	   including	   the	   lacrimal	   [1,2]	   and	   meibomian	  
glands	   [3],	   ocular	   surface	   cells	   [4],	   and	   by	   leakage	   through	   the	   blood	   vessels	   [5].	   It	   is	   therefore	   not	  
surprising	  that	  de	  Souza	  was	  able	  to	  detect	  491	  different	  types	  of	  proteins	   in	  the	  human	  tear	  film	  [6].	  
The	   total	   protein	   concentration	   is	   approximately	   8mg/mL	   [6,7]	   and	   the	   most	   abundant	   proteins	   are	  
lysozyme	  and	  lactoferrin,	  which	  together	  account	  for	  approximately	  50%	  of	  the	  total	  protein	  [2,8].	  The	  
exposure	  of	  biomaterials,	   such	  as	  contact	   lenses,	   typically	   results	   in	  deposition	  of	   tear	  proteins	   to	   the	  
contact	  lens	  surface	  and	  penetration	  into	  the	  lens	  matrix	  [9,10].	  The	  deposition	  profile	  is	  very	  material-­‐
specific	   and	   silicone	   hydrogel	   (SH)	   contact	   lens	  materials	   have	   shown	   to	   accumulate	   significantly	   less	  
protein	  than	  conventional	  hydrogel	  lenses	  [11];	  however,	  the	  protein	  that	  deposits	  onto	  the	  SH	  surface	  
is	  mainly	  denatured	  [12,13].	  Denatured	  proteins	  have	  been	  linked	  to	  giant	  papillary	  conjunctivitis	  [14],	  
which	  is	  an	  inflammatory	  reaction	  to	  proteins,	  occurring	  at	  the	  palpebral	  conjunctiva	  [15].	  
	  
Contact	  lens	  multi-­‐purpose	  solutions	  (MPS)	  and	  hydrogen	  peroxide-­‐based	  systems	  are	  used	  by	  contact	  
lens-­‐wearers	  in	  order	  to	  clean	  and	  disinfect	  the	  lenses	  between	  wearing	  cycles	  [16,17].	  Cleaning	  solution	  
components	  have	  the	  ability	   to	  change	  the	  chemical	  and/or	  physical	  properties	  of	   the	   lens	  surface,	  as	  
well	   as	   stick	   onto	   the	   lens	   surface	   or	   penetrate	   through	   the	   lens	   matrix	   [18].	   A	   study	   by	   Zhao	   and	  
colleagues	   determined	   that	   the	   amount	   of	   protein	   removed	   from	   lenses	  was	   dependent	   on	   the	  MPS	  
used	   as	  well	   as	   the	   lens	   type;	   OPTI-­‐FREE	   Express	   (OFE)	   and	  OPTI-­‐FREE	   RepleniSH	   (OFR)	   removed	   the	  
most	  protein	  from	  lotrafilcon	  B	  lenses	  (1.7μg	  (OFR)	  and	  3.6μg	  (OFE)	  compared	  to	  less	  than	  1μg	  for	  other	  
MPS	  tested)	  [18].	  Proteins	  were	  most	  efficiently	  removed	  from	  balafilcon	  A	  lenses	  regardless	  of	  the	  lens	  
care	   solution	   used	   (5.4	   to	   23.5μg)	   [18].	   For	   senofilcon	   A	   lenses,	   AQuify	   showed	   a	   better	   efficacy	   of	  
protein	  removal	  compared	  to	  the	  other	  products	  [18].	  	  
	  
A	  more	  recent	   in	  vitro	   study,	  conducted	  by	  Luensmann	  and	  colleagues,	  reported	  that	  the	  efficiency	  of	  
protein	  removal	  from	  contact	  lenses	  using	  various	  care	  regimens	  ranged	  from	  2.9%	  to	  62.4%	  and	  only	  a	  
minor	  difference	  was	   seen	  between	  manual	   lens	   rubbing	  and	   soaking	  alone	   [11].	   In	   this	   study,	  only	  a	  
single	   protein	   solution	   was	   used	   for	   incubation	   and	   the	   results	   suggested	   that	   lotrafilcon	   B	   lenses	  
accumulated	  small	  amounts	  of	  lysozyme,	  only,	  but	  this	  deposit	  was	  bound	  more	  tightly	  bound	  compared	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to	  etafilcon	  A,	  which	  accumulated	  high	  amounts	  of	   lysozyme,	  but	  which	   released	  a	  higher	  percentage	  
during	  the	  cleaning	  cycle	  [11].	  This	  could	  be	  explained,	  as	  denatured	  proteins	  typically	  bind	  more	  tightly	  
to	  contact	   lenses	   [19],	  and	   the	  percentage	  of	  denatured	  protein	   recovered	   from	  SH	   lenses	   is	   typically	  
higher	  compared	  to	  the	  content	  determined	  on	  conventional	  hydrogels	  [12,13].	  	  
	  
The	  purpose	  of	  this	  in	  vitro	  study	  was	  to	  determine	  the	  amount	  of	  protein	  deposition	  onto	  three	  SH	  lens	  
types	  when	  regularly	  cleaned	  with	  a	  MPS	  care	  regimen.	  A	  single	  protein	  solution	  and	  a	  complex	  artificial	  
tear	   solution	   (ATS)	   were	   used	   to	   determine	   lysozyme	   deposition	   rates.	   In	   a	   previous	   study	   [20]	  
differences	  were	   found	   for	   the	   amount	  of	   protein	   depositing	  when	  other	   tear	   film	   components	  were	  
present	   and	   the	   current	   study	   will	   determine	   whether	   these	   incubation	   solutions	   also	   impact	   MPS	  
cleaning	  efficacy.	  	  
	  
4.3 METHODS	  	  
	  
In	   this	   in	   vitro	   study,	   a	   simple	   saline	   solution	   and	   a	  more	   complex	   ATS	  were	   used	   to	   determine	   the	  
deposition	  of	  lysozyme	  onto	  different	  SH	  lenses,	  while	  undergoing	  frequent	  cleaning	  cycles	  with	  OFR.	  	  
Incubation	  solutions	  
A	   single	   protein	   solution	   (Solution	  A)	   and	   complex	  ATS	   (Solution	   B)	  were	   used	   for	   the	   contact	   lenses	  
incubation.	  Solution	  A	  contained	  a	  number	  of	  salts,	  glucose,	  and	  urea,	  and	  the	  composition	  details	  are	  
outlined	   in	   recent	   publication	   by	   Lorentz	   and	   colleagues	   [21].	   Lysozyme	   (1.9mg/mL)	   was	   added	   as	   a	  
single	   protein	   of	   interest	   to	   Solution	   A.	   The	   process	   of	  making	   both	   solutions	   has	   been	   described	   in	  
detail	   in	   a	   recent	   publication	   by	   Jadi	   et	   al.	   [20].	   In	   brief,	   Solution	   B	   consisted	   of	   the	   saline	   solution	  
described	   above	   with	   an	   addition	   of	   proteins	   (albumin,	   lactoferrin,	   lysozyme,	   and	   IgG),	   mucins,	   and	  
lipids	  (cholesterol,	  cholesteryl	  oleate,	  OAME,	  oleic	  acid,	  phosphatidylcholine,	  and	  triolein)	  [21].	  The	  pH	  
of	  both	  solutions	  was	  within	  human	  tear	  film	  limits	  at	  about	  7.4	  [22].	  	  
	  
Lysozyme	   was	   conjugated	   with	   iodine-­‐125	   (125I)	   through	   the	   iodine	   monochloride	   method	   [23].	   The	  
radiolabeled	  protein	  was	  added	  to	  the	  incubation	  solutions	  at	  a	  concentration	  of	  2%.	  Control	  solutions,	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not	  containing	  a	  contact	  lens,	  were	  used	  to	  verify	  radioactive	  decay	  over	  time.	  	  
Three	  SH	  contact	   lens	  materials	  (Table	  4-­‐1)	  were	  studied	  in	  this	  experiment	  -­‐	  senofilcon	  A	  (SA,	  Acuvue	  
Oasys,	   Johnson	  &	  Johnson,	   Jacksonville,	  FL),	   lotrafilcon	  B	   (LB,	  Air	  Optix;	  CIBA	  VISION,	  Duluth,	  GA),	  and	  
balafilcon	  A	  (BA,	  PureVision;	  Bausch	  &	  Lomb,	  Rochester,	  NY).	  
Table	  4-­‐1:	  Properties	  of	  silicone	  hydrogel	  contact	  lenses	  
	   Senofilcon	  A	   Lotrafilcon	  B	   Balafilcon	  A	  
FDA	  Group	   I:	  low	  water	  (<50%),	  
non-­‐ionic	  
I:	  low	  water	  (<50%),	  
non-­‐ionic	  
III:	  low	  water	  
(<50%),	  ionic	  
Water	  content	  (%)	   38	   33	   36	  
Charge	   Neutral	   Neutral	   Negative	  
Oxygen	  permeability	  (Dk)	   103	   110	   91	  
Surface	  modifications	   No	  surface	  
treatment.	  Internal	  






PVP=	  polyvinyl	  pyrrolidone	  
Contact	  lens	  incubation	  
Each	   contact	   lens	  was	  pre-­‐soaked	   in	   saline	   for	   24	  hours	   in	   order	   to	   remove	   the	  blister-­‐pack	   solution.	  
Glass	  jars	  (250mL;	  Qorpak,	  Bridgeville,	  PA),	  containing	  histology	  cassettes	  (VWR,	  Mississauga,	  ON),	  were	  
pre-­‐treated	  for	  4–7	  days	  with	  the	  same	  solution	  used	  for	  lens	  incubation.	  This	  was	  done	  to	  coat	  the	  jars	  
and	  cassettes	  and	  to	  minimize	  adsorption	  of	  solution	  components	  to	  the	  walls	  of	  the	  glass	  and	  cassettes	  
during	  the	  lens	  incubation.	  IgG	  was	  not	  used	  in	  the	  pre-­‐treatment	  of	  ATS	  vials	  due	  to	  cost	  limitations.	  	  
Contact	  lenses	  were	  placed	  in	  histology	  cassettes	  that	  held	  four	  lenses	  securely,	  incubated	  at	  37	  °C,	  and	  
placed	  on	  a	  rotatory	  shaker	  (VWR,	  Mississauga,	  ON)	  at	  60	  rpm	  for	  1,	  7,	  14,	  and	  28	  days	  (Figure	  4-­‐1).	  Four	  
replicates	  were	  used	  for	  each	  lens	  type	  and	  time	  point,	  resulting	  in	  576	  lenses	  total.	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Figure	  4-­‐1:	  Histology	  cassettes	  holding	  four	  lenses	  	  
	  
Following	   the	   incubation,	   50%	   of	   the	   lenses	   (test	   group)	   underwent	   a	   cleaning	   procedure	   using	   OFR	  
(Table	   4-­‐2).	   The	   other	   50%	   (control	   group)	   were	   not	   cleaned	   with	   OFR	   during	   the	   study.	  
	  
Table	  4-­‐2:	  Properties	  of	  the	  cleaning	  solution	  OPTI-­‐FREE	  RepleniSH	  




1304	  and	  C9-­‐ED3A	  	  
Sodium	  citrate	  
	  
After	   each	   time	  period,	   the	   test	   lenses	  was	   removed	   from	   the	   incubation	   solution	   and	  placed	   in	  OFR	  
overnight.	  The	  next	  morning,	  lenses	  were	  rinsed	  in	  saline	  twice	  and	  placed	  in	  a	  culture	  tube	  (12x75mm;	  
VWR,	  Mississauga,	  ON).	  The	  tubes	  were	   left	   to	  dry	   for	  about	  12	  hours	   in	  order	   for	  unbound	   iodine	  to	  
evaporate.	  The	  control	   lenses	  were	  treated	  in	  the	  same	  way,	  without	  undergoing	  the	  cleaning	  cycle	  at	  
this	   time	   point.	   The	   radioactive	   protein	   content	   on	   each	   lens	  was	   then	   determined	   using	   the	  Wallac	  
Wizard	   1470	   Gamma	   Counter	   (Perkin	   Elmer,	   Woodbridge,	   ON)	   and	   the	   total	   amount	   of	   lysozyme	  
deposited	  on	  the	  contact	  lens	  was	  calculated.	  	  
	  
The	   incubation	   solution	  was	   replenished	   once	   a	  week	   to	  minimize	   chances	   of	   the	   solution	   becoming	  
dilute	  between	  cleaning	  cycles.	  Lenses	  in	  the	  test	  group	  were	  cleaned	  five	  times	  a	  week	  in	  the	  evenings	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and	  removed	  from	  cleaning	  solution	  the	  following	  day.	  Lenses	  in	  the	  control	  group	  did	  not	  undergo	  any	  
cleaning.	  	  
	  
Statistica	  9	  (StatSoft	  Inc.	  Tulsa,	  OK),	  was	  used	  to	  conduct	  data	  analysis.	  A	  repeated	  measures	  analysis	  of	  
variance	   (ANOVA)	   was	   used	   to	   compare	   the	   amount	   of	   lysozyme	   deposition	   onto	   the	   different	   SH	  
materials	  over	  time	  (Main	  Factors:	   incubation	  solution,	  contact	   lens	  material,	  and	  time	  point).	  Tukey’s	  





This	   study	   consisted	   of	   two	   experiments	   performed	   simultaneously.	   A	   single	   protein	   solution	   and	   a	  
complex	  ATS	  were	  used	  to	  incubate	  SH	  lenses	  in	  order	  to	  compare	  the	  deposition	  of	  lysozyme	  onto	  the	  
materials	  and	  to	  determine	  the	  protein	  removal	  following	  a	  cleaning	  cycle.	  Figures	  4-­‐2	  to	  4-­‐4	  outline	  the	  
deposition	  profile	  of	  lysozyme	  with	  and	  without	  frequent	  cleaning	  cycles	  using	  OFR	  over	  a	  28-­‐day	  time	  
period.	  	  
	  
Figure	  4-­‐2	  outlines	  the	  deposition	  of	  lysozyme	  protein	  on	  SA	  lenses.	  After	  1	  day,	  SA	  lenses	  incubated	  in	  
either	   Solution	   A	   or	   Solution	   B	   accumulated	   similar	   amounts	   of	   lysozyme	   (Solution	   A:	   1.73±0.37	   μg,	  
Solution	   B:	   1.76±0.04	   μg;	   p=1.00).	   However,	   after	   28	   days,	   SA	   lenses	   incubated	   in	   Solution	   A	  
accumulated	  lower	  amounts	  in	  comparison	  to	  the	  results	  found	  on	  day	  1.	  This	  pattern	  was	  not	  seen	  for	  
SA	   lenses	   incubated	   in	   the	   complex	   Solution	   B.	   A	   statistically	   significant	   difference	   in	   deposition	  was	  
seen	   between	   these	   two	   solutions	   after	   the	   28	   days;	   SA	   lenses	   accumulated	   significantly	  more	  when	  


















Figure	  4-­‐2:	  Effect	  of	  a	  multi-­‐purpose	  cleaning	  solution	  (OPTI-­‐FREE	  RepleniSH)	  on	  lysozyme	  deposition	  to	  
senofilcon	   A	   lenses	   using	   a	   single	   protein	   solution	   (Solution	   A)	   and	   a	   complex	   ATS	   (Solution	   B).	  
Incubation	  time	  points:	  1,	  7,	  14	  and	  28	  days.	  
	  
With	   regards	   to	   the	   efficiency	   of	   protein	   removal	  when	   SA	   lenses	  were	   incubated	   in	   Solution	  A,	  OFR	  
removed	  the	  highest	  percentage	  of	  lysozyme	  (66%)	  after	  1	  day	  of	  incubation	  (p=0.006).	  Following	  this,	  
44%	  was	  removed	  after	  a	  week	  (p=0.22)	  and	  the	  least	  removed	  (19%)	  after	  14	  days	  (p=1.00).	  At	  day	  28,	  
lenses	  in	  the	  test	  group	  had	  undergone	  20	  cycles	  of	  over-­‐night	  soaking	  in	  MPS	  and,	  as	  a	  result,	  57%	  less	  
lysozyme	  was	   found	  on	  these	  SA	   lenses	   in	  comparison	  to	   the	  non-­‐cleaned	  control	   lenses	   (p=0.08).	  On	  
average,	  nearly	  50%	  of	   the	  protein	  deposited	  onto	   the	  SA	   lenses	  was	   removed	  with	  OFR	  when	   lenses	  
were	  incubated	  in	  a	  simple	  protein	  solution	  (Solution	  A).	  Similar	  amounts	  of	  lysozyme	  were	  detected	  on	  
the	  cleaned	  SA	  lenses,	  which	  did	  not	  change/increase	  over	  time	  	  (p>0.05).	  	  
	  
Lysozyme	  Deposition	  on	  SA	  Lenses
Current	  effect:	  F(3,	  9)=9.6353,	  p=.00359
Vertical	  bars	  denote	  0.95	  confidence	  intervals
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When	   the	   SA	   lenses	   were	   incubated	   in	   Solution	   B,	   OFR	   removed	   significant	   amounts	   of	   lysozyme,	  
regardless	   of	   the	   time	   point.	   After	   1	   day	   of	   incubation,	   90%	   of	   protein	  was	   removed	   (p<0.001);	   high	  
removal	   efficiencies	   were	   also	   observed	   after	   14	   (84%)	   and	   28	   (91%)	   days.	   Overall,	   a	   better	   protein	  
removal	  efficiency	  was	  seen	  when	  SA	  lenses	  were	  incubated	  in	  the	  more	  complex	  Solution	  B;	  however,	  
the	  amount	  of	  lysozyme	  remaining	  on	  lenses	  are	  quite	  similar	  regardless	  of	  the	  incubation	  solution	  used,	  
plateauing	  at	  about	  0.50μg.	  
	  
Figure	  4-­‐3	  shows	  the	  lysozyme	  deposition	  for	  LB	  lenses	  over	  the	  28-­‐day	  time	  period.	  LB	  lenses	  incubated	  
in	   a	   simple	   protein	   solution	   accumulated	   similar	   amounts	   of	   lysozyme	   as	   those	   lenses	   incubated	   in	   a	  
complex	   ATS	   after	   1	   day;	   Solution	   A:	   2.93±0.43	   μg,	   Solution	   B:	   2.83±0.60	   μg,	   p=1.00.	   A	   significant	  
increase	   in	   lysozyme	  deposition	  was	   seen	  with	   lenses	   incubated	   in	  Solution	  B	  between	  7	  and	  28	  days	  	  
(p<0.001);	   however,	   this	   was	   not	   apparent	   for	   LB	   lenses	   incubated	   in	   Solution	   A,	   which	   showed	   a	  
plateau	   immediately	   after	   day	   1	   (p>0.05).	   After	   28	   days,	   LB	   lenses	   accumulated	   2.57±0.16	   μg	   of	  
lysozyme	  when	  incubated	  in	  Solution	  A,	  which	  was	  significantly	  lower	  compared	  to	  LB	  lenses	  incubated	  
in	  Solution	  B	  (13.66±4.29	  μg)	  (p<0.001).	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Lysozyme	  Deposition	  on	  LB	  Lenses
Current	  effect:	  F(3,	  9)=20.185,	  p=.00025
Vertical	  bars	  denote	  0.95	  confidence	  intervals
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Figure	  4-­‐3:	  Effect	  of	  a	  multi-­‐purpose	  cleaning	  solution	  (OPTI-­‐FREE	  RepleniSH)	  on	  lysozyme	  deposition	  to	  
lotrafilcon	   B	   lenses	   using	   a	   single	   protein	   solution	   (Solution	   A)	   and	   a	   complex	   ATS	   (Solution	   B).	  
Incubation	  time	  points:	  1,	  7,	  14	  and	  28	  days.	  
	  
Following	  the	  OFR	  cleaning	  cycle,	  67%	  of	  the	  lysozyme	  was	  removed	  from	  the	  LB	  lenses	  after	  1	  day	  of	  
incubation	   in	  Solution	  A.	  A	  slightly	  reduced	  efficiency	  was	  seen	  after	  7,	  14	  and	  28	  days,	  showing	  44%,	  
40%,	  and	  35%,	  respectively.	  Significant	  differences	  were	  not	  seen	  between	  LB	  lenses	  that	  did	  or	  did	  not	  
undergo	  a	  cleaning	  cycle	  for	  the	  14	  and	  28-­‐day	  time	  points	  (p>0.05).	  The	  amount	  of	  protein	  remaining	  
on	   the	   cleaned	   LB	   contact	   lenses	   after	   each	   time	   point	   was	   similar	   throughout	   the	   experiment,	  
plateauing	  at	  about	  0.60μg.	  	  
	  
When	   LB	   lenses	  were	   incubated	   in	   Solution	  B,	   the	  amount	  of	  protein	   removed	  was	  overall	   greater	   in	  
comparison	   to	   lenses	   incubated	   in	   Solution	   A	   (p<0.01).	   At	   day	   1,	   there	   was	   a	   70%	   protein	   removal	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efficiency	   (p=0.04),	   followed	   by	   68%	   at	   day	   7	   (p=0.01),	   76%	  by	   day	   14	   (p<0.001),	   and	   87%	   at	   day	   28	  
(p<0.001).	   Overall,	   75%	   of	   the	   protein	   deposited	   throughout	   the	   Solution	   B-­‐incubated	   LB	   lenses	   was	  
removed.	  This	  allowed	  for	  a	  plateauing	  effect	  seen	  between	  days	  1	  and	  28	  at	  about	  1.40μg,	  which	  was	  
just	  over	  half	  the	  amount	  remaining	  when	  incubating	  LB	  lenses	  in	  Solution	  A.	  	  
	  
Figure	   4-­‐4	   shows	   the	   data	   collected	  with	   BA	   lenses.	   At	   day	   1,	   BA	   lenses	   accumulated	   10.21±0.28	   μg	  
when	  incubated	  in	  Solution	  A	  and	  accumulated	  slightly	  less	  when	  incubated	  in	  Solution	  B	  (9.48±0.64	  μg)	  
(p=0.095).	   BA	   lenses	   incubated	   in	   both	   solutions	   accumulated	   more	   lysozyme	   over	   time	   and	  
accumulated	  over	  twice	  the	  amount	  from	  day	  1	  to	  28	  for	  Solution	  A-­‐incubated	   lenses	  (22.37±0.68	  μg)	  
and	  three	  times	  the	  amount	  for	  lenses	  incubated	  in	  Solution	  B	  (28.18±0.26	  μg);	  p<0.001.	  	  
Lysozyme	  Deposition	  on	  BA	  Lenses	  
Current	  effect:	  F(3,	  9)=137.03,	  p=.00000
Vertical	  bars	  denote	  0.95	  confidence	  intervals
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Figure	  4-­‐4:	  Effect	  of	  a	  multi-­‐purpose	  cleaning	  solution	  (OPTI-­‐FREE	  RepleniSH)	  on	  lysozyme	  deposition	  to	  
balafilcon	  A	  lenses	  using	  a	  single	  protein	  solution	  (Solution	  A)	  and	  a	  complex	  ATS	  (Solution	  B).	  
Incubation	  time	  points:	  1,	  7,	  14	  and	  28	  days.	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BA	   lenses	   incubated	   in	  either	  Solution	  A	  or	  Solution	  B	  have	   shown	  similar	   trends	   in	  protein	  efficiency	  
when	   cleaned	   with	   OFR.	   BA	   lenses	   incubated	   in	   Solution	   A	   experience	   a	   similar	   lysozyme	   removal	  
efficiency	  independent	  of	  the	  length	  of	  incubation	  time.	  The	  removal	  efficiency	  was	  67%	  on	  day	  1,	  71%	  
on	  days	  7	  and	  14	  and	  69%	  on	  day	  28.	  The	  removal	  efficiency	  was	  significant	  at	  all	  time	  points	  (p<0.001).	  
On	  average,	  70%	  of	  Solution	  A’s	  deposited	  protein	  is	  removed	  throughout	  the	  28-­‐day	  time	  period.	  The	  
remaining	  protein	  on	  the	   lenses,	   following	  the	  cleaning	  cycles,	   increased	  slightly	  with	  each	  time	  point,	  
which	  was	  different	  for	  SA	  and	  LB	  lenses.	  
	  
When	   BA	   lenses	  were	   incubated	   in	   Solution	   B,	   OFR	   removed	   approximately	   70%	   of	   the	   accumulated	  
protein	  throughout	  days	  1	  to	  14	  and	  76%	  on	  day	  28	  (p<0.001).	  The	  total	  amount	  of	  lysozyme	  remaining	  
on	  the	  lens	  increased	  throughout	  each	  time	  point,	  which	  was	  similar	  to	  the	  pattern	  seen	  with	  Solution	  A;	  
between	  days	  1	  and	  7	  (p<0.001)	  and	  days	  7	  and	  14	  (p=0.001).	  A	  plateau	  began	  to	  surface	  near	  day	  28,	  as	  





The	  purpose	  of	  contact	  lens	  cleaning	  systems	  is	  to	  remove	  macromolecules,	  such	  as	  lipids,	  proteins	  and	  
other	  surface	  debris,	  and	  to	  eliminate	  microorganism	  growth.	  A	  number	  of	  cleaning	  systems	  have	  been	  
introduced	  that	  claim	  to	  further	  maintain	  wettability	  and	  comfort	  for	  the	  lens-­‐wearer	  [24].	  A	  number	  of	  
studies	   have	   been	   conducted	   to	   test	   the	   efficacy	   of	   contact	   lens	   cleaning	   solutions	   against	  microbial	  
growth	   and	   tear	   film	   deposits	   [13,24-­‐26].	   For	   multi-­‐purpose	   care	   regimens,	   manufacturers	   often	  
recommend	  manual	   lens	   rubbing	   to	  maximize	   the	  cleaning	  efficiency,	   since	   soaking	  alone	  may	  not	  be	  
able	   to	   remove	   deposits	   sufficiently,	   such	   as	   cosmetics	   and	   proteins	   [27,28].	   The	   visual	   presence	   of	  
proteins	   is	   found	  on	   contact	   lenses	   and	   this	  may	   result	   in	   a	   hazy-­‐look	   to	   the	   lens	   –	   this	   is	   decreased	  
significantly	  when	  lenses	  are	  rubbed	  prior	  to	  placing	  in	  a	  cleaning	  solution	  [27].	  
	  
Lysozyme	  deposition	  onto	  SH	  lens	  materials	  and	  the	  efficiency	  of	  an	  MPS	  to	  remove	  this	  protein	  was	  the	  
focus	  of	   this	   study.	  Two	   incubation	  solutions	  were	  used	   in	  order	   to	  determine	   the	   impact	  of	   tear	   film	  
 49	  
components	  after	  28	  days	  of	  incubation	  and	  daily	  cleaning	  procedures.	  Solution	  A	  was	  a	  single	  protein	  
solution	  that	  contained	  a	  saline	  base	  along	  with	  the	  protein	  lysozyme	  in	  a	  physiological	  concentration	  of	  
1.9mg/mL	  [2].	  Solution	  B	  was	  a	  complex	  ATS	  with	  the	  same	  saline	  base	  as	  Solution	  A;	  however,	  other	  
proteins,	   lipids,	   and	  mucins	  were	  added	   to	   allow	   for	   competitive	  binding.	   Studies	  have	  demonstrated	  
that	  proteins	  have	   the	  ability	   to	  displace	  one	  another	  when	  competing	   for	  binding	  sites	  onto	  artificial	  
surfaces,	  including	  contact	  lenses	  [29,30].	  
	  
A	  number	  of	  studies	  have	  shown	  that	  the	  ionic	  BA	  material	  typically	  accumulates	  more	  tear	  film	  proteins	  
compared	  to	  other	  SH	  lenses,	  including	  SA	  and	  LB	  lenses	  [12,31],	  which	  is	  in	  agreement	  with	  our	  current	  
results.	  We	   have	   recently	   demonstrated	   that	   the	   composition	   of	   the	   incubation	   solution	   can	   impact	  
protein	   deposition	   profiles	   to	   contact	   lenses	   [20].	   This	   study	   further	   confirmed	   that	   only	   SA	   lenses	  
accumulated	   similar	   amounts	   of	   protein-­‐	   albumin,	   lactoferrin,	   lysozyme-­‐	   regardless	   of	   the	   incubation	  
solution	   used.	   BA	   and	   LB	   lenses	   showed	   varying	   deposition	   profiles,	   depending	   on	   the	   protein	   and	  
solution	   composition	   [20].	   In	   a	   recent	   study	   undertaken	   by	   Ng	   and	   colleagues	   [32],	   SA	   lenses	  
accumulated	  greater	  lysozyme	  (5.3μg)	  when	  incubated	  in	  an	  artificial	  tear	  solution	  that	  did	  not	  contain	  
lipids	  than	  other	  solutions	  of	  varying	  complexity	  (3.9μg).	  It	  was	  demonstrated	  that	  LB	  lenses	  accumulate	  
significantly	   less	   lysozyme	  (9.7μg)	  when	   incubated	   in	  a	  complex	  solution	  containing	   lactoferrin	  protein	  
and	  a	  variety	  of	  lipids	  compared	  to	  a	  simple	  solution	  (11.8μg).	  	  	  	  	  
	  
This	   study	   consisted	   of	   two	   experiments	   run	   in	   parallel	   investigating	   three	   different	   SH	   contact	   lens	  
materials,	  which	  differed	  in	  their	  composition,	  surface	  treatment,	  and	  water	  content	  (Table	  4-­‐1).	  The	  SA	  
lens	   material	   contains	   a	   copolymerization	   of	   HEMA	   and	   N,	   N-­‐dimethyl	   acrylamide	   with	   (3-­‐
methylacryloxy-­‐2hydroxypropyloxy)	  propylbis	  (trimethylsiloxy)	  methylsilane	  [33].	  Additionally,	  SA	  lenses	  
contain	  an	  internal	  wetting	  agent,	  polyvinyl	  pyrrolidone	  (PVP),	  increasing	  surface	  hydrophilicity	  [34].	  In	  
previous	  ex	   vivo	   studies	   it	  was	   determined	   that	   lysozyme	   contributes	   nearly	   25%	   [35,36]	   of	   the	   total	  
protein	  (7μg)	  deposited	  onto	  SA	  lenses	  [18,35,36],	  which	  is	  similar	  to	  the	  total	  amount	  of	  lysozyme	  (6μg)	  
deposited	   onto	   these	   lenses	   over	   a	   2-­‐week	   time	   period	   in	   in	   vitro	   studies	   [12,31].	   After	   immediate	  
incubation,	   lysozyme	   deposition	   onto	   SA	   lenses	   was	   driven	   by	   non-­‐competitive	   factors	   (p=NS)	   as	  
Solution	  A	  and	  Solution	  B	  deposited	  similar	  quantities;	  however,	  this	  trend	  was	  not	  witnessed	  as	  further	  
time	  points	  were	  reached.	  	  By	  day	  28,	  SA	  lenses	  accumulated	  significantly	  greater	  amounts	  of	  lysozyme	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when	   incubated	   in	   the	   more	   complex	   ATS	   (p<0.001).	   This	   shows	   that	   lysozyme	   is	   affected	   in	   non-­‐
competitive	  ways	  when	  depositing	  onto	  the	  lens	  material,	  as	  with	  greater	  complexity	  of	  the	  incubation	  
fluid,	  more	  lysozyme	  deposits.	  It	  is	  possible	  that	  lysozyme	  deposits	  initially,	  followed	  by	  other	  negatively	  
charged	   proteins,	   such	   as	   albumin,	   and	   further	   packing	   of	   lysozyme	   on	   top,	   which	   will	   be	   attracted,	  
electronically,	  to	  the	  albumin	  [37,38].	  OFR	  was	  used	  as	  the	  MPS	  of	  interest	  in	  determining	  its	  efficacy	  in	  
removing	  protein	  from	  the	  lenses.	  Whether	  lenses	  were	  incubated	  in	  a	  simple	  or	  complex	  solution,	  the	  
final	   mass	   of	   lysozyme	   on	   the	   contact	   lenses	   was	   similar	   and	   did	   not	   change/increase	   over	   time,	  
averaging	   at	   0.50μg.	   This	   means	   that	   a	   higher	   percentage	   of	   protein	   was	   removed	   from	   SA	   lenses	  
incubated	  in	  Solution	  B,	  as	  they	  accumulated	  the	  most	  after	  the	  28-­‐day	  time	  period.	  	  
	  
The	  LB	  lens	  material	   is	  contains	  both	  a	  siloxy	  and	  hydrogel	  phase,	  allowing	  the	  maintenance	  of	  oxygen	  
and	  salt	  diffusion	  [33].	  The	  hydrophilicity	  of	  the	  lens	  surface	  is	  optimized	  using	  a	  25nm	  surface	  plasma	  
coating	  [39,40].	  This	  coating	  provides	  a	  boundary,	  controlling	  access	  to	  the	  underlying	  polymer,	  which	  
reduces	   protein	   penetration	   into	   the	   lens	   matrix	   [11,40].	   Ex	   vivo	   studies	   have	   shown	   that	   lysozyme	  
deposits	  approximately	  25%	  of	  the	  total	  protein	  accumulating	  on	  LB	  lenses	  [35,36],	  which	  equals	  2μg	  of	  
lysozyme	  [41,42].	  In	  vitro	  studies	  have	  shown	  that	  up	  to	  12μg	  of	  lysozyme	  deposit	  on	  LB	  lenses	  [11,32];	  
however,	   this	   study	  demonstrates	   that	   LB	   lenses	  may	  accumulate	  even	  greater,	   showing	  variability	  at	  
day	  28	  when	  incubated	  in	  Solution	  B	  (13.66μg).	  Like	  SA	  lenses,	  our	  current	  study	  suggests	  that	  primarily	  
non-­‐competitive	   factors	   drive	   the	   accumulation	   of	   lysozyme	   to	   LB	   lenses	   during	   the	   start	   of	   the	  
incubation	   period;	   there	   was	   no	   significant	   difference	   in	   the	   amount	   of	   lysozyme	   deposited	   from	  
Solution	  A	  and	  Solution	  B	  (p=NS).	  For	  the	  following	  three	  time	  points,	  there	  was	  a	  significant	  difference	  
in	   the	   amount	   of	   lysozyme	   that	   deposited	   to	   LB	   lenses.	   LB	   lenses	   that	  were	   incubated	   in	   Solution	   A	  
accumulated	   significantly	   less	   lysozyme	   than	   those	   incubated	   in	   Solution	   B	   (p<0.001).	   The	   deposition	  
pattern	  of	  LB	  lenses	  incubated	  in	  Solution	  B	  is	  different	  than	  that	  seen	  for	  Solution	  A-­‐incubated	  lenses	  in	  
that	  a	  plateau	  was	  not	  reached.	  Greater	  variability	  is	  seen	  for	  LB	  lenses	  incubated	  in	  a	  complex	  ATS	  and	  
this	   may	   be	   due	   to	   the	   increased	   interactions	   between	   proteins,	   lipids,	   and	   mucins	   and	   the	   overall	  
complexity	  of	  the	  incubation	  solution	  used.	  The	  accumulation	  of	   lysozyme	  to	  LB	  lenses	  may	  be	  caused	  
by	   non-­‐competitive	   factors	   as	   more	   lysozyme	   deposited	   when	   other	   tear	   film	   components	   were	  
available	   in	   the	   solution.	   A	   similar	   “sandwich-­‐phenomenon”	   may	   be	   responsible	   as	   described	   above	  
[37,38].	  When	  lenses	  incubated	  in	  Solution	  A	  were	  placed	  in	  OFR	  for	  cleaning,	  approximately	  50%	  of	  the	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total	  protein	  was	  removed	  by	   the	  end	  of	   the	  28-­‐day	   time	  period;	  however,	   for	  LB	   lenses	   incubated	   in	  
Solution	  B,	  the	  care	  regimen	  was	  able	  to	  remove	  75%	  of	  total	  lysozyme.	  There	  was	  an	  evident	  plateau	  at	  
about	   0.60μg	   throughout	   the	   cleaning	   process	   between	   days	   1	   and	   28	   for	   Solution	   A-­‐incubated	   LB	  
lenses,	  whereas	  lenses	  incubated	  in	  Solution	  B	  reached	  a	  plateau	  at	  near	  1.40μg	  following	  the	  cleaning	  
cycle.	  	  
	  
The	   BA	   lens	  material	   incorporates	   a	   co-­‐polymerization	   of	   TRIS	   derivative	   vinyl	   carbamate	   and	  N-­‐vinyl	  
pyrrolidone,	   providing	   it	   with	   biphasic	   characteristics	   [33].	   On	   the	   surface	   of	   the	   BA	   material	   are	  
hydrophilic	  glassy	  silicate	  ‘islands’	  [40],	  which	  result	  from	  the	  oxidation	  of	  TRIS	  [33].	  In	  addition	  to	  this,	  
the	  surface	  of	  BA	  lenses	  is	  porous,	  allowing	  molecules,	  such	  as	  proteins,	  to	  penetrate	  through	  the	  matrix	  
[43].	  N-­‐vinyl	  aminobutyric	  acid	  is	  incorporated	  into	  this	  lens	  material,	  which	  provides	  its	  ionic	  character,	  
hence	   attracting	   positively	   charged	   proteins	   to	   the	   material	   [18,31].	   Ex	   vivo	   studies	   reported	   that	  
numerous	  proteins	  deposit	  on	  BA	  lenses;	  however,	  lysozyme	  contributes	  for	  up	  to	  50%	  [11,44].	  In	  vitro	  
studies	  done	  on	  lysozyme	  deposition	  have	  concluded	  that	  up	  to	  50μg	  of	   lysozyme	  may	  accumulate	  on	  
the	   lens	  [11,12].	  After	  a	  day	  of	   incubation,	  this	  current	  study	  found	  significantly	  more	   lysozyme	  on	  BA	  
lenses	  incubated	  in	  simple	  lysozyme	  solution	  compared	  to	  lenses	  incubated	  in	  a	  complex	  ATS	  (p<0.001),	  
suggesting	  that	  competitive	  factors	  may	  drive	  the	  binding	  of	   lysozyme	  to	  the	   lenses.	  Since	   lysozyme	  is	  
overall	   positively	   charged	   and	   BA	   is	   an	   ionic	   lens,	   it	   is	   expected	   of	   lysozyme	   to	   deposit	   at	   greater	  
amounts	  than	  the	  other	  proteins	  due	  to	  electrostatic	  attraction,	  its	  small	  size,	  and	  overall	  abundance.	  By	  
the	  end	  of	  the	  28-­‐day	  time	  point,	  significantly	  more	  lysozyme	  accumulated	  on	  the	  BA	  lenses	  incubated	  
in	   the	   complex	   ATS	   (p<0.001).	   When	   the	   lenses	   were	   subject	   to	   over-­‐night	   cleaning	   with	   OFR,	   the	  
cleaning	  efficiency	  was	  similar	   independent	  of	  the	  incubation	  solution.	  Nearly	  70%	  of	  the	  accumulated	  
protein	  was	  removed	  from	  both	  sets	  of	  lenses.	  Despite	  the	  frequent	  cleaning	  cycles,	  a	  small	  increase	  in	  
lysozyme	  accumulation	  was	  seen	  over	  the	  28-­‐day	  period	  with	  both	  incubation	  solutions.	  A	  plateau	  was	  
reached	  by	  day	  28	  for	  Solution	  B-­‐incubated	  lenses.	  	  
	  
Studies	   have	   determined	   the	   efficacy	   of	   certain	   cleaning	   solutions	   in	   removing	   proteins	   from	   contact	  
lens	  materials.	   In	   a	   study	   undertaken	   by	   Luensmann	   and	   colleagues	   [11],	   it	  was	   determined	   that	   the	  
removal	  efficiency	  of	  lysozyme	  from	  LB	  lenses	  was	  less	  than	  10%	  when	  using	  either	  a	  hydrogen	  peroxide	  
system	   (Clear	   Care)	   or	   a	   MPS	   (COMPLETE	   MPS	   Easy	   Rub).	   With	   regards	   to	   BA	   lenses,	   on	   average,	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approximately	  60%	  of	  accumulated	   lysozyme	  was	   removed	  when	   lenses	  were	   subject	   to	   the	  different	  
care	   regimens	   [11].	   Jung	   and	   Rapp	   found	   that	   up	   to	   50%	   of	   protein	   was	   removed	   from	   hydrophilic	  
contact	   lenses	   incubated	   in	   a	   more	   complex	   tear	   solution	   that	   contained	   proteins	   and	   glycoprotein	  
when	  cleaned	  with	  a	  regimen,	  such	  as	  OPTI-­‐FREE	  [25].	  In	  a	  study	  conducted	  by	  Zhao	  and	  colleagues	  [18],	  
it	  was	  determined	   that	  higher	   amounts	  of	  protein	   could	  be	   removed	   from	  LB	   lenses	  when	  OPTI-­‐FREE	  
cleaning	   solutions	   were	   used.	   They	   further	   recovered	   over	   20μg	   of	   deposited	   protein	   from	  worn-­‐BA	  
lenses	  regardless	  of	  lens	  care	  solution	  used	  [18].	  	  
	  
Limitations	   of	   this	   study	   include	   placing	   contact	   lenses	   in	   histology	   cassettes	   in	   order	   to	   increase	  
efficiency	   in	   time	  during	   incubation	   and	  MPS-­‐soaking.	   The	   cassettes	  provided	   lenses	  with	   a	  boundary	  
and	   may	   not	   allow	   lysozyme	   to	   effectively	   bind	   to	   the	   lens	   materials	   and	   hence	   will	   maintain	   its	  
conformation;	  loose	  binding	  will	  allow	  appreciable	  removal	  of	  protein	  from	  the	  lens	  and	  hence	  can	  be	  a	  




In	  this	  in	  vitro	  study,	  the	  amount	  of	  lysozyme	  depositing	  to	  SH	  lenses	  was	  impacted	  by	  the	  complexity	  of	  
the	  incubation	  solution,	  which	  subsequently	  impacted	  the	  protein	  removal	  efficiency	  when	  using	  a	  MPS.	  
The	   largest	   difference	   in	   lysozyme	   deposition	   was	   found	   for	   LB	   lenses,	   which	   accumulated	  
approximately	   four	   times	   more	   lysozyme	   when	   incubated	   in	   a	   complex	   ATS	   compared	   to	   a	   simple	  
protein	  solution.	  Both	  SA	  and	  LB	  lenses	  showed	  a	  plateauing	  pattern	  in	  protein	  deposition	  when	  cleaned	  
regularly	  with	  the	  MPS	  independent	  of	  the	  complexity	  of	  the	  incubation	  solution.	  However,	  cleaned	  BA	  
lenses	  show	  a	  steady	  increase	  in	  deposition	  over	  the	  28-­‐day	  time	  period.	  	  
	  
Based	  on	  the	  range	  of	  deposition	  amounts	  found	  in	  this	  study,	  it	  is	  important	  that	  in	  vitro	  models	  take	  
into	  consideration	  the	  complexity	  -­‐	  or	  lack	  thereof	  -­‐	  of	  an	  incubation	  solution.	  The	  interaction	  between	  
individual	   proteins	   and	   other	   tear	   film	   components,	   such	   as	   lipids,	   significantly	   impacts	   protein	  
deposition	  pattern	  to	  SH	  contact	  lenses.	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Purpose:	  The	  purpose	  of	   this	   in	  vitro	   study	  was	  to	  determine	  both	  the	  effect	  of	  different	  contact	   lens	  
cleaning	  solutions	  and	  lens	  cases	  on	  lysozyme	  activity.	  	  
	  
Methods:	   A	   high	   (500μg)	   and	   a	   low	   (10μg)	   concentration	   of	   lysozyme	   were	   used	   to	   represent	   the	  
amount	  deposited	  on	  patient-­‐worn	  hydrogel	  and	  silicone	  hydrogel	  (SH)	  contact	   lenses.	  Three	  different	  
contact	   lens	   cleaning	   solutions	   (OPTI-­‐FREE	   RepleniSH	   (OFR),	   BioTrue	   (BT),	   and	   Clear	   Care	   (CC))	   were	  
placed	  in	  their	  respective	  lens	  cases	  and	  a	  control	  solution,	  phosphate-­‐buffered	  saline	  (PBS),	  was	  placed	  
in	   all	   test	   solution	   cases	   as	   well	   as	   polypropylene	   (PP)	   plastic	   vials.	   Lysozyme	   concentrations	   were	  
increased	  (high:	  1500μg,	   low:	  20μg)	  when	  using	  neutralization	  cassettes,	  to	  replicate	  the	  fact	  that	   lens	  
cases	  hold	  2	  lenses.	  The	  activity	  of	  lysozyme	  at	  1,	  12,	  24,	  and	  48	  hrs	  was	  determined.	  	  
	  
Results:	   For	  OFR,	   the	   high	   lysozyme	   concentration	   showed	   an	   enhanced	   activity	   of	   222%	   at	   the	   1-­‐hr	  
time	  point	  and	  dropped	  significantly	  to	  180%	  at	  12	  hrs	  (p<0.001).	  Lysozyme	  activity	  reduced	  further	  to	  
132%	   by	   hr	   24	   (p<0.001).	   No	   significant	   change	   was	   seen	   between	   the	   24-­‐hr	   (132%)	   and	   the	   48-­‐hr	  
(126%)	  time	  points	  (p>0.05).	  The	  low	  lysozyme	  concentration	  started	  at	  195%	  (1	  hr),	  dropped	  to	  138%	  
(12	  hrs;	   p<0.001)	   and	   remained	  unchanged	   for	   the	   subsequent	   time	  points	   (p>0.05).	   For	  BT,	   the	  high	  
lysozyme	   concentration	   started	   at	   65%	   activity	   (1	   hr)	   and	   significantly	   increased	   to	   99%	   by	   12	   hrs	  
(p<0.001),	   followed	   by	   a	   lack	   of	   change	   for	   successive	   time	   points	   (p>0.05).	   The	   low	   lysozyme	  
concentration	  exhibited	  an	  activity	  of	  45%	  at	  1	  hr,	  which	  increased	  significantly	  to	  86%	  (12	  hrs;	  p<0.001);	  
no	   further	   change	   was	   seen	   after	   this	   time	   point	   (p>0.05).	   For	   CC,	   the	   high	   lysozyme	   concentration	  
exhibited	  a	  low	  activity	  of	  32%	  (1	  hr),	  followed	  by	  an	  increase	  to	  48%	  at	  the	  12-­‐hr	  time	  point	  (p<0.001).	  
No	   further	   change	   was	   seen	   at	   24	   hrs	   (p>0.05)	   and	   a	   slight	   increase	   to	   54%	   was	   noted	   at	   48	   hrs	  
(p<0.001).	   The	   low	   lysozyme	   concentration	   dissolved	   in	   CC	   exhibited	   32%	   activity	   at	   1	   hr,	   which	  
significantly	  increased	  to	  44%	  by	  12	  hrs	  (p<0.001).	  Between	  12	  and	  24	  hrs	  there	  was	  a	  plateau	  (p>0.05)	  
followed	  by	  a	  final	  peak	  (95%)	  at	  48	  hrs	  (p<0.001).	  When	  high	  concentration	  lysozyme	  was	  dissolved	  in	  
PBS	  and	  placed	  in	  different	  lens	  cases,	  greatest	  initial	  activity	  (hr	  1;	  128%)	  was	  seen	  when	  OFR	  lens	  cases	  
were	   used	   (p<0.001);	   however,	   when	   the	   final	   time	   point	   (hr	   48)	   was	   reached,	   lysozyme	   was	   more	  
stable	  when	  placed	  in	  BT	  lens	  cases	  (BT	  case	  =	  42%;	  OFR	  case	  =	  34%).	  For	   low	  concentration	  lysozyme	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dissolved	   in	   PBS,	   initial	   lysozyme	   activity	   (hr	   1;	   61%)	  was	   also	   highest	  when	  placed	   in	  OFR	   lens	   cases	  
(p<0.001);	   however,	   by	   hr	   48,	   greater	   lysozyme	   activity	  was	   found	   in	   CC	   neutralization	   cassettes	   (CC	  
cassettes	  =	  48%;	  OFR	  case	  =	  18%;	  p<0.001).	  	  
	  
Conclusion:	  The	  three	  contact	  lens	  cleaning	  solutions	  showed	  varying	  impact	  on	  the	  activity	  of	  lysozyme	  
when	  exposing	  a	  high	  or	  a	  low	  lysozyme	  concentration	  to	  the	  solution.	  When	  lysozyme	  was	  dissolved	  in	  
OFR,	  the	  activity	  of	  protein	  was	  enhanced	  over	  100%.	  Lysozyme	  placed	  in	  BT	  solution,	  exhibited	  an	  initial	  
increase,	  after	  which	  the	  activity	  remained	  constant	  throughout	  the	  48-­‐hr	  time	  period.	  For	  CC,	  lysozyme	  
activity	  was	  lower	  compared	  to	  the	  other	  two	  care	  regimens.	  Lysozyme	  activity	  was	  further	  impacted	  by	  
the	  lens	  case,	  resulting	  in	  an	  initial	  increase	  when	  lysozyme	  dissolved	  in	  PBS	  was	  placed	  in	  OFR	  cases.	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Discovered	  in	  the	  early	  20th	  century,	   lysozyme	  was	  considered	  an	  enzymatic	  protein	  with	  antimicrobial	  
properties	  [1].	  It	  is	  found	  in	  a	  high	  concentration	  in	  the	  human	  tear	  film,	  constituting	  1.9	  mg/mL	  [2].	  This	  
positively	   charged	   [3]	   protein	   (14.5	   kDa	   [4])	   plays	   an	   important	   role	   in	   the	   human	   tear	   film	   as	   it	  
hydrolyzes	   glycosidic	   bonds	   in	   the	   peptidoglycan	   of	   bacteria	   and	   prevents	  microbial	   colonization	   [5].	  
Once	   lysozyme	   deposits	   onto	   contact	   lens	   materials,	   it	   is	   likely	   to	   denature	   [6]	   and	   may	   lose	   its	  
antimicrobial	  activity.	  An	  ex	  vivo	  study	  has	  shown	  that	  up	  to	  90%	  of	  lysozyme	  that	  deposited	  onto	  worn	  
silicone	  hydrogel	  (SH)	  contact	  lens	  surfaces	  was	  denatured	  [7].	  A	  number	  of	  negative	  consequences	  may	  
result	   from	   inactive	   protein	   deposits,	   including	   an	   immunological	   stimulus	   [8]	   causing	   papillary	  
conjunctivitis	  [9],	  reduced	  visual	  acuity	  [10],	  and	  an	  overall	  discomfort	  with	  the	  lenses	  [11].	  
	  	  
Introduced	   in	   the	   1970’s	   [12,13],	   conventional,	   poly-­‐2-­‐hydroxyethyl	   methacrylate	   (pHEMA)-­‐based	  
contact	  lenses	  exhibit	  a	  relatively	  low	  oxygen	  transmissibility,	  which	  can	  result	  in	  hypoxic	  complications	  
in	  some	  wearers	  [14,15].	  SH	  lenses,	  which	  were	  introduced	  in	  1999,	  have	  a	  higher	  oxygen	  permeability	  
[13,16],	  and	  exhibit	  a	  different	  deposition	  profile	  of	  tear	  film	  components	  compared	  with	  pHEMA-­‐based	  
materials.	  PHEMA-­‐based	  lenses	  typically	  accumulate	  greater	  amounts	  of	  protein	  and	  lower	  amounts	  of	  
lipid,	  in	  comparison	  to	  SH	  lenses,	  which	  attract	  more	  lipids	  and	  only	  very	  little	  protein	  [17-­‐19].	  A	  study	  
conducted	  by	  Jones	  et	  al.,	  determined	  that	  ionic	  pHEMA	  lenses	  accumulated	  approximately	  100x	  more	  
protein	  than	  SH	  lenses;	  however,	  SH	  lenses	  accumulated	  30x	  more	  lipid	  than	  ionic	  pHEMA-­‐based	  lenses	  
[20].	  Specifically,	  the	  ionic	  pHEMA	  lens,	  etafilcon	  A,	  accumulated	  1000μg	  of	  lysozyme	  per	  lens,	  whereas	  
the	  SH	  lens,	  balafilcon	  A,	  accumulated	  approximately	  10μg	  [20].	  
	  
Contact	   lens	  care	  systems,	  such	  as	  multi-­‐purpose	  solutions	  (MPS)	  and	  hydrogen	  peroxide	  systems,	  are	  
used	  to	  disinfect	  lenses	  [21,22]	  and	  to	  remove	  tear	  film	  deposits	  between	  wear-­‐times	  [23-­‐26].	  Cleaning	  
solution	   components	   have	   the	   ability	   to	   change	   the	   chemical	   and/or	   physical	   properties	   of	   the	   lens	  
surface	  [24].	  The	  components	  may	  also	  stick	  onto	  the	  lens	  surface	  or	  penetrate	  through	  the	  lens	  matrix	  
[24].	  Contact	  lens	  cases	  are	  specific	  to	  their	  cleaning	  solution	  and	  are	  considered	  class	  II	  devices	  under	  
the	  Food	  &	  Drug	  Administration	  (FDA).	  The	  FDA	  and	  the	  International	  Organization	  for	  Standardization	  
(ISO)	  tests	  contact	  lens	  case	  performance	  and	  prepares	  standards	  for	  testing	  lens	  care	  solutions	  [27].	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A	   recent	   study	   conducted	  by	  Barniak	   and	   colleagues	   [28]	   investigated	   the	   effect	   of	  MPS	  on	   lysozyme	  
activity	   and	   its	   ability	   to	   prevent	   denaturation	   of	   lysozyme	   in	   solution	   after	   adding	   sodium	   dodecyl	  
sulfate	   (SDS).	  Better	  maintenance	  of	   lysozyme	  activity	  was	  seen	  with	  BioTrue	  and	  ReNu,	  compared	   to	  
OPTI-­‐FREE	  (EXPRESS	  and	  RepleniSH),	  AQuify,	  and	  COMPLETE	  MPS	  Easy	  Rub	  Formula	  [28].	  Findings	  from	  
this	  study	  are	  of	   interest;	  however,	   it	  remains	  unclear	  how	  the	  activity	  of	   lysozyme	  changes	  over	  time	  
when	  exposed	  to	  these	  care	  regimens,	  without	  adding	  SDS.	  Our	  current	  study	  reports	  lysozyme	  activity	  





A	  recent	  in-­‐house	  study	  determined	  the	  effect	  of	  varying	  MPS	  concentrations	  on	  lysozyme	  activity	  when	  
a	   fixed	   amount	   of	   lysozyme	  was	   used.	   BioTrue	   (BT),	   Clear	   Care	   (CC),	   and	  OPTI-­‐FREE	   RepleniSH	   (OFR)	  
were	   diluted	   with	   phosphate-­‐buffered	   saline	   (PBS)	   to	   four	   different	   concentrations	   (2.67%,	   5.33%,	  
8.33%,	  and	  16.67%)	   in	  order	   to	  determine	   if	  MPS	  concentrations	  have	  a	  denaturing,	   renaturing,	  or	  no	  
effect	  on	  lysozyme	  activity.	  The	  diluted	  care	  regimens	  and	  the	  control	  solution	  (1x	  PBS)	  were	  placed	  in	  
individual	  Eppendorf	  tubes	  using	  a	  volume	  of	  50μL.	  Lysozyme	  (83ng)	  was	  dissolved	  in	  25μL	  of	  PBS	  and	  
added	   to	   the	   solution,	   followed	   by	   a	   final	   addition	   of	   300μL	   of	   bacteria.	   Lysozyme	   activity	   was	  
determined	  immediately	  as	  described	  below.	  	  
	  
For	   the	   main	   experiment,	   two	   different	   concentrations	   of	   lysozyme	   were	   used,	   which	   was	  
representative	  of	  the	  amount	  deposited	  onto	  ex	  vivo	   lenses-­‐	  a	  high	  concentration	  (500μg)	  was	  used	  to	  
mimic	   lysozyme	   deposition	   on	   ionic	   conventional	   hydrogel	   lens	   lysozyme	   deposits	   [8,29],	   and	   a	   low	  
concentration	   (10μg)	   was	   used	   to	   simulate	   deposition	   rates	   on	   SH	   lenses	   [7,8].	   Since	   the	   CC	  
neutralization	  cassettes	  hold	  two	  lenses,	  the	  amount	  of	  lysozyme	  was	  increased	  to	  1500μg	  and	  20μg	  for	  
conventional	  and	  SH	  lenses,	  respectively.	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The	  activity	  of	   lysozyme	  was	  determined	   for	  up	   to	  48	  hrs	  when	  added	   to	   three	  different	   contact	   lens	  
cleaning	  solutions,	  BT,	  CC,	  and	  OFR,	  which	  are	  described	  in	  Table	  5-­‐1.	  
	  
Table	  5-­‐1:	  Properties	  of	  contact	  lens	  care	  regimens	  investigated	  	  
	  
Property	  	   BioTrue	  (BT)	  
Bausch	  &	  Lomb	  
Clear	  Care	  (CC)	  
CIBA	  Vision	  
OPTI-­‐FREE	  RepleniSH	  (OFR)	  
Alcon	  







ALDOX	  (0.0005%)	  	  
PolyQuad	  (0.001%)	  







Pluronic	  17R4	  	  
TearGlyde-­‐	  Tetronic	  1304,	  	  
C9-­‐ED3A	  	  




Phosphate	   Sodium	  citrate	  
	  
Lysozyme	  was	   dissolved	   in	   PBS	   at	   a	   concentration	   of	   2mg/mL.	   Low	   and	   high	   concentration	   lysozyme	  
stocks	  were	  prepared	   separately	   for	  each	   test	   solution,	   including	   the	  PBS	   control	   solution.	  Once	  both	  
the	   high	   and	   low	   concentration	   solutions	   were	   prepared,	   this	   was	   considered	   hr	   0.	   The	   lens	   cases	  
specific	  to	  the	  different	  care	  regimens	  were	  used	  in	  the	  study,	  in	  addition	  to	  polypropylene	  (PP)	  plastic	  








Figure	  5-­‐1:	  Contact	  lens	  cases	  and	  solutions	  used	  in	  experiment	  
	  
For	   OFR	   and	   BT	   lens	   cases,	   the	   right	   lens	   compartments	   were	   filled	   with	   3mL	   of	   low	   concentration	  
lysozyme	   solution	   (10μg	   total	   protein)	   and	   the	   left	   lens	   compartments	   were	   filled	   with	   3mL	   of	   high	  
concentration	   lysozyme	   solution	   (500μg	   total	   protein).	   For	   CC,	   three	   cases	  were	   filled	  with	   9mL	   high	  
concentration	   lysozyme	   CC	   solution	   (1500μg	   total	   protein)	   and	   three	   cases	   were	   filled	   with	   low	  
concentration	   lysozyme	   CC	   solution	   (20μg	   total	   protein).	   This	   resulted	   in	   three	   replicates	   for	   each	  
solution	  and	  lens	  case.	  	  
	  
In	  addition,	  the	  PBS	  control	  solutions	  containing	  the	  respective	  amounts	  of	   lysozyme	  were	  filled	  in	  the	  
original	  lens	  cases	  of	  the	  different	  care	  regimens	  using	  the	  solution	  quantities	  mentioned	  above	  (n=3	  for	  












Table	  5-­‐2:	  Outline	  of	  experimental	  procedure	  	  
	   OFR,	  BT,	  and	  PBS	   CC	  
Volume	  of	  stock	  solution	  (mL)	   0.833	   5	  
Volume	  of	  test	  solution	  	  (mL)	   9.167	   25	  
Volume	  in	  lens	  case	  (mL)	   3	   9	  




Initial	  concentration	  in	  lens	  case	  (mg/mL)	   0.167	   0.333	  
Volume	  removed	  from	  lens	  case	  (μL)	   25	   25	  
Dilution	  of	  sample	  (mL)	   1.224	   1.216	  
Final	  concentration	  in	  assay	  (mg/mL)	   0.00333	   0.00672	  
Final	  mass	  in	  assay	  (ng)	   83	   168	  
L=low	  lysozyme	  concentration,	  H=high	  lysozyme	  concentration	  	  
	  
The	  cases	  were	  tightly	  closed	  and	  kept	  at	  room	  temperature	  in	  a	  Styrofoam	  container	  for	  the	  duration	  of	  
the	   experiment.	   At	   each	   time	   point	   of	   1,	   12,	   24,	   and	   48	   hrs,	   three	   samples	   of	   25μL	   of	   each	   low	  
concentration	   case	   compartment	   were	   taken	   to	   determine	   lysozyme	   activity	   and	   hence	   nine	  
measurements	   were	   obtained	   for	   each	   solution-­‐lens	   case	   combination	   and	   time	   point.	   For	   high	  
lysozyme	   concentrations,	   each	   25μL	   sample	   underwent	   a	   50-­‐fold	   dilution	   with	   the	   respective	   test	  
solution	  prior	  to	  analysis.	  	  
	  
A	  micrococcal	  turbidity	  assay	  [7,8,30]	  was	  performed	  on	  all	  samples,	  which	  consisted	  of	  25μL	  aliquots	  in	  
300μL	  of	  bacteria.	  Micrococcus	  lysodeikticus	  (M.	  lysodeikticus)	  bacteria	  were	  prepared	  at	  1mg/mL	  of	  50	  
mM	  phosphate	  buffer	  (pH	  6.3)	  and	  diluted	  to	  an	  optical	  density	  of	  1.1	  at	  450nm.	  Readings	  were	  taken	  at	  
32°C	  with	   the	  SpectraMax	  M5	  Multi-­‐Mode	  Microplate	  Reader	   (Molecular	  Devices,	  Sunnyvale,	  CA)	  and	  
lysozyme	  activity	  was	   then	  determined	  every	  30	  seconds	  over	  a	  period	  of	  15	  minutes.	  Standards	  with	  
known	  mass	  were	  prepared	  at	  hr	  0	  and	  were	  used	  to	  convert	  the	  rates	  of	  lysozyme	  activity	  computed	  by	  
the	   SoftMax	   Pro	   5.4.1	   software	   (Molecular	   Devices,	   Sunnyvale,	   CA)	   into	  mass	   of	   lysozyme	   present	   in	  
each	   well.	   Negative	   control	   samples	   containing	   only	   the	   contact	   lens	   cleaning	   solutions	   without	   the	  
addition	  of	  lysozyme	  were	  included	  to	  correct	  for	  background	  noise.	  
	  
Statistica	   9	   (StatSoft	   Inc.	   Tulsa,	   OK)	   was	   used	   to	   analyze	   the	   data	   and	   repeated	   measures	   ANOVA	  
(analysis	  of	  variance)	  was	  performed	   in	  order	   to	  compare	  the	  activity	  of	   lysozyme	  when	  placed	   in	   the	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different	  solutions.	  Factors	   included	   in	   the	  ANOVA	  were:	   solution	  of	   interest,	   lysozyme	  concentration,	  
and	  time	  point.	  Tukey’s	  HSD	  (Honestly	  Significant	  Difference)	  test	  was	  used	  for	  post-­‐hoc	  comparisons,	  




The	   impact	  of	  different	  contact	   lens	  care	   solutions	  on	   lysozyme	  activity	  was	   investigated	  over	  a	  48-­‐hr	  
time	  period.	  PBS	  was	  included	  as	  a	  control	  solution	  as	  it	  contained	  neither	  surfactants	  nor	  disinfectants.	  
	  
In	   a	   recent	   in-­‐house	   study,	   lysozyme	   activity	   was	   determined	   after	   being	   added	   to	  MPS,	   which	   was	  
diluted	   with	   different	   amounts	   of	   PBS.	   A	   fixed	   amount	   of	   lysozyme	   was	   added	   to	   all	   dilutions.	   The	  
results	  are	  shown	  in	  Figure	  5-­‐2.	  	  
	  
	  
Figure	   5-­‐2:	   Effect	   of	  multi-­‐purpose	   solution	   (MPS)	   concentration	   on	   lysozyme	   activity	   using	   a	   fixed	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It	  was	  confirmed	  that	  varying	  concentrations	  of	  OFR	  enhanced	  the	  activity	  of	   lysozyme	  to	  up	  to	  170%;	  
however,	   when	   a	   low	   concentration	   (2.67%)	   of	   MPS	   was	   used,	   the	   apparent	   increase	   of	   lysozyme	  
activity	  was	  slightly	   less	  (135%).	  Regardless	  of	  the	  concentration	  of	  BT	  and	  CC,	  the	  solutions’	  effect	  on	  
lysozyme	  was	  relatively	  similar	  throughout	  the	  experiment,	  with	  slightly	   increased	  activities	  when	  high	  
concentrations	  of	  MPS	  were	  used.	  The	  concentration	  of	  care	  regimen	  present	  in	  the	  assay	  of	  the	  main	  
experiment	  was	  16.67%.	  
	  
OPTI-­‐FREE	  REPLENISH	  	  
	  
The	  results	  of	  the	  two	  different	  lysozyme	  solutions	  placed	  in	  OFR	  lens	  cases	  are	  presented	  in	  Figure	  5-­‐3.	  
All	   conditions	   (high	   and	   low	   concentration	   lysozyme	   dissolved	   in	   OFR	   and	   in	   PBS)	   showed	   an	   overall	  
decrease	  in	  lysozyme	  activity	  from	  hr	  1	  to	  48,	  where	  the	  difference	  in	  activity	  was	  significant	  for	  each	  of	  
the	  conditions	  (p<0.001).	  	  
	  
For	  OFR	  solution,	  there	  was	  a	  significant	  difference	  in	  lysozyme	  activity	  for	  high	  and	  low	  concentrations	  
(p<0.001).	   After	   1	   hr	   of	   exposure	   to	   OFR	   solution,	   the	   activity	   of	   the	   high	   lysozyme	   concentration	  
increased	  to	  222±28%.	  After	  12	  hrs,	  lysozyme	  activity	  significantly	  decreased	  to	  180±15%	  (p<0.001)	  and	  
continued	  to	  decrease	  to	  132±13%	  after	  24	  hrs	  (p<0.001),	  after	  which	  it	  remained	  relatively	  unchanged	  
(126±10%	   at	   48	   hrs;	   p=1.00).	  When	   the	   low	   concentration	   of	   lysozyme	  was	   used,	   the	   activity	   of	   the	  
protein	  was	  enhanced	  to	  195±11%	  after	  1	  hr	  of	  exposure	  to	  OFR	  and	  reduced	  to	  138±5%	  after	  12	  hrs	  
(p<0.001).	  The	  following	  time	  points,	  24	  and	  48	  hrs,	  exhibited	  no	  significant	  change	  in	  activity	  (p>0.05).	  	  
	  
For	   PBS,	   there	   was	   a	   significant	   difference	   in	   lysozyme	   activity	   for	   the	   high	   and	   low	   protein	  
concentrations	  (p<0.001).	  High	  concentration	  of	  lysozyme	  in	  PBS	  was	  enhanced	  less	  strongly	  compared	  
to	   OFR	   (p<0.001)	   and	   exhibited	   an	   activity	   of	   128±18%	   after	   1	   hr.	   At	   hr	   12,	   the	   activity	   dropped	  
significantly	   to	   62±9%	   (p<0.001).	   Lysozyme	   activity	   was	   further	   reduced	   after	   24	   hrs	   (p<0.001)	   and	  
plateaued	  between	  the	  last	  two	  time	  points	  (34±8%	  at	  48	  hrs;	  p=1.00).	  When	  the	  low	  concentration	  of	  
lysozyme	  in	  PBS	  was	  placed	  in	  OFR	  cases,	  the	  activity	  decreased	  to	  61±7%	  after	  1	  hr	  and	  continued	  to	  
reduce	   to	   41±6%	   by	   12	   hrs	   (p=0.004).	   At	   24	   hrs,	   the	   activity	   halved	   to	   19±3%	   (p=0.003),	   and	   then	  
remained	  unchanged	  at	  48	  hrs	  (p=1.00).	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Effect	  of	  OPTI-­‐FREE	  RepleniSH	  and	  PBS	  on	  Lysozyme	  Activity	  
Current	  effect:	  F(9,	  72)=15.013,	  p=.00000



























Figure	   5-­‐3:	   Effect	   of	  OPTI-­‐FREE	   RepleniSH	  (OFR)	  and	   phosphate-­‐buffered	   saline	   (PBS)	   on	   lysozyme	  
activity	  using	  a	  high	  (500μg)	  and	  low	  (10μg)	  protein	  concentration	  in	  an	  OFR	  lens	  case.	  Time	  points:	  1,	  




The	  effect	  of	  BT	   lens	  cases	  on	   lysozyme	  activity	   is	  presented	   in	  Figure	  5-­‐4.	  The	  high	  and	   low	  lysozyme	  
concentrations	   in	   BT	   showed	   an	   overall	   significant	   increase	   in	   activity	   from	   hr	   1	   to	   48	   (p<0.001);	  
however,	   the	  high	  and	   low	  concentrations	  of	   lysozyme	   in	  PBS	  did	  not	   indicate	   a	   significant	   change	   in	  
activity	   between	   the	   first	   and	   final	   time	   point	   (p=1.00).	   Lysozyme	   activity	   was	   overall	   significantly	  
greater	  when	  high	   concentrations	   of	   lysozyme	  were	   placed	   in	   BT	   lens	   cases,	   independent	   of	   solution	  
used	  (p<0.05).	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There	  was	  a	  significant	  difference	  in	  lysozyme	  activity	  for	  the	  high	  and	  low	  concentrations	  with	  the	  use	  
of	  BT	  solution	  (p=0.001).	  At	  the	  1-­‐hr	  time	  point,	  the	  high	  lysozyme	  concentration	  showed	  an	  activity	  of	  
65±15%	  followed	  by	  a	  significant	  increase	  to	  99±8%	  at	  12	  hrs	  (p<0.001).	  No	  further	  change	  was	  seen	  for	  
the	   successive	   time	  points	   (p=1.00).	   For	   the	   low	   concentration	   of	   lysozyme,	   the	   initial	   activity	  was	   at	  
45±3%	   for	   the	   first	   time	  point,	  which	  was	   significantly	   less	   than	   the	  activity	  of	   the	  high	  concentration	  
(p=0.006).	   As	   seen	   with	   high	   concentration	   lysozyme,	   the	   activity	   increased	   by	   12	   hrs	   to	   86±8%	  
(p<0.001).	  No	  further	  change	  was	  noted	  after	  12	  hrs	  (p>0.05).	  
	  
After	   1	   hr,	   nearly	   20%	   less	   activity	   was	   found	   in	   high	   concentrations	   of	   lysozyme	   placed	   in	   BT	   cases	  
when	  immersed	  in	  PBS	  (46±14%)	  in	  comparison	  to	  BT	  solution	  (65±15%);	  p=0.01.	  No	  changes	  were	  seen	  
between	   12	   and	   24	   hrs	   (p>0.05),	   followed	   by	   a	   significant	   decrease	   in	   activity	   at	   48	   hrs	   (42±4%;	  
p=0.001).	   When	   the	   low	   concentration	   of	   lysozyme	   in	   PBS	   was	   placed	   in	   BT	   cases,	   the	   activity	   of	  
lysozyme	   initially	  decreased	  to	  36±4%,	   followed	  by	  an	   increase	  to	  50±7%	  at	  hr	  12	   (p<0.001).	  At	  hr	  24,	  
there	  was	  an	  additional	  increase	  in	  lysozyme	  activity	  (59±5%;	  p<0.001).	  A	  significant	  reduction	  was	  seen	  
between	  the	  last	  two	  time	  points,	  resulting	  in	  35±4%	  activity	  after	  48	  hrs	  (p<0.001).	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Effect	  of	  BioTrue	  and	  PBS	  on	  Lysozyme	  Activity
Current	  effect:	  F(9,	  72)=10.281,	  p=.00000
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Figure	  5-­‐4:	  Effect	  of	  BioTrue	  (BT)	  and	  phosphate-­‐buffered	  saline	  (PBS)	  on	  lysozyme	  activity	  using	  a	  high	  
(500μg)	  and	  low	  (10μg)	  protein	  concentration	  in	  a	  BT	  lens	  case.	  Time	  points:	  1,	  12,	  24,	  and	  48	  hrs	  (n=3).	  
	  
	  
CLEAR	  CARE	  	  
	  
The	   effect	   of	   the	   CC	   neutralization	   cassettes	   on	   lysozyme	   activity	   is	   presented	   in	   Figure	   5-­‐5.	   All	  
conditions	  (high	  and	  low	  concentration	  lysozyme)	  showed	  an	  overall	  increase	  in	  lysozyme	  activity	  from	  
hr	  1	  to	  48,	  where	  the	  overall	  difference	  in	  activity	  was	  significant	  for	  each	  of	  the	  conditions	  (p<0.001).	  
	  
For	   the	   CC	   solution,	   there	   was	   a	   significant	   difference	   in	   lysozyme	   activity	   for	   the	   high	   and	   low	  
concentrations	  (p<0.001).	  After	  1	  hr,	  the	  high	  concentration	  of	  lysozyme	  exhibited	  an	  activity	  of	  32±2%,	  
followed	  by	   a	   significant	   increase	   to	   48±4%	  by	   hr	   12	   (p<0.001).	   The	   24-­‐hr	   time	  point	   did	   not	   show	   a	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significant	  change	  in	  activity	  (p=0.89);	  however,	  there	  was	  a	  slight	  increase	  in	  activity	  by	  hr	  48	  (54±3%;	  
p<0.001).	  For	  low	  concentration	  lysozyme,	  the	  initial	  1-­‐hr	  showed	  a	  low	  activity	  of	  32±1%,	  followed	  by	  a	  
slight	   increase	   to	   44±2%	   by	   12	   hrs	   (p<0.001).	   The	   activity	   subtly	   plateaued	   between	   hrs	   12	   and	   24	  
(p=1.00).	  After	  48	  hrs,	   the	  activity	  of	   low	  concentration	   lysozyme	   in	  CC	   increased	  drastically	   to	  95±4%	  
(p<0.001).	  
	  
For	  protein	  exposed	  to	  PBS,	  there	  was	  an	  overall	  significant	  difference	  in	  lysozyme	  activity	  between	  the	  
high	   or	   low	   concentrations	   (p<0.001).	   Similar	   to	   CC	   in	   neutralization	   cassettes,	   the	   high	   lysozyme	  
concentration	  in	  PBS	  had	  a	  low	  activity	  of	  24±4%	  at	  the	  1-­‐hr	  time	  point.	  The	  activity	  increased	  to	  36±1%	  
at	  12	  hrs	  (p<0.001),	  plateaued	  at	  hr	  24	  (p=1.00),	  and	  finally	  decreased	  significantly	  to	  32±4%	  (p<0.001).	  
When	  the	  low	  concentration	  of	  lysozyme	  in	  PBS	  was	  placed	  in	  CC	  neutralization	  cassettes,	  the	  activity	  of	  
lysozyme	  decreased	  to	  25±1%,	  increased	  to	  33±2%	  by	  12	  hrs	  (p<0.001),	  and	  remained	  unchanged	  for	  hr	  




Effect	  of	  Clear	  Care	  and	  PBS	  on	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  Activity	  
Current	  effect:	  F(9,	  72)=260.58,	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Figure	  5-­‐5:	  Effect	  of	  Clear	  Care	   (CC)	   and	  phosphate-­‐buffered	   saline	   (PBS)	  on	   lysozyme	  activity	  using	   a	  
high	  (1500μg)	  and	  low	  (20μg)	  protein	  concentration	  in	  a	  CC	  neutralization	  cassette.	  Time	  points:	  1,	  12,	  
24,	  and	  48	  hrs	  (n=3).	  
	  
An	   interesting	   trend	  occurred	   for	  both	   lysozyme	   concentrations	  when	  both	  CC	  and	  PBS	  were	  used	   to	  
determine	   lysozyme	   activity	   over	   time-­‐	   a	   peak	  was	   seen	   at	   hr	   48	   (p<0.001).	   Commonly,	   there	  was	   a	  









Figure	   5-­‐6	   represents	   the	   effect	   of	   lens	   cases	   on	   lysozyme	   activity	   when	   a	   high	   concentration	   of	  
lysozyme	   was	   dissolved	   in	   PBS	   and	   placed	   in	   different	   cases.	   Similar	   to	   both	   BT	   cases	   and	   CC	  
neutralization	  cassettes,	  lysozyme	  dissolved	  in	  PBS	  and	  placed	  in	  PP	  plastic	  vials	  had	  a	  low	  1-­‐hr	  lysozyme	  
activity	  reading	  (40±3%).	  The	  activity	  increased	  to	  53±10%	  at	  12	  hrs	  (p=0.008)	  and	  continued	  to	  increase	  
to	   66±4%	   by	   hr	   24	   (p=0.03).	   At	   hr	   48,	   lysozyme	   activity	   dropped	   significantly	   to	   20±2%	   (p<0.001).	  
Comparing	  1-­‐hr	  time	  point	  activities,	  it	  was	  seen	  that	  lysozyme	  was	  most	  stable	  (128±18%)	  when	  placed	  
in	  OFR	   lens	   cases	   (p<0.001).	   By	   the	  end	  of	   the	  48-­‐hr	   time	  period,	   lysozyme	  activity	  was	   similar	  when	  









Activity	  of	  High	  Lysozyme	  Concentrations	  when	  in	  Different	  Lens	  Cases
Current	  effect:	  F(9,	  72)=118.19,	  p=0.0000




























Figure	  5-­‐6:	  Effect	  of	  phosphate-­‐buffered	  saline	  on	  lysozyme	  activity	  when	  high	  concentrations	  of	  
lysozyme	  are	  placed	  in	  multi-­‐purpose	  and	  polypropylene,	  control	  cases	  (500μg)	  and	  neutralization	  
cassettes	  (1500μg).	  Time	  points:	  1,	  12,	  24,	  and	  48	  hrs	  (n=3).	  
	  
	  
Overall,	   when	   a	   high	   concentration	   of	   lysozyme	   was	   placed	   in	   OFR	   cases,	   there	   was	   a	   significant	  
decrease	  in	  activity	  between	  1	  and	  48	  hrs	  (p<0.001).	  For	  both	  BT	  cases	  and	  CC	  neutralization	  cassettes,	  
hrs	  1	  and	  48	  showed	  no	  significant	  change	  in	  activity	  (p>0.05).	  Finally,	  when	  PBS	  was	  filled	   in	  PP	  vials,	  
there	  was	  an	  ultimate	  decrease	  in	  lysozyme	  activity	  after	  48	  hrs	  (p<0.001).	  
	  
Figure	  5-­‐7	  depicts	   the	  effect	  of	   lens	  cases	  on	   lysozyme	  activity	  when	  a	   low	  concentration	  of	   lysozyme	  
was	  dissolved	   in	  PBS	  and	  placed	   in	  different	  cases.	  Similar	  to	  BT	  cases,	   lysozyme	  dissolved	   in	  PBS	  that	  
was	   placed	   in	   PP	   plastic	   vials	   had	   a	   lower	   1-­‐hr	   lysozyme	   activity	   reading	   compared	   to	   OFR	   (PP	   vial=	  
36±3%;	  OFR	   case=	  61±7%).	   The	  activity	   increased	   to	  54±5%	  at	  12	  hrs	   (p<0.001)	   and	   then	   significantly	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decreased	  to	  39±4%	  at	  hr	  24	  and	  13±3%	  by	  hr	  48	  (p<0.001).	  At	  the	  1-­‐hr	  time	  point,	  lysozyme	  activity	  was	  
highest	  when	  placed	  in	  OFR	  cases	  (61±7%;	  p<0.001);	  however,	  activity	  was	  lowest	  by	  hr	  48	  when	  placed	  
in	  either	  OFR	  cases	  or	  PP	  vials	  compared	  to	  the	  other	  cases.	  	  
	  
Activity	  of	  Low	  Lysozyme	  Concentrations	  when	  in	  Different	  Lens	  Cases	  
Current	  effect:	  F(9,	  72)=158.26,	  p=0.0000




























Figure	   5-­‐7:	   Effect	   of	   phosphate-­‐buffered	   saline	   on	   lysozyme	   activity	   when	   low	   concentrations	   of	  
lysozyme	   are	   placed	   in	   multi-­‐purpose	   and	   polypropylene,	   control	   cases	   (10μg)	   and	   neutralization	  
cassettes	  (20μg).	  Time	  points:	  1,	  12,	  24,	  and	  48	  hrs	  (n=3).	  
	  
A	   similar	   trend	   compared	   to	  high	   concentration	   lysozyme	  was	   found	   for	   low	   concentration	   lysozyme,	  
where	   there	  was	  a	  significant	  decrease	   in	  activity	  between	  1	  and	  48	  hrs	  when	  PBS	  was	  placed	   in	  OFR	  
lens	   cases	   (p<0.001).	  No	   significant	   change	   in	   lysozyme	  activity	  was	  noted	  between	   the	   first	   and	   final	  
time	  points	  when	  PBS	  was	  placed	  in	  BT	  cases	  (p=1.00).	  When	  PBS	  was	  added	  to	  CC	  cassettes,	  there	  was	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a	  significant	  increase	  in	  lysozyme	  activity	  over	  time	  (p<0.001).	  Lysozyme	  in	  PBS,	  when	  placed	  in	  PP	  vials,	  
showed	  a	  significant	  decrease	  in	  activity	  between	  hrs	  1	  and	  48	  (p<0.001).	  
	  
In	  summary,	  the	  activity	  of	  protein	  when	  either	  a	  high	  or	  low	  concentration	  of	  lysozyme	  was	  placed	  in	  
PBS,	   specifically	   at	   the	   12-­‐hr	   time	   point,	   was	   similar	   between	   lens	   cases.	   For	   the	   high	   lysozyme	  
concentration,	   during	   the	   first	   time	   point	   (1	   hr),	   PBS	   in	   OFR	   lens	   cases	   exhibited	   a	   higher	   activity;	  
however,	   a	   strong	  decrease	   in	   activity	  was	   seen	   as	   the	   final	   time	  point	  was	   reached.	   In	   contrast,	   the	  
drop	   in	   low	   concentration	   lysozyme	   activity	   with	   OFR	   was	   steadier,	   reaching	   a	   similar	   activity	   level	  
compared	   to	   the	   PP	   control	   vials	   at	   48	   hrs.	   Lysozyme	   placed	   in	   CC	   neutralization	   cassettes	   had	   the	  
greatest	  activity	  by	   the	  end	  of	   the	  48-­‐hr	   time	   frame;	  however,	  OFR	  and	  BT	  exhibited	  a	  similar	  activity	  




Contact	   lens	  cleaning	  solutions	  have	  a	  number	  of	  functions,	  the	  major	  ones	  being	  to	  disinfect	  the	  lens	  
after	  wear	   and	   to	   remove	   any	   tear	   film	   deposition	   components.	   One	   of	   the	  many	   proteins	   that	  may	  
deposit	   onto	   the	   contact	   lens	   is	   lysozyme,	   a	   protein	   that	   carries	   antimicrobial	   properties	   [1].	   Studies	  
have	   demonstrated	   the	   efficacy	   of	   disinfection	   solutions	   against	   an	   array	   of	  microorganisms	   [31,32].	  
Interestingly,	   one	   of	   the	   biocides	   or	   disinfecting	   agents,	   PHMB,	   found	   in	   some	   cleaning	   solutions,	  
including	  BT	  and	  CC,	  has	  been	  known	  to	  partly	  stick	  to	  glass	  [33]	  and	  to	  the	  manufacturers’	  bottles	  [31],	  
which	   may	   cause	   differences	   in	   MPS’	   efficacy	   against	   microorganisms.	   The	   efficacy	   of	   a	   lens	   care	  
solution	  is	  dependent	  on	  a	  number	  of	  factors,	  including	  pH,	  temperature,	  concentration	  of	  disinfectant,	  
and	  the	  amount	  of	  organic	  matter	  present	  [34].	  The	  antimicrobial	  efficacy	  is	  further	  dependent	  on	  the	  
buffer	   system	   and	   surfactants	   [32].	   The	   polyquad-­‐based	   system	   in	   OFR	   has	   proven	  more	   effective	   in	  
disinfecting	  than	  the	  polyhexanide-­‐based	  MPS	  [35,36].	  	  
	  
In	   this	   study,	   lysozyme	   activity	  was	   consistently	   over	   100%	   throughout	   the	   48	   hrs	   of	   the	   experiment	  
when	   exposed	   to	   OFR	   in	   the	   original	   lens	   cases,	   regardless	   of	   the	   lysozyme	   concentration.	   For	   high	  
concentration	  lysozyme,	  the	  activity	  decreased	  from	  222%	  to	  180%	  and	  plateaued	  after	  24	  hrs.	  Certain	  
 73	  
components	   in	  MPS	  seem	  to	  enhance	  the	  stabilization	  of	   lysozyme	  protein	  through	  synergistic	  actions	  
[37]	  and	  hence,	  during	   this	  experiment,	   it	  appeared	   that	   there	  was	  an	  enhanced	  activity	  of	   lysozyme,	  
where	  M.	  lysodeikticus	  bacteria	  was	  lysed	  at	  a	  faster	  than	  normal	  rate.	  For	  OFR	  lens	  cases,	  the	  rate	  of	  
lysozyme	  activity	  was	  typically	  greater	  when	  a	  high	  concentration	  of	  lysozyme	  was	  used	  compared	  to	  a	  
low	  lysozyme	  concentration.	  However,	  by	  the	  end	  of	  the	  48-­‐hr	  time	  period,	  the	  activity	  of	  lysozyme	  was	  
similar	  for	  both	  concentrations	  in	  OFR	  solution.	  This	  would	  indicate	  that	  the	  ratio	  of	  active	  lysozyme	  to	  
total	  lysozyme,	  as	  time	  progressed,	  was	  independent	  of	  the	  amount	  of	  lysozyme	  present	  in	  the	  OFR	  lens	  
case.	  This	  would	   further	   confirm	   that	   the	  buffer	   system	  and	   the	   surfactants	   in	   the	  MPS	  play	  a	   critical	  
role	  in	  maintaining	  antimicrobial	  activity	  of	  lysozyme	  [32].	  We	  expect	  the	  activity	  of	  lysozyme	  to	  remain	  
constant	  despite	  changing	  the	  concentration	  of	  lysozyme.	  Nevertheless,	  the	  results	  indicate	  that	  a	  lower	  
concentration	  of	  lysozyme	  presents	  with	  lower	  activity	  levels.	  An	  explanation	  for	  this	  lies	  in	  the	  fact	  that	  
lysozyme	  will	  adsorb	  onto	  the	  walls	  of	  the	  container,	  regardless	  of	  the	  amount	  present.	  When	  present	  in	  
a	  higher	  concentration,	   the	  amount	  of	  enzyme	   that	  binds	   to	   the	  container	  does	  not	   significantly	  alter	  
the	  activity.	  However,	  at	  a	  lower	  concentration,	  the	  amount	  present	  is	  sufficiently	  low	  that	  when	  it	  binds	  
to	  the	  wall	  of	  the	  container,	  the	  amount	  of	  lysozyme	  present	  decreases	  enough	  for	  it	  to	  present	  as	  an	  
apparent	   decrease	   in	   the	   activity	   level.	   Therefore,	   the	   decrease	   in	   activity	   is	   exaggerated	   due	   to	   a	  
decrease	  in	  the	  amount	  present	  for	  the	  reaction	  and	  not	  entirely	  as	  a	  result	  of	  a	  decline	  in	  activity.	  	  
	  
Lysozyme	  activity	   is	  enhanced	  not	  only	   in	  the	  presence	  of	  an	  MPS,	  but	  also	   in	  the	  presence	  of	  certain	  
tear	  film	  components.	  In	  a	  study	  undertaken	  by	  Ellison	  and	  Giehl	  [38],	  it	  was	  shown	  that	  both	  lactoferrin	  
and	   lysozyme	   protein	   exert	   an	   additive	   anti-­‐microbial	   effect	   on	   bacteria	   [38],	   thereby	   potentially	  
eliciting	  an	  enhanced	  activity	  of	  lysozyme	  when	  using	  a	  turbidity	  assay.	  If	  this	  current	  study	  had	  used	  an	  
artificial	   tear	   solution	   (ATS)	   instead	   of	   PBS	   to	   dissolve	   the	   lysozyme,	   the	   resulting	   lysozyme	   activity	  
would	   have	   been	   the	   summation	   of	   both	   the	   MPS	   and	   the	   lactoferrin-­‐lysozyme	   synergy.	   Since	   this	  
current	   study	   did	   not	   use	   lactoferrin	   in	   the	   turbidity	   assay,	   MPS	   was	   the	   only	   variable	   that	   could	  
potentially	  enhance	  lysozyme	  activity.	  Similarly,	  a	  study	  conducted	  by	  Leitch	  and	  Willcox	  [39]	  confirmed	  
that	   there	   is	   a	   synergistic	   relationship	   between	   lactoferrin	   and	   lysozyme	   against	   Staphylococcus	  
epidermidis	  strains	  of	  bacteria	  [39].	  Lysozyme	  has	  a	  direct	  antimicrobial	  effect	  on	  gram-­‐negative	  bacteria	  
through	   its	   adherence	   to	   the	   cell	   wall	   and	   hydrolysis	   of	   the	   N-­‐acetylglucosamine	   linkages	   [40,41].	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Lactoferrin	  makes	  the	  cell	  wall	  more	  susceptible	  to	  hydrolysis	  of	  bond	  linkages	  by	  lysozyme	  [38]	  due	  to	  
its	  permeability	  and	  interference	  with	  the	  lipopolysaccharide	  layer	  [42].	  	  
	  
When	  BT	  solution	  was	  placed	  in	  the	  respective	  BT	  lens	  case,	  the	  activity	  of	  lysozyme	  plateaued	  almost	  
immediately;	  however,	  when	  PBS	  was	  placed	   in	  BT	   lens	  cases,	   the	   lysozyme	  activity	  decreased	  slightly	  
over	   the	   48	   hours.	   After	   1	   hr,	   the	   activity	   of	   high	   concentration	   lysozyme	   and	   low	   concentration	  
lysozyme	  in	  BT	  solution	  was	  65%	  and	  45%,	  respectively;	  both	  concentrations	  increased	  to	  a	  peak	  activity	  
(99%	  and	  86%,	  respectively)	  and	  did	  not	  change	  significantly	  after.	  This	   increase	  in	  activity	  began	  right	  
after	  hr	  1,	  which	  could	  be	  due	  to	  the	  stabilization	  of	  lysozyme	  as	  the	  time	  progressed.	  This	  could	  cause	  a	  
renaturation	  of	  protein,	  allowing	  lysozyme	  to	  more	  rapidly	  lyse	  the	  bacteria	  during	  the	  turbidity	  assay.	  	  
	  
A	   recent	   study	   undertaken	   by	   Barniak	   and	   colleagues	   determined	   the	   ability	   of	   MPS	   to	   prevent	   the	  
chemical	   denaturation	   (using	   SDS)	   of	   lysozyme	   [43].	   Two	   of	   the	   test	   solutions,	   BT	   and	   ReNu	   Fresh,	  
presented	  with	  the	  ability	  to	  stabilize	  lysozyme	  after	  exposure	  to	  SDS.	  SDS	  is	  known	  to	  bind	  to	  lysozyme	  
and	  change	   its	  conformational	  protein	  structure	  from	  a	  β-­‐structure	  to	  an	  α-­‐helix	   formation,	  as	  well	  as	  
change	   its	   side	   chain	   residues	   [43,44].	   OFR,	   OPTI-­‐FREE	   EXPRESS,	   AQuify,	   COMPLETE	   MPS	   Easy	   Rub	  
Formula,	  and	  PBS	  were	  among	  the	  test	  solutions	  that	  did	  not	  have	  a	  significant	  impact	  on	  the	  activity	  of	  
lysozyme	  [43].	  The	  component	  of	  BT,	  which	  preserves	  the	  active	  state	  of	  lysozyme,	  could	  be	  hyaluronic	  
acid	  (HA),	  a	  glycosaminoglycan	  lubricant	  [45],	  which	  decreases	  denaturation	  of	  protein	  at	  the	  solid-­‐liquid	  
interface	  [46].	  Certain	  surfactant	   ingredients	   in	  BT	  may	  play	  a	  pivotal	  role	  to	  keep	  protein	   in	   its	  active	  
state	   including	   poloxamine	   surfactant,	   which	   reduces	   denaturation	   of	   hen	   egg	   lysozyme	   [47]	   and	  
sulfobetaine	  10,	  which	  aid	  in	  the	  refolding	  of	  lysozyme	  back	  into	  its	  active	  conformation	  [37]	  by	  binding	  
to	  the	  protein	  without	  affecting	  its	  lysing	  function	  [48].	  	  
	  
For	   CC	   solution,	   there	   was	   a	   slight	   increase	   in	   lysozyme	   activity	   throughout	   the	   48-­‐hr	   time	   frame;	  
however,	  it	  exhibited	  a	  lower	  lysozyme	  activity	  compared	  to	  the	  other	  two	  MPS.	  An	  increase	  in	  activity	  
was	  seen	  particularly	  for	  CC	  low	  lysozyme	  concentration	  at	  the	  48-­‐hr	  time	  point.	  Previous	  in-­‐house	  work	  
determined	   that	   a	   similar	   increase	  was	   found;	   however,	   this	  was	   at	   the	   24-­‐hr	   time	   point.	   A	   possible	  
explanation	   for	   this	   increase	  may	  be	   that	   the	  protein	   is	   regaining	  activity	   in	   the	  neutral	  environment;	  
however,	   more	   work	   is	   required	   to	   speculate	   what	   potentially	   can	   cause	   such	   a	   drastic	   increase.	   It	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remained	  unclear	   from	   this	  experiment	  whether	   lysozyme	  deposition	   to	   the	   lens	   case,	  particularly	  CC	  
neutralization	  cassettes,	  may	  have	   impacted	   the	   final	  outcome.	  For	  cases	   that	  attract	  more	   lysozyme,	  
the	  total	  concentration	  in	  the	  solution	  may	  have	  been	  lower	  than	  expected,	  which	  would	  subsequently	  
impact	   the	   activity	   readings.	   Future	   studies	   should	   therefore	   quantify	   the	   amount	   of	   lysozyme	   in	   the	  
solution	   for	  each	   time	  point	  at	  which	  activity	   is	  determined.	   In	  addition	   to	   this,	   the	  amount	  of	  added	  
lysozyme	   in	   the	   high	   concentration	   situation	   was	   not	   double	   the	   amount	   placed,	   it	   was	   three	   times	  
greater	   thus,	   because	   there	   was	   an	   increase	   in	   the	   amount	   added,	   the	   activities	   may	   potentially	   be	  
exaggerated	   for	  high	   lysozyme	  concentration	   readings	  and	  are	  not	  exactly	   comparable	   to	  OFR	  and	  BT	  
findings.	  	  
	  
CC	  is	  a	  hydrogen	  peroxide-­‐based	  system,	  which	  denatures	  lysozyme	  and	  hence	  decreases	  the	  efficiency	  
of	  active	  proteins,	  such	  as	  lysozyme	  [49].	  Immediately	  after	  insertion	  of	  the	  contact	  lens	  basket	  into	  the	  
3%	   hydrogen	   peroxide	   solution,	   both	   an	   aggressive	   disinfection	   and	   a	   neutralization	   process	   occur	  
simultaneously	   over	   a	   6-­‐hr	   time	   frame	   [50].	   A	   platinum	   catalyst	   disc,	   attached	   to	   the	   lens	   basket,	  
neutralizes	   the	   hydrogen	   peroxide	   solution	   [51].	   This	   study	   demonstrated	   that	   of	   the	   three	   cleaning	  
solutions	  used,	  CC	  was	  less	  effective	  in	  maintaining	  the	  activity	  of	  lysozyme	  compared	  to	  the	  other	  two	  
MPS.	   Although	   hydrogen	   peroxide-­‐based	   systems	   denature	   lysozyme,	   this	   may	   not	   present	   a	   critical	  
problem	  to	  lens-­‐wearers,	  as	  3%	  hydrogen	  peroxide-­‐based	  care	  solutions,	  such	  as	  AOSEPT,	  provide	  a	  high	  
disinfection	  efficacy	  as	  shown	  by	  Hildebrandt	  [52]	  and	  Lowe	  [53].	  The	  protein	  removal	  efficiency	  of	  CC	  is	  
quite	   high	   [24]	   and	   thus	   the	   amount	   of	   protein	   remaining	   on	   the	   lens	   is	   quite	   low.	   Therefore,	   the	  
increased	  denaturation	  of	  this	  very	  low	  amount	  of	  protein	  may	  be	  clinically	  irrelevant.	  	  	  	  
	  
Proteins	   that	   deposit	   onto	   contact	   lenses	   typically	   undergo	   conformational	   changes	   and	   denature,	  
which	  may	  cause	   inflammatory	   reactions,	   such	  as	  giant	  papillary	  conjunctivitis	   (GPC)	   [54,55].	  A	   recent	  
study	  by	  Wright	  et	  al.	  [37]	   investigated	  a	  new	  MPS	  solution-­‐	  Bausch	  &	  Lomb’s	  BioTrue	  without	  its	  two	  
disinfectants,	   as	   they	   would	   interfere	   with	   the	   antimicrobial	   assessment	   of	   proteins.	   The	   solution,	  
however,	  contained	  the	  buffer	  system	  and	  unique	  components	  found	  in	  BioTrue,	  such	  as	  hyaluronic	  acid	  
[37].	   It	   was	   demonstrated	   that	   contact	   lenses	   that	   are	   repeatedly	   exposed	   to	   this	   MPS	   allowed	   the	  
proteins	  to	  stay	   in	  their	  active	  state	  [37].	  Protein	  stabilizers,	  such	  as	  those	  found	  in	  MPS,	  may	  prevent	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ocular	   responses	   caused	   by	   lens	   deposits	   by	   either	   preventing	   protein	   denaturation	   or	   reversing	   the	  
process	  [37].	  
	  
Future	  studies	  should	  determine	  the	  impact	  of	  MPS	  products	  on	  lysozyme	  activity	  when	  an	  ATS	  is	  used.	  
Studies	  have	  previously	  shown	  that	  the	  organic	  load	  has	  a	  negative	  impact	  on	  contact	  lens	  disinfecting	  
efficiency	  [56-­‐58].	  Interestingly,	  in	  the	  recent	  study	  by	  Hildebrandt	  and	  colleagues	  [52],	  the	  ATS	  utilized	  
increased	  the	  efficacy	  of	  contact	  lens	  solutions	  against	  Staphylococcus	  aureus,	  particularly	  for	  OFR	  [52].	  
In	  vitro	  study	  designs	  should	  advance	  in	  order	  for	  a	  true	  mimic	  of	  ex	  vivo	  situations.	  
	  	  
In	  summary,	  contact	   lens	  cleaning	  solutions	  varied	  in	  their	  effect	  on	  lysozyme	  activity,	  as	  OFR	  typically	  
enhanced,	  BT	  stabilized,	  and	  CC	  decreased	  activity.	  This	  in	  vitro	  study	  confirmed	  not	  only	  that	  MPS	  had	  
an	  effect	  on	  lysozyme	  activity,	  but	  also	  that	  the	  lens	  case	  in	  which	  solution	  was	  stored	  impacted	  activity	  














6 GENERAL	  DISCUSSION	  AND	  CONCLUSION	  
 
The	  experiments	   conducted	   in	   this	   thesis	   investigated	   the	  effect	  of	   incubation	   solution	   complexity	  on	  
protein	   deposition	   to	   silicone	   hydrogel	   (SH)	   contact	   lens	   materials	   and	   the	   subsequent	   removal	  
efficiency	   using	   a	   multi-­‐purpose	   solution	   (MPS).	   In	   addition	   to	   this,	   the	   activity	   of	   lysozyme	   was	  
examined	  when	  placed	   in	  different	  contact	   lens	  cleaning	  solutions	  and	   lens	  cases.	  Furthermore,	  active	  
and	  total	  lysozyme	  and	  total	  protein	  was	  determined	  for	  patient-­‐worn	  SH	  lenses.	  This	  thesis	  provides	  a	  
chapter-­‐by-­‐chapter	  series	  of	  studies	  performed	  and	  results	  are	  summarized	  in	  this	  section.	  
	  
The	   third	   chapter	  of	   this	   thesis	  determined	   the	  effect	  of	   incubation	   solution	  on	   the	  deposition	  of	   the	  
proteins	   albumin,	   lactoferrin,	   and	   lysozyme	   to	   three	   different	   SH	   contact	   lenses	   using	   a	   radioactive	  
tracer.	  This	  study	  confirmed	  that	  the	  complexity	  of	  the	  incubation	  solution	  has	  a	  significant	  effect	  on	  the	  
deposition	  profile	  of	  proteins	  to	  SH	  contact	  lenses.	  Greatest	  deposition	  of	  protein	  was	  seen	  on	  balafilcon	  
A	   (BA)	   lenses,	   which	   accumulated	   significantly	   greater	   lysozyme	   when	   lenses	   were	   incubated	   in	   a	  
complex	  artificial	  tear	  solution	  (ATS)	  compared	  to	  a	  simple	  salt	  solution	  containing	  only	  a	  single	  protein.	  
The	  deposition	  of	   lysozyme	   to	   senofilcon	  A	   (SA)	  and	   lotrafilcon	  B	   (LB)	   lenses	  was	   less	  affected	  by	   the	  
complexity	   of	   the	   incubation	   solution.	   LB	   and	   BA	   lenses	   that	   were	   incubated	   in	   the	   simple	   protein	  
solution	  accumulated	  greater	  amounts	  of	  lactoferrin;	  however,	  SA	  lenses	  that	  were	  incubated	  in	  the	  ATS	  
accumulated	  more	  lactoferrin.	  This	  may	  be	  because	  lactoferrin	  is	  larger	  in	  size	  than	  lysozyme	  and	  hence	  
is	  outcompeted	   in	   the	  ATS	  by	   the	  much	  smaller	   lysozyme,	  which	  will	  accumulate	   in	  greater	  quantities	  
when	  it	  is	  the	  only	  protein	  available	  in	  solution.	  SA	  lenses	  demonstrated	  that	  primarily	  non-­‐competitive	  
factors	  were	  affecting	  the	  deposition	  of	  albumin	  to	  these	  lenses.	  LB	  lenses	  accumulated	  greater	  albumin	  
when	   lenses	  were	   incubated	   in	   the	  simple	  protein	  solution;	  however,	  BA	   lenses	  accumulated	  greatest	  
albumin	   when	   incubated	   in	   the	   complex	   ATS.	   Again,	   albumin	   is	   not	   being	   out-­‐competed	   by	   other	  
proteins	   to	  bind	  onto	  LB	   lenses	  and,	  with	   regards	   to	  BA	   lenses,	  electronic	   repulsion	  may	  have	  caused	  
less	   albumin	   to	   bind	  when	   no	   other	   proteins	   are	   available	   in	   solution,	  which	  may	   have	   resulted	   in	   a	  
“sandwich	  phenomenon”.	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Chapter	  4	  investigated	  the	  effect	  of	  MPS	  on	  lysozyme	  removal	  after	  its	  deposition	  to	  various	  SH	  lenses,	  
using	  either	  a	  simple	  protein	  solution	  or	  a	  complex	  ATS.	  When	  SA	  lenses	  were	  cleaned	  with	  OPTI-­‐FREE	  
RepleniSH	   (OFR),	   only	   small	   amounts	  of	   lysozyme	   remained	  on	   the	   cleaned	   lenses	   and	  no	   increase	   in	  
deposition	   was	   seen	   throughout	   the	   28-­‐day	   time	   period,	   independent	   of	   the	   complexity	   of	   the	  
incubation	  solution.	  Nearly	  50%	  of	  the	  deposited	  lysozyme	  was	  removed	  when	  lenses	  were	  incubated	  in	  
a	   simple	   solution	   and	   there	   was	   about	   a	   90%	   removal	   efficiency	   when	   lenses	   were	   incubated	   in	   a	  
complex	  ATS.	  When	  LB	  lenses	  incubated	  in	  a	  simple	  solution	  were	  cleaned,	  nearly	  half	  of	  the	  deposited	  
protein	  was	   removed	  and	   resulted	   in	  a	  plateauing	  effect	  over	   time.	  However,	   the	   removal	  efficacy	  of	  
OFR	  was	  increased	  by	  over	  25%	  when	  cleaning	  LB	  lenses	  incubated	  in	  a	  complex	  ATS,	  concluding	  with	  a	  
plateaued	  deposition	  pattern	  that	  was	  over	  two	  times	  greater	  than	  that	  of	  the	  simple	  protein	  solution.	  
When	   BA	   lenses	   underwent	   20	   days	   of	   cleaning	   with	   OFR,	   the	   lenses	   incubated	   in	   either	   of	   the	  
incubation	   solutions	   had	   the	   same	   amount	   of	   protein	   removed	   (approximately	   70%).	   The	   plateau	  
pattern	  that	  was	  witnessed	  for	  SA	  and	  LB	  lenses	  was	  not	  as	  evident	  for	  BA	  lenses,	  as	  there	  was	  a	  slight	  
incline	  in	  the	  amount	  of	  lysozyme	  accumulated	  on	  the	  lenses	  as	  each	  time	  point	  was	  approached.	  
	  
There	  was	  a	   significant	   change	   in	  deposition	  patterns	   seen	   for	   lysozyme	  deposition	   to	  SA,	   LB,	   and	  BA	  
lenses	  when	  comparing	  Chapter	  3	  and	  Chapter	  4.	   In	  Chapter	  3,	  the	  deposition	  pattern	  of	   lysozyme	  for	  
both	  SA	  and	  LB	  lenses	  was	  independent	  of	  incubation	  solution	  used;	  however,	  for	  Chapter	  4,	  there	  was	  a	  
significant	   increase	   in	   lysozyme	  deposition	  when	  both	   SA	  and	   LB	   lenses	  were	   incubated	   in	   a	   complex	  
ATS.	  Although	  BA	   lenses	  accumulated	  significantly	  greater	   lysozyme	  when	   incubated	   in	  a	  complex	  ATS	  
for	  both	  Chapters	  3	  and	  4,	  there	  is	  double	  the	  amount	  of	   lysozyme	  deposited	  for	  Chapter	  3.	  All	  of	  the	  
variations	  seen	  between	  the	   two	  chapters	  could	  be	  attributed	  to	  a	  number	  of	   things.	   In	   the	   following	  
discussion,	  I	  have	  grouped	  these	  into	  lens	  material,	  radiolabeling,	  and	  procedural	  factors.	  	  
	  
Lens	  material-­‐dependent	  variations	  seen	  in	  data	  would	  be	  due	  to	  a	  change	  in	  lot	  numbers,	  a	  change	  in	  
the	   lens	   material	   chemical	   make-­‐up,	   and	   a	   change	   in	   the	   blister-­‐pack	   solution	   that	   houses	   the	   lens	  
material.	  There	  was	  a	  short	  timeframe	  between	  conducting	  the	  two	  experiments	  and	  since	  then,	  there	  
has	   not	   been	   any	   change	   in	   chemical	  make-­‐up	  or	   blister-­‐pack	   solution	   to	   either	   of	   the	   lens	  materials	  
investigated.	   So,	   the	   lot	   number	   is	   essentially	   the	   only	   factor	   that	   could	   potentially	   affect	   deposition	  
profiles.	   Even	   then,	   this	  would	   only	   permit	   a	  marginal	   change	   in	   the	   amount	   of	   protein	   accumulated	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onto	  a	  lens	  material	  when	  different	  lot	  numbers	  are	  used.	  Therefore,	  this	  factor	  is	  unlikely	  to	  be	  a	  major	  
contributor	  to	  the	  variation	  in	  results	  seen.	  	  
	  
With	  regards	  to	  the	  radiolabeling	  technique,	  the	  iodine	  monochloride	  (ICL)	  method	  is	  repeatable	  and	  it	  
is	  not	  expected	  that	  the	  procedure	  itself	  would	  cause	  significant	  variations	  in	  deposition	  profiles	  for	  lens	  
materials.	  However,	   there	  may	  be	  differences	   in	   the	  amount	  of	   free	   iodine	  and	  the	  specific	  activity	  of	  
the	  radiolabeled	  protein	  between	  the	  batches	  of	  radiolabeling	  protein	  used	  in	  the	  two	  chapters.	  There	  is	  
a	   target	   percentage	   (<2%)	   of	   free	   iodine	  when	   performing	   the	   ICL	  method	   and	   this	   target	   value	  was	  
never	  surpassed	  for	  either	  of	  the	  two	  experiments;	  however,	  the	  free	  iodine	  was	  not	  checked	  on	  a	  28-­‐
day	  time	  course,	  so	  there	  may	  be	  alterations	  in	  the	  amount	  of	  free	  iodine	  available	  as	  time	  progressed	  
for	   either	   of	   the	   Chapters.	   These	   differences	   could	   potentially	   alter	   deposition	   profiles	   for	   lenses;	  
however,	   theoretically,	   there	  should	  be	  a	  uniform	  change	  to	  all	  materials.	  Free	   iodine	  may	  potentially	  
cause	  false	  positive	  readings,	  but	  those	  readings	  would	  be	  expected	  for	  all	  lens	  types	  and	  so	  it	  is	  unclear	  
as	  to	  why	  Chapter	  4	  had	  increased	  deposition	  values	  for	  SA	  and	  LB	  lenses,	  and	  decreased	  values	  for	  BA	  
lenses.	   Further	   investigation	   is	   needed	   to	  understand	  whether	  or	   not	   the	   free	   iodine	   is	   the	   cause	   for	  
these	  changes	  and	  hence	  future	  studies	  should	  measure	  free	  iodine	  in	  parallel	  with	  protein	  deposition	  
measurements	   and	   determine	   whether	   there	   is	   a	   consistent	   pattern	   in	   the	   amount	   of	   free	   iodine	  
present	  in	  solution.	  Dialysis	  was	  not	  used	  for	  either	  experiment	  and	  so	  future	  studies	  should	  incorporate	  
dialysis	  into	  the	  methodology	  in	  order	  to	  limit	  the	  amount	  of	  free	  iodine	  in	  solution.	  Sufficient	  controls	  
were	   used	   for	   both	   Chapters	   and	   the	   differences	   in	   specific	   activities	  were	   accounted	   for	   during	   the	  
calculations	  to	  determine	  the	  amount	  of	  hot	  radiolabeled	  protein	  needed	  for	  each	  experiment.	  	  
	  
Variations	   in	  experimental	  procedures	  could	  also	  account	   for	   the	  differences	   in	  deposition	  profiles	   for	  
both	  Chapters	  3	  and	  4.	  For	  both	  experiments,	  the	  container	  in	  which	  lenses	  were	  incubated	  was	  always	  
pre-­‐treated	  and	  exposed	  to	  the	  various	  macromolecules	  that	  may	  potentially	  bind	  to	  the	  container	  wall.	  
For	  Chapter	  3,	  6	  mL	  glass	  vials	  were	  used	  and	  pre-­‐treated;	  however,	  due	  to	  the	  increase	  in	  lens	  number	  
and	  steps	  involved	  for	  Chapter	  4,	  larger	  containers	  (Qorpak	  bottles)	  were	  used.	  These	  bottles	  were	  also	  
pre-­‐treated,	  and	  in	  addition	  the	  histology	  cassettes	  in	  which	  lenses	  were	  placed	  were	  also	  pre-­‐treated	  to	  
minimize	  adsorption	  to	  the	  container	  wall.	  The	  pre-­‐treatment	  procedure	  was	  consistent	  and	  hence	  it	  is	  
not	   expected	   for	   this	   to	   be	   a	  major	   factor	   in	   the	   lack	   of	   repeatability	   between	   the	   two	   experiments.	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Also,	  there	  was	  a	  variation	  between	  Chapter	  3	  and	  4’s	  method	  of	  rinsing	  lenses	  to	  remove	  loosely	  bound	  
protein.	  For	  Chapter	  4,	   the	   lenses	  were	  never	  removed	  from	  the	  histology	  cassettes	  when	  undergoing	  
rinsing	  cycles,	  and	  so	  the	  cassettes	  themselves	  were	  being	  rinsed	  with	  the	  lenses	  inside.	  This	  was	  carried	  
throughout	  the	  experiment	  for	  each	  of	  the	  lens	  types	  and	  so	  if	  this	  change	  in	  rinsing	  mechanism	  had	  an	  
effect	  on	  deposition	  profiles,	  it	  would	  be	  expected	  that	  all	  lenses	  acted	  uniformly.	  It	  is	  clear	  that	  Chapter	  
3	   and	   Chapter	   4	   had	   variations	   in	   lens	   material	   lot	   numbers,	   radiolabeling	   batches	   used,	   and	  
experimental	  procedures;	  however,	  these	  variations	  were	  negated	  as	  best	  as	  possible	  to	  limit	  any	  sort	  of	  
significant	  changes	  in	  deposition	  profiles.	  	  
	  
The	   final	   chapter	   of	   this	   thesis	   (Chapter	   5)	   explored	   the	   effect	   of	   contact	   lens	   cleaning	   solutions	   and	  
respective	   lens	  cases	  on	   lysozyme	  activity	  by	  using	  OFR,	  BioTrue	  (BT),	  Clear	  Care	  (CC),	  and	  phosphate-­‐
buffered	  saline	  (PBS)	  as	  test	  solutions.	  To	  mimic	  typical	  amounts	  of	  lysozyme	  depositing	  to	  hydrogel	  and	  
SH	   lenses,	   high	   and	   low	   lysozyme	   concentrations	   were	   dissolved	   in	   the	   solutions.	   For	   OFR	   and	   BT,	  
500µg/lens	   and	   10µg/lens	   were	   added	   for	   high	   and	   low	   concentrations	   respectively,	   whereas	   for	   CC	  
1500µg	  and	  20µg	  were	  used	  to	  represent	  two	  lenses	  stored	  in	  the	  same	  container.	  For	  OFR,	  there	  was	  
greater	   lysozyme	   activity	   when	   the	   high	   protein	   concentration	   was	   used.	   Both	   concentrations	   of	  
lysozyme	  demonstrated	  over	  100%	  activity	  throughout	  the	  48-­‐hour	  time	  frame,	  which	  decreased	  slightly	  
over	   time;	   however,	   after	   24	   hrs,	   there	   was	   no	   further	   change	   in	   activity	   for	   either	   lysozyme	  
concentration.	  Similar	   to	  OFR,	   there	  was	  greater	  protein	  activity	   for	  high	  versus	   low	  concentrations	  of	  
lysozyme	   that	  was	   dissolved	   in	   BT.	   After	   an	   initial	   increase	   in	   activity	   by	   6	   hrs,	   the	   activity	   remained	  
relatively	  stagnant	  when	  lysozyme	  was	  dissolved	  as	  two	  separate	  concentrations.	  For	  the	  test	  solution,	  
CC,	  there	  was	  an	  increase	  in	  lysozyme	  activity	  for	  low	  lysozyme	  concentration	  after	  both	  6	  and	  48	  hours;	  
however,	  this	  was	  not	  seen	  with	  high	  concentrations	  as	  a	  plateauing	  effect	  was	  noted	  between	  the	  12-­‐	  
and	   24-­‐hr	   time	   points.	   It	  was	   evident	   that	  OFR	   enhanced	   lysozyme	   activity,	  whereas	   CC	   reduced	   the	  
activity	   and	   BT	   had	   no	   major	   effect	   throughout	   the	   experiment.	   When	   PBS	   was	   placed	   in	   different	  
contact	   lens	  cases,	   the	  activity	  of	   the	  high	  concentration	   lysozyme	  was	  more	  consistent	  amongst	  time	  
points	   than	   low	  concentration	   lysozyme	  activity.	  For	  both	   lysozyme	  concentrations,	   there	  was	  greater	  
activity	  when	   lysozyme	   in	  PBS	  was	  placed	   in	  OFR	   lens	  cases	   for	  1	  hr	  compared	  to	  all	  other	   lens	  cases;	  
however,	  by	   the	  end	  of	   the	  48-­‐hr	   time	  period	   there	  was	  slightly	  greater	  activity	   seen	   in	  BT	   lens	  cases	  
when	  using	  high	  concentration	  lysozyme	  and	  CC	  neutralization	  cassettes	  when	  using	  low	  concentration	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lysozyme.	  The	  OFR	  and	  BT	   lens	   case	  both	  contain	  a	  polypropylene	  base;	  however,	   the	  coating	  on	   the	  
case	  may	  be	  specific	  to	  each	  manufacturer.	  No	  details	  are	  available	  on	  specific	  material	  make-­‐up	  and	  so	  
it	  is	  possible	  to	  speculate	  that	  the	  coatings	  on	  each	  lens	  case	  may	  potentially	  impact	  lysozyme	  activity.	  
For	  the	  CC	  neutralization	  cassettes,	  there	  is	  no	  empirical	  evidence	  on	  whether	  or	  not	  the	  platinum	  disc	  
may	  or	  may	  not	  have	  an	  effect	  on	  lysozyme	  activity.	  Overall,	  this	  study	  not	  only	  proved	  that	  contact	  lens	  
solutions	  differ	  in	  their	  impact	  on	  lysozyme	  activity,	  but	  also	  confirmed	  that	  lens	  cases	  have	  an	  impact	  
on	  protein	  activity.	  	  
	  
To	  conclude,	   the	  complexity	  of	   incubation	  solutions	  has	  a	  direct	   impact	  on	  the	  deposition	  of	   tear	   film	  
proteins	  to	  SH	  contact	  lens	  materials.	  The	  importance	  of	  using	  an	  artificial	  model	  that	  better	  mimics	  the	  
human	   tear	   film	   is	   emphasized.	   Furthermore,	   differences	   were	   found	   in	   the	   cleaning	   efficiency	   with	  
certain	  MPS,	  which	   likewise	  was	   related	   to	   the	   complexity	   of	   the	   incubation	   solution.	   Future	   studies	  
should	  consider	  the	  complexity	  of	  the	  human	  tear	  film	  when	  designing	  in	  vitro	  studies	  in	  order	  to	  better	  
















7 FUTURE	  STUDIES	  
 
A	  number	  of	  future	  studies	  could	  be	  performed	  in	  continuation	  of	  the	  results	  developed	  from	  this	  thesis.	  
This	   thesis	   conducted	   a	   number	   of	   in	   vitro	   studies	   to	   investigate	   the	   effect	   of	   incubation	   solution	  
complexity	  on	  protein	  deposition	  to	  silicone	  hydrogel	  (SH)	  contact	  lens	  materials,	  as	  well	  as	  determined	  
the	   effect	   of	   a	   multi-­‐purpose	   solution	   (MPS)	   on	   protein	   removal	   from	   lenses	   incubated	   in	   different	  
solutions.	  The	  ability	  of	  different	  MPS	  to	  stabilize	  lysozyme	  protein	  was	  also	  investigated	  and	  further	  it	  
determined	   total	   active	   lysozyme	   as	   well	   as	   total	   lysozyme	   and	   protein	   on	   worn	   lens	  materials.	   The	  
overall	  purpose	  of	  future	  studies	  would	  be	  to	  enhance	  current	  understanding	  of	  the	  tear	  film	  interaction	  
with	  contact	  lens	  materials,	  such	  as	  protein	  and	  lipid	  deposition,	  and	  to	  limit	  such	  by	  developing	  more	  
advanced	  contact	  lens	  materials.	  	  
	  
One	  future	  study	  may	  include	  the	  true	  mimic	  of	  the	  human	  tear	  film	  when	  investigating	  the	  deposition	  
of	   proteins	   onto	   the	   contact	   lens	   materials.	   A	   substantial	   number	   of	   studies	   have	   evaluated	   the	  
deposition	   of	   proteins	   to	   lenses;	   however,	   there	   have	   been	   several	   factors	   left	   out	   that	   could	  
significantly	   affect	   the	   deposition	   pattern	   of	   proteins,	   such	   as	   the	   effect	   of	   blinking,	   surface	   drying,	  
cleansing	  cycles,	  and	  physiological	  processes.	  In	  vitro	  experiments	  complement	  ex	  vivo	  data	  as	  individual	  
components	  of	  the	  tear	  film	  can	  be	  investigated	  alone,	  in	  addition	  to	  a	  controlled	  setting	  with	  other	  tear	  
film	  components.	  In	  vivo	  conditions	  are	  very	  complex	  and	  current	  in	  vitro	  studies	  typically	  lack	  exposure	  
of	   lenses	   to	  an	  air-­‐water	   interface,	   in	  order	   to	  mimic	   the	  effect	  of	  blinking,	  where	   the	   contact	   lens	   is	  
exposed	   to	   air,	   resulting	   in	   an	   intermediate,	   hydrophobic	   state	   for	   the	   lens	   surface.	  Recently,	   “model	  
blink	  cells”	  have	  been	  engineered	  to	  imitate	  the	  effect	  of	  blinking	  and	  to	  determine	  whether	  there	  is	  a	  
significant	  effect	  on	  the	  deposition	  of	  macromolecules,	  such	  as	  proteins	  and	  lipids.	  During	  each	  “blink”,	  
the	  contact	  lens	  surface	  is	  rewetted	  and	  there	  is	  a	  constant	  replenishing	  of	  artificial	  tear	  solution	  (ATS),	  
which	   is	   typically	   lacking	   from	   in	   vitro	   studies.	   Replenishment	   of	   the	   incubation	   solution	   is	   often	  
maintained	  on	  a	  daily	  or	  weekly	  basis	  (Chapter	  4).	  As	  seen	  in	  Chapter	  4	  of	  this	  thesis,	  the	  use	  of	  cleaning	  
solutions	   was	   maintained	   on	   a	   frequent	   basis.	   Future	   studies	   should	   attempt	   to	   clean	   lenses	   like	   a	  
patient	  would,	  every	  day.	  Overall,	  the	  development	  of	  a	  model	  that	  could	  mimic	  all	  factors	  affecting	  the	  
deposition	  of	  macromolecules	  to	  lens	  materials	  would	  be	  valuable.	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This	  thesis	  confirmed	  that	  the	  complexity	  of	  the	  tear	  film	  should	  be	  maintained	  in	  future	  in	  vitro	  studies.	  
Ex	  vivo	  studies	  could	  further	  be	  evaluated	  for	  the	  concentration	  of	  proteins	  and	  lipids	  that	  are	  currently	  
not	   in	   ATS	   incubation	   solutions.	   Typically,	   only	   common	   proteins	   such	   as	   albumin,	   lactoferrin,	   and	  
lysozyme,	  are	  added	  in	  the	  incubation	  solutions,	  in	  addition	  to	  a	  few	  other	  components	  such	  as	  IgG	  and	  
mucins.	  However,	  the	  human	  tear	  film	  consists	  of	  more	  than	  100	  proteins	  [1]	  and	  	  over	  40	  lipids	  [2-­‐4],	  of	  
which	   most	   are	   typically	   lacking	   when	   using	   in	   vitro	   tear	   film	   models.	   In	   order	   to	   improve	   in	   these	  
models,	   a	  more	  comprehensive	  number	  of	  proteins	  and	   lipids	  need	   to	  be	   included	   to	   truly	  mimic	   the	  
effect	  of	  competitive	  binding	  of	  tear	  film	  components.	  Future	  in	  vitro	  models	  should	  consider	  findings	  of	  
previous	  studies	  evaluating	  the	  concentration	  of	  specific	  proteins,	  lipids,	  and	  mucins	  found	  in	  the	  human	  
tear	  film.	  	  	  
	  
This	   thesis	   investigated	   the	  protein	   removal	  efficiency	  of	  MPSs	   (Chapter	  4)	  and	   the	  effect	  of	  MPSs	  on	  
lysozyme	   activity	   (Chapter	   5).	   Chapter	   4	   determined	   the	   efficiency	   of	   protein	   removal	   by	   OPTI-­‐FREE	  
RepleniSH	   from	   SH	   contact	   lenses.	   Lysozyme	   is	   typically	   found	   in	   one	   of	   two	   forms,	   either	   active	   or	  
denatured,	   as	   once	   the	   protein	   adsorbs	   onto	   the	   hydrogel	   contact	   lens	   material,	   it	   may	   undergo	  
conformational	  changes	  [5,6].	  Previous	  studies	  have	  shown	  that	  denatured	  protein	  binds	  more	  strongly	  
to	   surfaces	   and	   is	   therefore	   less	   likely	   to	   be	   removed	   from	   hydrogel	   biomaterials	   [7,8].	   The	   current	  
experiment	  did	  not	  classify	   if	  primarily	  active	  or	  denatured	  lysozyme	  was	  removed	  during	  the	  cleaning	  
cycle	  and	  should	  therefore	  be	  the	  focus	  for	  future	  studies.	  Chapter	  5	  determined	  that	   lens	  cases	  have	  
varying	  effects	  on	   lysozyme	  activity	  when	  a	  control	  solution	  (phosphate-­‐buffered	  saline	  (PBS))	   is	  used.	  
This	  chapter	  used	  a	  PBS	  control	  with	  each	  lens	  case	  and	  also	  investigated	  each	  MPS	  when	  used	  with	  its	  
respective	   lens	   case.	   Future	   studies	   should	   use	   a	   single	   lens	   case	   as	   a	   variable,	  which	  would	   then	   be	  
cycled	  through	  different	  MPSs	  and	  determine	  whether	  a	  certain	  MPS-­‐lens	  case	  combination	  optimizes	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Purpose:	  The	  purpose	  of	  this	  ex	  vivo	  study	  was	  to	  determine	  total	  protein	  and	  lysozyme	  deposition	  onto	  
silicone	  hydrogel	  contact	  lenses.	  
	  
Methods:	   	   Two	   silicone	   hydrogel	   (SH)	   materials	   -­‐	   senofilcon	   A	   (SA)	   and	   lotrafilcon	   B	   (LB)	   -­‐	   were	  
investigated	   in	   this	   study.	   SA	   lenses	  were	  worn	   for	   two	  weeks	   and	   cleaned	  with	   either	   Clear	   Care	   or	  
OPTI-­‐FREE	  RepleniSH	  and	  LB	   lenses	  were	  worn	   for	  one	  month	  cleaned	  with	  Clear	  Care	   (n=20	  per	   lens	  
type).	  Total	  protein,	  total	  lysozyme,	  and	  total	  active	  lysozyme	  were	  determined	  using	  a	  Bradford	  assay,	  
enzyme-­‐linked	  immunosorbent	  assay	  (ELISA),	  and	  micrococcal	  assay,	  respectively.	  The	  effect	  of	  freezing	  
on	  lysozyme	  activity	  was	  further	  investigated.	  
	  
Results:	   Statistically	   significantly	   more	   protein	   deposited	   on	   LB	   lenses	   (9.23±1.60μg)	   than	   SA	   lenses	  
(8.23±1.23μg);	   p=0.03.	   There	   was	   no	   significant	   difference	   between	   the	   amounts	   of	   total	   protein	  
deposited	   on	   SA	   lenses	   cleaned	   with	   Clear	   Care	   or	   OPTI-­‐FREE	   RepleniSH	   (p>0.05).	   The	   amount	   of	  
lysozyme	   depositing	   on	   SA	   lenses	   was	   however	   higher	   compared	   to	   LB	   lenses	   (0.025±0.013	   μg	   vs.	  
0.012±0.009	   μg);	   p<0.001,	   while	   similar	   amounts	   of	   active	   lysozyme	   were	   recovered	   from	   both	   lens	  
types.	   A	   decrease	   in	   active	   lysozyme	   of	   27%	   (SA)	   and	   54%	   (LB)	   was	   found	   when	   extracted	   protein	  
samples	  were	  kept	  frozen	  for	  3	  months	  instead	  of	  1	  month.	  	  
	  
Conclusion:	   This	   study	   confirmed	   that	   there	   is	   a	   difference	   in	   deposition	   patterns	   between	   silicone	  
hydrogel	  contact	  lenses,	  even	  those	  within	  the	  same	  FDA	  group.	  However,	  these	  changes	  are	  very	  small	  
and	  their	  likelihood	  of	  being	  clinically	  significant	  are	  very	  low.	  	  
	  








Over	  the	  years,	  the	  use	  of	  contact	  lenses	  for	  vision	  correction	  has	  become	  a	  popular	  choice,	  as	  they	  are	  
convenient	  and	  more	  cosmetically	  appealing.	  A	  study	  conducted	  in	  2009	  reported	  that	  silicone	  hydrogel	  
(SH)	   lenses	  were	  fit	  to	  60%	  of	  all	  contact	   lens-­‐wearers	  compared	  to	  29%	  of	   lens	  fits	  with	  conventional	  
poly(2-­‐hydroxyethyl	   methacrylate)	   (pHEMA)-­‐based	   lenses	   [1].	   In	   a	   more	   recent	   survey	   conducted	   in	  
2010,	   the	   percentage	   of	   SH	  wearers	   increased	   to	   66%	   and	   the	   number	   of	   conventional	   lens-­‐wearers	  
decreased	  to	  25%	  [1].	  This	  is	  in	  agreement	  with	  the	  market	  in	  Canada	  and	  the	  US,	  which	  reported	  that	  
SH	   lenses	   currently	   account	   for	   about	   70%	   of	   daily-­‐wear	   lens	   fits	   [2].	   With	   regards	   to	   replacement	  
schedules,	  contact	  lenses	  that	  are	  replaced	  monthly	  are	  the	  most	  popular,	  accounted	  for	  46%	  of	  contact	  
lens	  fits	  and	  refits	  in	  2011	  [1].	  Bi-­‐weekly	  replaced	  lenses	  accounted	  for	  33%	  [1].	  	  
	  
SH	   lenses	   have	   a	   higher	   oxygen	   permeability	   compared	   to	   pHEMA-­‐based	   lenses,	   due	   to	   the	  
incorporation	   of	   siloxane	   groups	   [3,4].	   However,	   the	   hydrophobic	   nature	   of	   silicone	   requires	  
modifications	   of	   the	   contact	   lens	   surface	   to	   improve	  wettability	   of	   the	   lens	  material	   [5]	   and	   hence	   a	  
number	   of	   different	   surface	   treatments	   have	   been	   developed	   [6,7].	   For	   example,	   lotrafilcon	  A	   (Focus	  
Night	  &	  Day)	  has	  a	  plasma	  coating	  to	  increase	  wettability,	  whereas	  balafilcon	  A	  (PureVision)	  undergoes	  a	  
plasma	  oxidation	  process	  [8].	  
	  
During	   contact	   lens	   wear,	   various	   tear	   film	   components	   such	   as	   proteins	   and	   lipids	   deposit	   on	   the	  
lenses,	  which	  may	  result	   in	   reduced	  visual	  acuity	   [9],	  poor	  wettability	   [10],	  and	   reduced	  comfort	   [11].	  
These	  deposits	  may	  act	  as	  antigens	  [12]	  and	  hence	  cause	  ocular	  complications	  such	  as	  acute	  red	  eye	  [13]	  
and	  inflammatory	  reactions	  [14],	  which	  may	  lead	  to	  giant	  papillary	  conjunctivitis	  [15].	  The	  lens	  rubbing	  
against	  the	  upper	  tarsal	  conjunctiva	  may	  further	  cause	  mechanical	  trauma	  with	  a	  subsequent	   increase	  
of	  inflammatory	  markers	  in	  the	  tear	  film	  [12,16].	  And	  finally,	  a	  protein	  coating	  on	  certain	  lens	  types	  can	  
impact	   subsequent	   binding	   of	   bacterial	   organisms	   such	   as	   gram-­‐negative	   Pseudomonas	   aeruginosa,	  
which	  may	  increase	  the	  risk	  of	  developing	  microbial	  keratitis	  [17].	  	  
	  
Contact	  lenses	  require	  a	  care	  regimen	  in	  order	  to	  disinfect	  the	  worn	  lens	  and	  to	  remove	  exogenous	  and	  
tear	  film	  deposits	  [18-­‐20].	  A	  study	  conducted	  in	  2011	  reported	  that	  practitioners	  primarily	  recommend	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multi-­‐purpose	  solutions	   (MPS)	   (77%)	  to	  their	  patients,	  with	  hydrogen	  peroxide	  systems	  accounting	  for	  
the	  remainder	  of	  the	  market	  (23%)	  [1].	  The	  composition	  of	  MPSs	  is	  typically	  a	  complex	  combination	  of	  
anti-­‐microbial	  agents	  [21],	  surfactants,	  and	  buffer	  systems	  and	  although	  an	  important	  task	  is	  to	  remove	  
tear	  film	  components	  from	  contact	  lenses,	  the	  removal	  efficiency	  is	  typically	  less	  than	  50%	  [22,23].	  	  
	  
The	   purpose	   of	   this	   ex	   vivo	   study	   was	   to	   determine	   the	   total	   amount	   of	   protein	   and	   percentage	   of	  
lysozyme	  activity	  on	  worn	   lenses.	  Senofilcon	  A	  and	   lotrafilcon	  B	   lenses	  were	   investigated,	  which	  were	  




Two	  SH	  contact	  lens	  materials	  were	  investigated	  in	  this	  study,	  senofilcon	  A	  (SA,	  ACUVUE	  OASYS,	  Johnson	  
&	   Johnson)	   and	   lotrafilcon	  B	   (LB,	  Air	  Optix	  Aqua,	   CIBA	  VISION).	   Both	   lenses	  have	  been	   categorized	   in	  
Group	  1	  under	  the	  Food	  and	  Drug	  Administration	  (FDA)	  (<50%	  water	  content,	  non-­‐ionic).	  	  
	  
In	  this	  study,	  SA	  lenses	  were	  cleaned	  with	  either	  OPTI-­‐FREE	  RepleniSH	  or	  Clear	  Care,	  whereas	  LB	  lenses	  
were	  only	  cleaned	  with	  Clear	  Care.	  Table	  6-­‐1	  outlines	  the	  components	  of	  the	  two	  lens-­‐care	  products.	  	  
	  
Table	  1:	  Composition	  of	  lens-­‐care	  products	  used	  in	  the	  study	  
	   Clear	  Care	   OPTI-­‐FREE	  RepleniSH	  
Disinfectant	  	   Hydrogen	  peroxide	  (3%)	   ALDOX	  (0.0005%)	  
PolyQuad	  (0.001%)	  
Components	   Sodium	  chloride	  (0.79%)	  
Phosphonic	  acid	  
Pluronic	  17R4	  	  
TearGlyde-­‐	  Tetronic	  1304	  
and	  C9-­‐ED3A	  
Buffer	   Phosphate	   Sodium	  citrate	  
	  
SA	   lenses	   (n=20)	   and	   LB	   lenses	   (n=20,	   including	  13	   spherical	   and	  7	  multifocal	   designs)	  were	   collected	  
from	  study	  participants	  after	  being	  worn	  for	  two	  or	  four	  weeks	  respectively.	  The	  lenses	  were	  collected	  
ad	  hoc	  from	  participants	  involved	  in	  one	  of	  two	  ongoing	  studies	  at	  the	  Centre	  for	  Contact	  Lens	  Research	  
(CCLR)	  and	  from	  volunteers	  at	  the	  School	  of	  Optometry	  and	  Vision	  Science.	  Details	  of	  the	  subjects	  are	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described	   in	  Table	  6-­‐2.	  Lenses	  were	  removed	  by	   the	  participant	  at	   the	  end	  of	   the	  wearing	  period	  and	  
placed	  in	  empty	  plastic	  vials	  (6mL,	  VWR,	  Mississauga,	  ON).	  	  
	  
Table	  2:	  Study	  participant	  details	  	  
	  
	   Age	   Rx	   Cleaning	  Solution	  
Senofilcon	  A	   19	   OD:	  -­‐4.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐4.25	   Clear	  Care	  
lens-­‐wearers	   19	   OD:	  +4.75	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐1.50	   Clear	  Care	  
	   20	   OD:	  -­‐1.00	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐1.50	   OPTI-­‐FREE	  RepleniSH	  
	   20	   OD:	  -­‐4.75	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐4.50	   Clear	  Care	  
	   21	   OD:	  -­‐4.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.75	   Clear	  Care	  
	   22	   OD:	  -­‐3.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.00	   Clear	  Care	  
	   22	   OD:	  -­‐3.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.25	   OPTI-­‐FREE	  RepleniSH	  
	   23	   OD:	  -­‐3.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐4.25	   Clear	  Care	  
	   23	   OD:	  -­‐6.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐7.50	   OPTI-­‐FREE	  RepleniSH	  
	   25	   OD:	  -­‐2.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.00	   OPTI-­‐FREE	  RepleniSH	  
	   25	   OD:	  -­‐2.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐2.50	   OPTI-­‐FREE	  RepleniSH	  
	   25	   OD:	  -­‐4.75	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐4.25	   Clear	  Care	  
	   27	   OD:	  -­‐1.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐1.50	   Clear	  Care	  
	   27	   OD:	  -­‐4.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐5.75	   Clear	  Care	  
	   28	   OD:	  -­‐5.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐5.00	   Clear	  Care	  
	   32	   OD:	  -­‐2.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐2.00	   Clear	  Care	  
	   36	   OD:	  -­‐3.00	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐2.75	   OPTI-­‐FREE	  RepleniSH	  
	   40	   OD:	  -­‐2.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  2.75	   OPTI-­‐FREE	  RepleniSH	  
	   49	   OD:	  -­‐3.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.50	   OPTI-­‐FREE	  RepleniSH	  
	   50	   OD:	  -­‐3.75	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.75	   OPTI-­‐FREE	  RepleniSH	  
Lotrafilcon	  B	   8	   OD:	  -­‐1.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐1.50	   Clear	  Care	  
lens-­‐wearers	   10	   OD:	  -­‐1.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐1.75	   Clear	  Care	  
	   10	   OD:	  -­‐1.75M	  	  	  	  	  	  	  	  OS:	  -­‐1.50M	   Clear	  Care	  
	   10	   OD:	  -­‐2.25M	  	  	  	  	  	  	  	  OS:	  -­‐3.75M	   Clear	  Care	  
	   10	   OD:	  -­‐3.00M	  	  	  	  	  	  	  	  OS:	  -­‐3.00M	   Clear	  Care	  
	   10	   OD:	  -­‐3.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.25	   Clear	  Care	  
	   10	   OD:	  -­‐3.25M	  	  	  	  	  	  	  	  OS:	  -­‐3.25M	   Clear	  Care	  
	   14	   OD:	  -­‐1.50M	  	  	  	  	  	  	  	  OS:	  -­‐2.00M	   Clear	  Care	  
	   15	   OD:	  -­‐0.75M	  	  	  	  	  	  	  	  OS:	  -­‐0.75M	   Clear	  Care	  
	   15	   OD:	  -­‐1.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐1.75	   Clear	  Care	  
	   15	   OD:	  -­‐2.00	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.00	   Clear	  Care	  
	   16	   OD:	  -­‐2.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐1.75	   Clear	  Care	  
	   16	   OD:	  -­‐3.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.50	   Clear	  Care	  
	   16	   OD:	  -­‐5.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐4.25	   Clear	  Care	  
	   18	   OD:	  -­‐1.75	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐1.50	   Clear	  Care	  
	   22	   OD:	  -­‐2.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐2.25	   Clear	  Care	  
	   23	   OD:	  -­‐3.00	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.00	   Clear	  Care	  
	   24	   OD:	  -­‐3.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐3.50	   Clear	  Care	  
	   24	   OD:	  -­‐6.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐7.25	   Clear	  Care	  
	   27	   OD:	  -­‐2.25	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐2.25	   Clear	  Care	  
	   27	   OD:	  -­‐2.50	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐2.25	   Clear	  Care	  
	   27	   OD:	  -­‐5.00	  	  	  	  	  	  	  	  	  	  	  	  OS:	  -­‐4.00	   Clear	  Care	  
	   49	   OD:	  -­‐5.25M	  	  	  	  	  	  	  	  OS:	  -­‐3.50M	   Clear	  Care	  
M=	  multifocal	  design	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Two	   different	   solutions	   were	   used	   to	   extract	   the	   proteins	   from	   the	   lenses:	   Solution	   A	   containing	  
acetonitrile/0.02%	   trifluoroacetic	   acid	   was	   used	   for	   SA	   lenses,	   and	   Solution	   B,	   containing	  
acetonitrile/0.2%	   trifluoroacetic	   acid	   was	   used	   for	   LB	   lenses.	   The	   lower	   concentration	   is	   used	   for	   SA	  
lenses	  as	  these	  lenses	  disintegrate	  when	  0.2%	  solution	  is	  used	  (in-­‐house	  data).	  This	  does	  not	  occur	  for	  LB	  
lenses.	   Previous	   work	   has	   shown	   that	   both	   extraction	   methods	   are	   suitable	   to	   ensure	   adequate	  
extraction	  of	  the	  deposited	  protein	  [24,25].	  Details	  are	  seen	  in	  Table	  6-­‐3.	  	  
	  
Table	  3:	  Composition	  of	  the	  extraction	  solutions	  	  
	  
Components	   Solution	  A	   Solution	  B	  
CH3CN*	   250	  mL	   250	  mL	  
CF3CO2H+	   50	  μL	   500	  μL	  	  
H2O	  	   250	  mL	   249.5	  mL	  
CH3CN	  (acetonitrile),	  CF3CO2H	  (trifluoroacetic	  acid),	  H2O	  (Milli-­‐Q	  gradient)	  
*EMD	  Chemicals	  Inc.,	  Gibbstown,	  NJ,	  +	  Caledon	  Laboratories	  LTD.,	  Georgetown,	  ON	  
	  
Both	  solutions	  were	  prepared	  prior	   to	  use.	   Lenses	  were	  placed	   individually	   in	  1.5mL	  of	   the	   respective	  
extraction	  solution	  and	  kept	  in	  the	  dark	  at	  room	  temperature	  for	  24±1	  hours.	  Aliquots	  of	  650μL,	  275μL,	  
and	  375μL	  were	  taken	  to	  measure	  total	  protein,	  total	  lysozyme,	  and	  total	  active	  lysozyme,	  respectively.	  
All	   aliquots	   were	   dried	   down	   using	   the	   Savant	   SpeedVac	   apparatus	   (Halbrook,	   NY)	   and	   the	   protein	  
pellets	  were	  stored	  at	  -­‐80°C.	  
	  
Measurement	  of	  Total	  Protein	  	  
	  
A	  Bradford	  assay	  was	  performed	  to	  determine	  the	  amount	  of	  total	  protein	  deposited	  on	  each	  lens	  (μg),	  
as	  previously	  described	  [26,27].	  	  
	  
Measurement	  of	  Total	  Lysozyme	  
	  
An	  enzyme-­‐linked	   immunosorbent	  assay	   (ELISA)	  was	  used	   to	  determine	   the	   total	  amount	  of	   lysozyme	  
deposited	   on	   each	   lens.	   The	   protocol	   outlined	   on	   the	   ELISA	   kit	   (CALBIOTECH,	   San	   Diego,	   FL)	   was	  
followed,	  as	  described	  below.	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Standards,	  controls,	  and	  samples	  were	  pipetted	  (25μL)	  into	  a	  96-­‐well	  plate	  and	  100μL	  of	  anti-­‐lysozyme	  
enzyme	   conjugate	   solution	  was	   added	   to	   all	  wells.	   The	  plate	  was	   incubated	  and	  placed	  on	  a	   rotatory	  
shaker	   (VWR,	   Mississauga,	   ON)	   at	   10	   rpm	   for	   60	   min.	   After	   the	   incubation	   period,	   the	   wells	   were	  
emptied	  and	  washed	  3x	  with	  300μL	  of	  1x	  wash	  buffer.	  The	  plate	  was	  blotted	  on	  absorbent	  paper	  and	  
100μL	  of	  3,3ʹ′,5,5ʹ′-­‐tetramethylbenzidine	  (TMB)	  substrate	  solution	  was	  added	  to	  all	  wells.	  The	  plate	  was	  
once	  again	   incubated	   for	  15	  min	  at	   room	  temperature.	  Finally,	  50μL	  of	  stop	  solution	  was	  added	  to	  all	  
wells	   and	   the	   plate	   was	   gently	   mixed	   for	   15-­‐20	   sec.	   Samples	   were	   read	   immediately	   after	   in	   the	  
SpectraMax	  M5	  Multi-­‐Mode	  Microplate	  Reader	  (Molecular	  Devices,	  Sunnyvale,	  CA)	  at	  450	  nm.	  	  
	  
Measurement	  of	  Total	  Active	  Lysozyme	  
	  
Lysozyme	  activity	  of	  the	  lens	  extracts	  was	  determined	  using	  a	  micrococcal	  assay,	  as	  previously	  described	  
[28-­‐30].	  Micrococcus	  lysodeikticus	  bacteria	  were	  prepared	  at	  a	  concentration	  of	  1	  mg	  per	  1	  mL	  of	  50	  mM	  
phosphate	  buffer	  (pH	  6.3)	  and	  then	  further	  diluted	  with	  this	  buffer	  to	  an	  optical	  density	  of	  about	  1.1	  at	  
450	  nm	  using	  the	  Multiskan	  Spectrum	  ELISA	  Plate	  Reader	   (Thermo	  Labsystems).	  10	  μL	  of	   tear	  dilution	  
buffer	  (pH	  8.0,	  containing	  Tris,	  0.9%	  NaCl,	  and	  EDTA)	  was	  added	  to	  the	  lens	  extracts	  and	  the	  activity	  of	  
lysozyme	  was	  determined	  over	  4	  min	  reads	  at	  30°C.	  	  
	  
The	  percentage	  of	  active	   lysozyme	  deposited	  on	  the	   lens	  was	  calculated	   (total	  active	   lysozyme	  ÷	   total	  




Total	  Protein	  Deposition	  	  
	  
All	  LB	  lenses	  were	  cleaned	  with	  Clear	  Care.	  There	  was	  no	  significance	  difference	  between	  the	  amounts	  
of	   protein	   deposited	   on	   single	   vision	   LB	   spherical	   compared	   to	  multifocal	   LB	   lenses	   (p>0.05).	   For	   this	  
reason	  data	  from	  both	  LB	  lens	  types	  were	  combined.	  Likewise,	  similar	  amounts	  of	  protein	  were	  detected	  
on	   SA	   lenses,	   independent	   of	   whether	   they	   were	   cleaned	   with	   OPTI-­‐FREE	   RepleniSH	   or	   Clear	   Care	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(p>0.05),	  which	  also	  permitted	  combining	  both	  groups.	  Statistically,	  significantly	  more	  protein	  deposited	  
on	  LB	  lenses	  compared	  to	  SA	  lenses	  (9.23±1.60	  vs.	  8.23±1.23μg/lens;	  p=0.03),	  as	  seen	  in	  Figure	  6-­‐1.	  	  
	  
Figure	  1:	  Total	  amount	  of	  protein	  (μg)	  deposited	  on	  senofilcon	  A	  and	  lotrafilcon	  B	  lenses	  
	  
Total	  Lysozyme	  Deposition	  
	  
Greater	  amounts	  of	  lysozyme	  accumulated	  on	  SA	  lenses	  compared	  to	  LB	  lenses	  (0.025	  ±	  0.013	  vs.	  0.012	  
±	  0.009	  μg/lens).	  When	  investigating	  the	  impact	  of	  the	  different	  care	  regimens	  used	  by	  SA	  lens-­‐wearers,	  
there	  was	  no	  significant	  difference	  between	  the	  amounts	  of	  total	  lysozyme	  deposited	  on	  the	  lenses.	  	  
	  
Total	  Active	  Lysozyme	  Deposition	  	  
	  
The	  amount	  of	  active	   lysozyme	  deposited	  on	  SA	  and	  LB	  was	  similar	  for	   lenses	  cleaned	  with	  Clear	  Care	  






























Total	  Protein	  Deposited	  on	  Ex	  Vivo	  Silicone	  Hydrogel	  Lenses	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lysozyme	  on	  SA	  lenses	  that	  were	  cleaned	  with	  OPTI-­‐FREE	  RepleniSH	  than	  those	  cleaned	  with	  Clear	  Care	  




The	  different	  aliquots	   taken	   from	  the	   lens	  extraction	  were	  stored	  at	   -­‐80°C	   for	  analysis	  at	  a	   later	  date,	  
with	   an	   exception	   for	   total	   protein,	   which	  was	   analysed	   immediately.	   The	   effect	   of	   freezing	   on	   total	  
lysozyme	   and	   total	   active	   lysozyme	   was	   determined	   at	   1	   and	   3	  months,	   as	   total	   lysozyme	   and	   total	  
active	  lysozyme	  were	  frozen	  between	  2	  and	  3	  months.	  
	  
Freezing	   had	   a	   significant	   impact	   on	   lysozyme	   activity.	   For	   SA	   lenses,	   the	   amount	   of	   active	   lysozyme	  
determined	  after	  one	  month	  was	  4.68μg,	  which	  decreased	  by	  27%	  to	  3.40μg	  after	   three	  months.	  The	  
decrease	   in	   lysozyme	   activity	   was	   even	  more	   apparent	   for	   LB	   lenses	   (54%),	   with	   1.55μg	   and	   0.72μg	  




One	  major	  drawback	  of	  this	  ex	  vivo	  study	  is	  that	  the	  patient	  populations	  for	  the	  two	  lens	  materials	  were	  
different,	   as	   these	   lenses	  were	   collected	  opportunistically	   from	   two	  ongoing	   studies	   in	   the	  CCLR.	   The	  
results	  must	  be	  considered	  in	  this	  context.	  	  
	  
Previous	   studies	   have	   determined	   that	   the	   amount	   of	   total	   protein	   depositing	   on	   worn	   LB	   lenses	   is	  
between	  6.6	  μg	  and	  12.1	  μg	  [31-­‐33],	  which	  is	  similar	  to	  our	  current	  findings	  of	  9.23	  μg.	  The	  amount	  of	  
total	  protein	  detected	  on	  worn	  SA	   lenses	   is	   typically	   slightly	   lower	   compared	   to	   LB	   lenses,	   estimating	  
between	  6.6	  μg	  and	  8.3	  μg	  per	   lens	  [28,34,35].	  This	   is	  again	   in	  agreement	  with	  our	  data	  of	  8.23	  μg.	  In	  
order	   to	   improve	   the	   wettability	   of	   these	   materials,	   SA	   lenses	   contain	   the	   wetting	   agent	   polyvinyl	  
pyrrolidone	   (PVP),	   whereas	   LB	   lenses	   undergo	   a	   surface	  modification	   to	   create	   a	   hydrophilic	   plasma	  
coating.	  This	  may	  account	   for	  some	  of	   the	  differences	   in	  deposition	  between	  the	  materials.	  While	   the	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results	  were	   statistically	   significant,	   the	   clinical	   significance	  of	   such	   a	   small	   difference	   is	   very	   dubious	  
and	  it	  is	  unlikely	  that	  such	  a	  small	  difference	  is	  truly	  that	  relevant.	  	  
	  
Lysozyme	  is	  one	  of	  the	  most	  prevalent	  tear	  film	  proteins,	  accounting	  for	  approximately	  1.9	  mg/mL	  [36]	  
and	  numerous	  studies	  have	  shown	  that	  lysozyme	  deposition	  can	  be	  found	  on	  all	  types	  of	  contact	  lenses.	  
Worn	   senofilcon	   A	   lenses	   accumulate	   between	   0.9	   μg	   [31]	   and	   1.6	   μg	   [28,34]	   of	   lysozyme,	   which	   is	  
similar	  to	  the	  amount	  determined	  for	  lotrafilcon	  B	  lenses,	  which	  report	  between	  0.3	  μg	  [28]	  and	  1.4	  μg	  
[31]	  per	  lens.	  The	  current	  study	  data	  suggest	  a	  lower	  lysozyme	  content	  of	  0.025	  μg	  and	  0.012	  for	  SA	  and	  
LB	  lenses	  respectively;	  however,	  these	  data	  are	  incomparable	  to	  previous	  studies.	  	  Likewise,	  the	  amount	  
of	  active	  lysozyme	  was	  found	  to	  be	  exceptionally	  low;	  0.035	  μg	  and	  0.075	  μg	  for	  SA	  lenses	  cleaned	  with	  
Clear	  Care	  and	  OPTI-­‐FREE	  RepleniSH,	  respectively,	  and	  0.055	  μg	  for	  LB	   lenses	  cleaned	  with	  Clear	  Care.	  
Because	   the	   contact	   lens	   samples	   were	   frozen	   after	   collection,	   protein	   underwent	   conformational	  
changes,	  thereby	  decreasing	  the	  mass	  of	  detected	  lysozyme	  when	  using	  an	  ELISA	  method.	  The	  detected	  
mass	  of	  total	  lysozyme	  and	  active	  lysozyme	  for	  both	  SA	  and	  LB	  lenses	  was	  significantly	  less	  than	  that	  of	  
previous	   studies,	   as	   samples	  were	   exposed	   to	   a	   thermally	   stressful	   environment.	   Even	   though	   direct	  
comparison	   to	  previous	   studies	   cannot	  be	  made	  due	   to	  a	   change	   in	  environment	   for	   the	  protein,	   the	  
exposure	   of	   lysozyme	   to	   thermal	   stress	   provides	   researchers	   with	   an	   understanding	   of	   what	   effects	  
temperature	  have	  on	  protein.	  
	  
Karlsson	  and	  colleagues	  established	  that	  the	  Western	  Blotting	  (WB)	  technique	  is	  more	  sensitive	  than	  the	  
ELISA	  in	  quantifying	  total	  lysozyme	  [37].	  This	  study	  determined	  total	  lysozyme	  deposited	  on	  lenses	  using	  
the	   ELISA	   method.	   WB	   involves	   a	   fundamental	   step-­‐	   electrophoresis.	   This	   process	   denatures	   and	  
linearizes	  proteins	  thereby	  allowing	  inactive	  lysozyme	  to	  be	  detected.	  The	  detection	  range	  for	  the	  WB	  is	  
within	   nanograms;	   however,	   the	   ELISA	   is	   capable	   of	   ascertaining	   levels	   among	   the	   picogram	   range.	  
Albeit	  lacking	  sensitivity,	  ELISA	  is	  less	  time	  consuming	  and	  significantly	  more	  efficient	  considering	  it	  can	  
read	  96	  samples	  at	  one	  time.	  The	  sensitivity	  of	  the	  lysozyme	  ELISA	  is	  0.021	  ng/mL;	  however,	  denatured	  
protein	  is	  not	  detected	  because	  protein	  is	  not	  linearized	  during	  the	  procedure.	  	  
	  
The	   impact	  of	   contact	   lens	  cleaning	   solutions	  on	  protein	  deposition	  and	   lysozyme	  activity	  was	   further	  
investigated	   in	   this	   study.	   A	   minor	   effect	   of	   the	   care	   regimen	   was	   seen	   on	   lysozyme	   confirmation	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extracted	  from	  SA	  materials,	   indicating	  slightly	  higher	  amounts	  of	  active	   lysozyme	  on	  lenses	  that	  were	  
cleaned	  with	  Opti-­‐FREE	  RepleniSH	  compared	  to	  Clear	  Care	  [28].	  In	  a	  previous	  study,	  Zhao	  and	  colleagues	  
found	  that	  after	  30	  days	  of	  LB	  lens	  wear,	  lenses	  accumulated	  less	  protein	  when	  cleaned	  with	  Clear	  Care	  
(0.5μg)	  compared	  to	  Opti-­‐FREE	  RepleniSH	  (1.7μg)	  [18].	  The	  authors	  further	  report	  a	  similar	  pattern	  for	  
SA	  lenses	  that	  were	  worn	  for	  two	  weeks,	  suggesting	  that	  Clear	  Care	  is	  more	  efficient	  in	  removing	  protein	  
from	   the	   lenses	   than	   Opti-­‐FREE	   RepleniSH	   [18].	   Furthermore,	   an	   in	   vitro	   study	   undertaken	   by	  
Luensmann	  and	  colleagues,	   found	  that	  7.2%	  of	   lysozyme	  deposited	  on	  LB	   lenses	  could	  be	  removed	  by	  
Clear	  Care,	  compared	  to	  <4%	  when	  using	  a	  MPS	  system	  [22].	  	  
	  
The	   decrease	   in	   active	   lysozyme	   has	   been	   confirmed	   in	   an	   in-­‐house	   study	   determining	   the	   effect	   of	  
freezing	  on	  total	  lysozyme	  deposited	  on	  SA	  and	  balafilcon	  A	  (BA)	  lenses.	  It	  was	  shown	  that	  the	  activity	  of	  
lysozyme	  decreased	  within	  a	  week	  of	   storage	   in	   a	   freezer.	   Tothova	  and	   colleagues,	   in	   a	   recent	   study,	  
determined	  that	  there	  is	  an	  effect	  of	  freezing	  on	  serum	  amyloid	  A	  (SAA)	  samples	  [38].	  SAA	  are	  a	  part	  of	  
the	  apolipoprotein	  family	  and	  are	  associated	  with	  the	  high-­‐density	  lipoproteins	  of	  the	  blood	  plasma.	  The	  
researchers	  presented	  a	   trend	  showing	  a	  decrease	   in	  SAA	  concentrations	  over-­‐time,	  with	  a	   significant	  
decrease	  just	  after	  2	  days	  of	  storage;	  the	  initial	  concentration	  of	  SAA	  is	  30.30	  μg/mL	  and	  by	  the	  end	  of	  3	  
weeks,	  there	  was	  just	  13.94	  μg/mL,	  reflecting	  a	  >50%	  drop	  in	  concentration	  [38].	  There	  is	  a	  clear	  effect	  
on	  proteins	  when	  they	  are	  stored	  in	  the	  freezer	  for	  long	  periods	  of	  time,	  which	  may	  be	  due	  to	  protein	  
degradation	  [38].	  Lysozyme,	  on	  the	  contrary,	  is	  an	  enzyme	  and	  does	  not	  present	  with	  a	  similar	  structure	  
as	  SAA;	  however,	  a	  trend	  in	  denaturation	  is	  proven	  from	  this	  experiment.	  A	  way	  to	  protect	  the	  lysozyme	  
from	  denaturation	   is	  by	  adding	  stabilizing	  agents,	   such	  as	  BioStabTM,	  before	   the	   lysozyme	  aliquots	  are	  
dried	  down	  and	  further	  frozen	  for	  storage.	  Work	  to	  further	  examine	  this	  would	  be	  worthwhile.	  	  
	  
In	   conclusion,	   this	   study	   confirms	   that	   LB	   lenses	   accumulated	   greater	   amounts	   of	   protein	   compared	  
than	   SA	   lenses,	   but	   these	   differences	   were	   likely	   clinically	   irrelevant.	   SA	   lenses	   accumulated	   similar	  
amounts	   of	   total	   protein	   independent	   of	   whether	   lenses	   were	   cleaned	   with	   OPTI-­‐FREE	   RepleniSH	   or	  
Clear	   Care.	   Freezing	   the	   extracted	   protein	   samples	   up	   to	   3	   months	   had	   a	   significant	   effect	   on	   the	  
amount	   of	   active	   lysozyme	   detected,	   with	   significantly	   lower	   amounts	   found	   with	   longer	   freezing	  
periods.	  This	  highlights	   the	   importance	  of	   immediate	  data	  collection	  or	   the	  potential	  use	  of	  stabilizing	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